// Auto-generated by scripts/generate-verified-claims.js on 2025-10-29T07:40:51.462Z
// Do not edit by hand. Re-run the script with updated inputs.

export const MOCK_SIMILAR_PAPERS_LIBRARY = {
  "version": 2,
  "defaultEntryId": "an-open-science-study-of-ageing-in-companion-dog",
  "entries": [
    {
      "id": "an-open-science-study-of-ageing-in-companion-dog",
      "sourcePdf": {
        "path": "An open science study of ageing in companion dogs.pdf",
        "publicPath": "/mock-papers/an-open-science-study-of-ageing-in-companion-dog.pdf",
        "title": "An open science study of ageing in companion dogs",
        "originalFileName": "An open science study of ageing in companion dogs.pdf",
        "doi": "10.1038/s41586-021-04282-9",
        "pages": 15
      },
      "label": "An open science study of ageing in companion dogs",
      "generatedAt": "2025-10-29T06:01:55.852Z",
      "claimsAnalysis": {
        "text": "# Executive Summary This paper is a design and protocol description for the Dog Aging Project (DAP), not a results paper. Its core claims concern the scale, structure, and planned analyses of an open, longitudinal study of ageing in companion dogs, including a randomised clinical trial of rapamycin. Headline numbers: more than 30,000 canine participants and owners engaged; at least 10,000 dogs slated for low-pass whole-genome sequencing; Precision cohort n=1,000; TRIAD cohort n=350; participation currently across all 50 US states. Overall evidence strength: High for the existence and scope of the platform; Moderate for multi-omic biomarker discovery plans; Low for rapamycin efficacy claims pending results. Sources: Abstract; Design of the DAP (p.2-5); Fig. 1-3 (pp.12-14); Table 1 (p.15); Key outcomes (p.6); Data and sample release (p.7).  # Top 3 Claims and Evidence  ## C1. The DAP is a large-scale, open-data, long-term longitudinal study of ageing in tens of thousands of companion dogs, designed to identify genetic, environmental and lifestyle determinants of healthy lifespan. **Evidence summary:** Protocol paper describing an open-data, community science platform capturing survey, veterinary records, biospecimens, and environmental measures, with annual updates and public data release. Multi-cohort design: Pack, Foundation, Precision, TRIAD, and Centenarian cohorts; nationwide US enrolment; structured owner consent and data governance; REDCap-based data capture; biobanking. Evidence type: observational platform description.   **Key numbers:** \"tens of thousands\" of dogs (Abstract); \"more than 100\" team members across \"more than 20\" institutions and \"over 30,000 canine participants and their owners\" (p.2); annual data and biospecimen collection (p.2); Pack membership persists for a dog's lifetime unless withdrawn (p.3); all 50 US states represented (Fig. 1b, p.12).   **Source location:** Abstract; Design of the DAP (p.2-4); Fig. 1a-c (p.12); Data and sample release (p.7).   **Strength:** High, as this is a factual description of an established platform with specific enrolment, cohorts, and data-release commitments.   **Assumptions/conditions:** None beyond what is stated.  ## C2. The project will generate large-scale genetic, multi-omic, and environmental datasets to identify determinants and biomarkers of canine ageing and build systems biology models. **Evidence summary:** Planned low-coverage whole-genome sequencing with imputation for at least 10,000 dogs, annual metabolome, epigenome, and microbiome profiling in Precision and TRIAD cohorts, and linkage to tract-level environmental exposures; explicit goal to develop predictive and prognostic biomarkers and a systems biology model. Evidence type: planned analyses and active processing; protocol-level commitments.   **Key numbers:** \"at least 10,000\" dogs for low-pass WGS (p.3); Precision n=1,000 and TRIAD n=350 for multi-omic sampling (Fig. 3a, p.14; Table 1, p.15); environmental variables include O3, CO, SO2, NO2, PM10, PM2.5, temperature, precipitation, walkability, neighbourhood sociodemographics (p.5). \"Processing of the first year of omic samples for Precision and TRIAD dog samples will be completed during 2022\" (p.6).   **Source location:** Scientific aims (p.3); Fig. 3a-b (p.14); Table 1 (p.15); Key outcomes (p.6).   **Strength:** Moderate, as data generation is substantial and underway, but biomarker performance and causal inferences are not yet reported.   **Assumptions/conditions:** Biomarker validity contingent on subsequent analyses and lifespan follow-up, as noted by authors (p.6).  ## C3. The DAP includes TRIAD, a randomised, double-masked, placebo-controlled clinical trial to test whether weekly low-dose rapamycin for one year increases lifespan and healthspan in middle-aged, large-breed dogs. **Evidence summary:** Trial protocol embedded within DAP; biannual sampling and cardiac evaluations at veterinary teaching hospitals; endpoints include lifespan, cardiac and cognitive function, and age-related disease incidence. Evidence type: trial design description; enrolment timeline provided; no results reported.   **Key numbers:** TRIAD cohort n=350 (Fig. 3a, p.14); \"one-year course of weekly low-dose rapamycin\" (p.6); enrolment began June 2021 and continued through 2022 (p.6) [day not stated]; double-masked, placebo-controlled design (p.3-4); cardiac exam, echocardiogram, ECG, blood pressure listed (Table 1, p.15).   **Source location:** Scientific aims (p.3-4); Key outcomes (p.6); Table 1 (p.15); Fig. 3a (p.14).   **Strength:** Low, pending trial results; design is appropriate but efficacy is unproven in this paper.   **Assumptions/conditions:** None beyond protocol details.  # Gaps & Limitations (linked to C1-C3) - **Selection bias in sampled cohorts (C1-C2):** Eligibility for deeper cohorts requires qualifying veterinary medical records, potentially biasing towards dogs with regular care (p.3).   - **Generalisability (C1-C2):** Participation limited to the USA at present (p.3), which may constrain environmental and demographic diversity relative to global dog populations.   - **Owner-reported data quality (C1-C2):** HLES relies on owner reports; although age certainty is captured and some reproducibility testing is noted, quantitative reliability metrics are not reported here [DETAIL NEEDED] (p.4).   - **Statistical plans and power (C2-C3):** No power calculations, statistical analysis plans, or pre-specified biomarker performance thresholds reported in this text [DETAIL NEEDED].   - **TRIAD outcomes not yet available (C3):** Efficacy claims for rapamycin remain hypothetical; only design and timelines are provided (p.6).   - **OCR artefacts:** Minor spacing and hyphenation anomalies observed; no numeric conflicts detected. Where day-level dates are absent, exact dates are [UNCLEAR].  # Methods Snapshot - **Design:** Interdisciplinary, open-data, community science platform; observational components include retrospective cross-sectional and prospective longitudinal data; embedded randomised, double-masked, placebo-controlled clinical trial (TRIAD) (p.2).   - **Cohorts:** Pack, Foundation, Precision, TRIAD, Centenarian; stratified sampling by size, sex, age, breed background, geography; random sampling within strata for deeper cohorts (p.3; Fig. 1a, p.12).   - **Data collection:** Annual HLES baseline and updates; additional surveys on cognition and end-of-life; veterinary electronic medical records; biospecimens in Precision and TRIAD including blood, urine, faeces, hair; accelerometry; cardiology assessments for TRIAD; cheek swab WGS in sampled cohorts (p.4; Table 1, p.15; Fig. 3a, p.14).   - **Environment linkage:** Neighbourhood sociodemographics, air pollution, climate, and walkability based on geocodes (p.5; Fig. 3b, p.14).   - **Data quality:** Documented pre- and post-analytical quality metrics, QC/QA for biospecimens, reproducible computational pipelines with versioning (p.4-5).   - **Open science:** Annual data and sample releases via Terra; DAP Biobank for qualified researchers (p.7).  # Risk-of-Bias/Quality Checklist - **Sampling frame:** Broad Pack enrolment; deeper cohorts require records, introducing potential care-access bias. Mitigation: stratified random sampling within designed strata (p.3).   - **Measurement:** Combination of owner-reported and veterinarian-recorded data; biospecimen QC/QA described; owner age-certainty captured (p.4-5).   - **Confounding:** Observational analyses will face environmental and lifestyle confounding; design acknowledges need for genetic and environmental modelling (p.3, p.5).   - **Outcome ascertainment:** Clinicopathology and multi-omics standardised; TRIAD cardiac measures specified (Table 1, p.15).   - **Randomisation/blinding:** TRIAD described as randomised, double-masked, placebo-controlled (p.3-4).   - **Data completeness/retention:** Engagement strategies outlined; quantitative retention and missingness metrics not reported here [DETAIL NEEDED] (p.3).   - **Transparency:** Open-data commitment, data-use agreement, and biobank access stated (p.7).  # Open Questions & Next Steps - **Biomarker validation:** What are the predefined accuracy thresholds and validation plans for predictive biomarkers against true lifespan within cohort follow-up [DETAIL NEEDED] (p.6)?   - **Causal inference:** How will the project integrate genetic instruments, longitudinal confounding control, or quasi-experiments to strengthen causal claims about environmental and lifestyle factors [DETAIL NEEDED] (p.3, p.5)?   - **TRIAD endpoints and power:** What is the statistical analysis plan, effect-size target, and power for lifespan and healthspan endpoints in TRIAD [DETAIL NEEDED] (p.6)?   - **Generalisation:** Plans for international expansion to capture broader environmental diversity and reduce geographic bias [DETAIL NEEDED] (p.3).   - **Data quality metrics:** Publication of reproducibility, missingness, and measurement error summaries for key owner-reported and veterinary-derived variables [DETAIL NEEDED] (p.4).  # QA - All required sections present.   - Numbers match the provided text exactly.   - C1-C3 each include a strength rating and precise source locations.   - Where statistics are not reported, marked as [DETAIL NEEDED] or [UNCLEAR] without inference.",
        "structured": {
          "executiveSummary": [
            "This paper is a design and protocol description for the Dog Aging Project (DAP), not a results paper.",
            "Headline numbers: more than 30,000 canine participants and owners engaged; at least 10,000 dogs slated for low-pass whole-genome sequencing; Precision cohort n=1,000; TRIAD cohort n=350; participation currently across all 50 US states.",
            "Overall evidence strength: High for the existence and scope of the platform; Moderate for multi-omic biomarker discovery plans; Low for rapamycin efficacy claims pending results."
          ],
          "claims": [
            {
              "id": "C1",
              "claim": "The DAP is a large-scale, open-data, long-term longitudinal study of ageing in tens of thousands of companion dogs, designed to identify genetic, environmental and lifestyle determinants of healthy lifespan.",
              "evidenceSummary": "Protocol paper describing an open-data, community science platform capturing survey, veterinary records, biospecimens, and environmental measures, with annual updates and public data release. Multi-cohort design: Pack, Foundation, Precision, TRIAD, and Centenarian cohorts; nationwide US enrolment; structured owner consent and data governance; REDCap-based data capture; biobanking.",
              "keyNumbers": [
                "\"tens of thousands\" of dogs (Abstract)",
                "\"more than 100\" team members across \"more than 20\" institutions and \"over 30,000 canine participants and their owners\" (p.2)",
                "annual data and biospecimen collection (p.2)",
                "Pack membership persists for a dog's lifetime unless withdrawn (p.3)",
                "all 50 US states represented (Fig. 1b, p.12)"
              ],
              "source": "Abstract; Design of the DAP (p.2-4); Fig. 1a-c (p.12); Data and sample release (p.7).",
              "strength": "High",
              "assumptions": "None beyond what is stated.",
              "evidenceType": "observational platform description"
            },
            {
              "id": "C2",
              "claim": "The project will generate large-scale genetic, multi-omic, and environmental datasets to identify determinants and biomarkers of canine ageing and build systems biology models.",
              "evidenceSummary": "Planned low-coverage whole-genome sequencing with imputation for at least 10,000 dogs, annual metabolome, epigenome, and microbiome profiling in Precision and TRIAD cohorts, and linkage to tract-level environmental exposures; explicit goal to develop predictive and prognostic biomarkers and a systems biology model.",
              "keyNumbers": [
                "\"at least 10,000\" dogs for low-pass WGS (p.3)",
                "Precision n=1,000 and TRIAD n=350 for multi-omic sampling (Fig. 3a, p.14; Table 1, p.15)",
                "environmental variables include O3, CO, SO2, NO2, PM10, PM2.5, temperature, precipitation, walkability, neighbourhood sociodemographics (p.5)",
                "\"Processing of the first year of omic samples for Precision and TRIAD dog samples will be completed during 2022\" (p.6)"
              ],
              "source": "Scientific aims (p.3); Fig. 3a-b (p.14); Table 1 (p.15); Key outcomes (p.6).",
              "strength": "Moderate",
              "assumptions": "Biomarker validity contingent on subsequent analyses and lifespan follow-up, as noted by authors (p.6).",
              "evidenceType": "planned analyses and active processing; protocol-level commitments"
            },
            {
              "id": "C3",
              "claim": "The DAP includes TRIAD, a randomised, double-masked, placebo-controlled clinical trial to test whether weekly low-dose rapamycin for one year increases lifespan and healthspan in middle-aged, large-breed dogs.",
              "evidenceSummary": "Trial protocol embedded within DAP; biannual sampling and cardiac evaluations at veterinary teaching hospitals; endpoints include lifespan, cardiac and cognitive function, and age-related disease incidence.",
              "keyNumbers": [
                "TRIAD cohort n=350 (Fig. 3a, p.14)",
                "\"one-year course of weekly low-dose rapamycin\" (p.6)",
                "enrolment began June 2021 and continued through 2022 (p.6) [day not stated]",
                "double-masked, placebo-controlled design (p.3-4)",
                "cardiac exam, echocardiogram, ECG, blood pressure listed (Table 1, p.15)"
              ],
              "source": "Scientific aims (p.3-4); Key outcomes (p.6); Table 1 (p.15); Fig. 3a (p.14).",
              "strength": "Low",
              "assumptions": "None beyond protocol details.",
              "evidenceType": "trial design description"
            }
          ],
          "gaps": [
            {
              "category": "Selection bias",
              "detail": "Eligibility for deeper cohorts requires qualifying veterinary medical records, potentially biasing towards dogs with regular care (p.3).",
              "relatedClaimIds": [
                "C1",
                "C2"
              ]
            },
            {
              "category": "Generalisability",
              "detail": "Participation limited to the USA at present (p.3), which may constrain environmental and demographic diversity relative to global dog populations.",
              "relatedClaimIds": [
                "C1",
                "C2"
              ]
            },
            {
              "category": "Measurement quality",
              "detail": "HLES relies on owner reports; although age certainty is captured and some reproducibility testing is noted, quantitative reliability metrics are not reported here [DETAIL NEEDED] (p.4).",
              "relatedClaimIds": [
                "C1",
                "C2"
              ]
            },
            {
              "category": "Statistical planning",
              "detail": "No power calculations, statistical analysis plans, or pre-specified biomarker performance thresholds reported in this text [DETAIL NEEDED].",
              "relatedClaimIds": [
                "C2",
                "C3"
              ]
            },
            {
              "category": "Unreported outcomes",
              "detail": "Efficacy claims for rapamycin remain hypothetical; only design and timelines are provided (p.6).",
              "relatedClaimIds": [
                "C3"
              ]
            },
            {
              "category": "Data integrity",
              "detail": "Minor OCR spacing and hyphenation anomalies; where day-level dates are absent, exact dates are [UNCLEAR].",
              "relatedClaimIds": [
                "C1",
                "C2",
                "C3"
              ]
            }
          ],
          "methodsSnapshot": [
            "Design: Interdisciplinary, open-data, community science platform; observational components include retrospective cross-sectional and prospective longitudinal data; embedded randomised, double-masked, placebo-controlled clinical trial (TRIAD) (p.2).",
            "Cohorts: Pack, Foundation, Precision, TRIAD, Centenarian; stratified sampling by size, sex, age, breed background, geography; random sampling within strata for deeper cohorts (p.3; Fig. 1a, p.12).",
            "Data collection: Annual HLES baseline and updates; additional surveys on cognition and end-of-life; veterinary electronic medical records; biospecimens in Precision and TRIAD including blood, urine, faeces, hair; accelerometry; cardiology assessments for TRIAD; cheek swab WGS in sampled cohorts (p.4; Table 1, p.15; Fig. 3a, p.14).",
            "Environment linkage: Neighbourhood sociodemographics, air pollution, climate, and walkability based on geocodes (p.5; Fig. 3b, p.14).",
            "Data quality: Documented pre- and post-analytical quality metrics, QC/QA for biospecimens, reproducible computational pipelines with versioning (p.4-5).",
            "Open science: Annual data and sample releases via Terra; DAP Biobank for qualified researchers (p.7)."
          ],
          "riskChecklist": [
            {
              "item": "Sampling frame",
              "status": "partial",
              "note": "Broad Pack enrolment; deeper cohorts require records, introducing potential care-access bias; stratified random sampling used (p.3)."
            },
            {
              "item": "Measurement",
              "status": "partial",
              "note": "Owner-reported plus veterinarian-recorded data; biospecimen QC/QA described; owner age-certainty captured, but no quantitative reliability metrics reported (p.4-5)."
            },
            {
              "item": "Confounding",
              "status": "partial",
              "note": "Observational analyses subject to environmental and lifestyle confounding; plan acknowledges modelling needs (p.3, p.5)."
            },
            {
              "item": "Outcome ascertainment",
              "status": "partial",
              "note": "Standardised clinicopathology and multi-omics; specified TRIAD cardiac measures, but no completeness metrics yet (Table 1, p.15)."
            },
            {
              "item": "Randomisation/blinding",
              "status": "met",
              "note": "TRIAD is randomised, double-masked, placebo-controlled (p.3-4)."
            },
            {
              "item": "Data completeness/retention",
              "status": "missing",
              "note": "Engagement strategies described; no quantitative retention/missingness metrics reported [DETAIL NEEDED] (p.3)."
            },
            {
              "item": "Transparency",
              "status": "met",
              "note": "Open-data commitment via Terra and biobank access (p.7)."
            }
          ],
          "openQuestions": [
            "Biomarker validation: What are the predefined accuracy thresholds and validation plans for predictive biomarkers against true lifespan within cohort follow-up [DETAIL NEEDED] (p.6)?",
            "Causal inference: How will the project integrate genetic instruments, longitudinal confounding control, or quasi-experiments to strengthen causal claims about environmental and lifestyle factors [DETAIL NEEDED] (p.3, p.5)?",
            "TRIAD endpoints and power: What is the statistical analysis plan, effect-size target, and power for lifespan and healthspan endpoints in TRIAD [DETAIL NEEDED] (p.6)?",
            "Generalisation: Plans for international expansion to capture broader environmental diversity and reduce geographic bias [DETAIL NEEDED] (p.3).",
            "Data quality metrics: Publication of reproducibility, missingness, and measurement error summaries for key owner-reported and veterinary-derived variables [DETAIL NEEDED] (p.4)."
          ],
          "crossPaperComparison": []
        }
      },
      "createdAt": "2025-10-29T05:55:58.724Z",
      "updatedAt": "2025-10-29T07:40:51.459Z",
      "agent": {
        "maxChars": 9335,
        "promptNotes": "ETL only from provided analyst notes; no new sources added."
      },
      "sourcePaper": {
        "title": "An open science study of ageing in companion dogs",
        "summary": "Protocol for the Dog Aging Project, a large open longitudinal community-science platform with embedded randomized trial.",
        "keyMethodSignals": [
          "Multi-cohort design with Pack, Foundation, Precision, TRIAD, and Centenarian cohorts",
          "Annual owner surveys, veterinary EMRs, biospecimens, accelerometry, and data governance with biobanking",
          "Low-pass WGS with imputation for at least 10,000 dogs",
          "Annual metabolome, epigenome, and microbiome profiling in Precision and TRIAD",
          "Geocoded environmental linkage to tract-level exposures"
        ],
        "methodComparison": {
          "sample": "Community science platform with more than 30,000 pet dogs across all 50 US states and stratified sampling into deeper cohorts.",
          "materials": "Owner surveys including HLES, veterinary EMRs, biospecimens (blood, urine, faeces, hair), cheek-swab DNA, and accelerometry; biobanking with annual releases.",
          "equipment": "REDCap for data capture; veterinary clinics and teaching hospitals; echocardiogram, ECG, and blood pressure systems for TRIAD.",
          "procedure": "Prospective longitudinal follow-up with annual updates; low-pass WGS with imputation; multi-omic profiling in Precision and TRIAD; environmental exposure linkage; embedded RCT.",
          "outcomes": "Platform build and open data releases; discovery of genetic, environmental, and biomarker predictors of healthspan; TRIAD endpoints on lifespan, cardiac and cognitive function."
        }
      },
      "similarPapers": [
        {
          "identifier": "10.1371/journal.pone.0269425",
          "title": "Cohort profile: The Golden Retriever Lifetime Study",
          "authors": [
            "Labadie et al."
          ],
          "year": 2022,
          "venue": "PLOS ONE",
          "whyRelevant": "Large, prospective US companion-dog cohort with owner questionnaires, veterinary EMRs, scheduled clinic visits, and biospecimen biobanking. Mirrors DAP community-science infrastructure, sample handling, and access model.",
          "methodOverlap": [
            "Annual owner and veterinary questionnaires plus EMR capture",
            "Routine biobanking of blood, serum, hair, nails, faeces, urine",
            "Necropsy requests and tumour biobanking for outcome adjudication"
          ],
          "methodComparison": {
            "sample": "3,044 US Golden Retrievers enrolled at 6-24 months with long-term follow-up.",
            "materials": "Owner and veterinarian questionnaires, clinical records, multiple biospecimen types, and necropsy tissues.",
            "equipment": "Standard veterinary exam equipment and histopathology workflows.",
            "procedure": "Annual surveys and exams; scheduled biospecimen collection and storage under SOPs; data request pathway.",
            "outcomes": "Cohort established with retention and event tracking; data and samples available to researchers."
          },
          "gaps": "Breed-restricted cohort limits generalisability. Power calculations for biomarker discovery are not central. Environmental linkage appears less granular than tract-level.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1126/science.abk0639",
          "title": "Ancestry-inclusive dog genomics challenges popular breed stereotypes",
          "authors": [
            "Morrill et al."
          ],
          "year": 2022,
          "venue": "Science",
          "whyRelevant": "Open community-science cohort combining owner-reported phenotypes with low-pass whole-genome sequencing and imputation. Aligns with DAP low-pass WGS plan and survey linkage.",
          "methodOverlap": [
            "Low-pass sequencing with imputation using deep reference panel",
            "Owner-reported phenotypes at scale with explicit QC checks",
            "Combined array and low-pass data with post-imputation filtering"
          ],
          "methodComparison": {
            "sample": "Diverse pet-dog cohort including mixed breeds; sequencing selected by enrolment and survey completion.",
            "materials": "Owner surveys, saliva or blood DNA, low-pass WGS and genotyping arrays.",
            "equipment": "High-throughput sequencers, imputation software pipelines, standard GWAS toolchains.",
            "procedure": "Sequencing at about 0.6-1x coverage, imputation against high-coverage reference, QC on MAF, call rate, and HWE.",
            "outcomes": "Dense genome-wide variant sets enabling GWAS and ancestry inference with reported imputation accuracy."
          },
          "gaps": "Owner report bias persists. Environmental exposures were not systematically linked. Not a biospecimen-rich longitudinal protocol like DAP Precision or TRIAD.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1186/s12917-020-02730-8",
          "title": "Generation Pup: protocol for a longitudinal study of dog behaviour and health",
          "authors": [
            "Murray et al."
          ],
          "year": 2020,
          "venue": "BMC Veterinary Research",
          "whyRelevant": "Longitudinal UK community-science cohort with scheduled owner surveys, optional EMR access, and non-invasive biospecimens routed to a biobank. Mirrors DAP cohort and sample-handling design.",
          "methodOverlap": [
            "Owner consent covering questionnaires, EMRs, and biospecimens",
            "Home-collected faeces, urine, hair, buccal swabs with SOP kits",
            "EMR acquisition with scripted pipelines for free-text extraction"
          ],
          "methodComparison": {
            "sample": "Nationwide UK puppies with lifetime follow-up; self-selected owner enrolment.",
            "materials": "Repeated questionnaires, veterinary health cards, EMRs, biospecimen kits, and long-term storage via a biobank partner.",
            "equipment": "Routine veterinary instruments; laboratory processing at RVC then biobank storage.",
            "procedure": "Timed mailouts for samples at 12-16 weeks, 6 and 12 months, then annually; consent refresh; scripted data extraction.",
            "outcomes": "Established data flows, early retention and missingness metrics; plans for metabolomics and microbiome from stored samples."
          },
          "gaps": "Selection bias and retention challenges acknowledged. Fewer clinic-based assessments than TRIAD. Environmental linkage less granular than DAP.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1073/pnas.2120887119",
          "title": "DNA methylation clocks for dogs and humans",
          "authors": [
            "Horvath et al."
          ],
          "year": 2022,
          "venue": "PNAS",
          "whyRelevant": "Epigenome-based biomarker construction from dog blood with cross-species models and explicit assay details. Aligns with DAP epigenomic profiling and biomarker goals.",
          "methodOverlap": [
            "Blood-derived DNA methylation profiling to build ageing biomarkers",
            "Array-based cross-species design enabling translational models",
            "Associations with lifespan predictors for prognostic modelling"
          ],
          "methodComparison": {
            "sample": "Multi-breed dog blood samples curated for clock training and validation.",
            "materials": "Mammalian methylation array targeting conserved CpGs and bisulphite conversion reagents.",
            "equipment": "Array scanners, standard QC pipelines, and modelling in R.",
            "procedure": "Model development for dog and human-dog clocks with cross-validation and EWAS linking sites to traits.",
            "outcomes": "High-accuracy age estimators and loci linked to body-size-lifespan relationships."
          },
          "gaps": "Array coverage limits CpG breadth relative to WGS methylomes. Calibration to longitudinal health outcomes remains to be demonstrated.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1007/s11357-017-9972-z",
          "title": "A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs",
          "authors": [
            "Urfer et al."
          ],
          "year": 2017,
          "venue": "GeroScience",
          "whyRelevant": "RCT in client-owned dogs with masked allocation, owner-administered rapamycin, repeated clinical pathology and echocardiography. Direct methodological precursor to DAP TRIAD cardiac and safety endpoints.",
          "methodOverlap": [
            "Double-masked placebo-controlled dosing in client-owned dogs",
            "Baseline and follow-up echocardiography plus clinical pathology",
            "Structured adverse event capture and tolerability tracking"
          ],
          "methodComparison": {
            "sample": "Twenty-four middle-aged healthy dogs randomized to rapamycin or placebo for 10 weeks.",
            "materials": "Oral rapamycin at non-immunosuppressive doses, placebo, and standard imaging and blood consumables.",
            "equipment": "Echocardiography equipment and clinical haematology and chemistry analysers.",
            "procedure": "Baseline and week-11 echocardiograms, serial exams and labs, masked assessment, and standard analyses.",
            "outcomes": "Trends toward improved fractional shortening and E/A ratio with acceptable short-term safety."
          },
          "gaps": "Short duration and small sample limit power for mortality or long-term healthspan. No multi-omic sampling.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        }
      ],
      "authorContacts": {
        "maxChars": 2396,
        "truncated": false,
        "text": "Paper: An open science study of ageing in companion dogs (Source)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Kate E. Creevy | kcreevy@cvm.tamu.edu | Professor of Small Animal Internal Medicine, Texas A&M; Chief Veterinary Officer, Dog Aging Project | 0000-0002-5945-1519 |\n| The Dog Aging Project Consortium | Not found | Consortium author group | Not found |\n| Daniel E. L. Promislow | promislo@uw.edu | Professor, Department of Biology, University of Washington | 0000-0002-4740-3708 |\n\nPaper: Cohort profile: The Golden Retriever Lifetime Study\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Julia D. Labadie | jdlabadie@gmail.com | Researcher; affiliation listed in paper as Morris Animal Foundation, Denver, USA | 0000-0002-2472-429X |\n| Janet Patterson-Kane | Not found | Chief Scientific Officer, Morris Animal Foundation | 0000-0001-8212-6424 |\n\nPaper: Ancestry-inclusive dog genomics challenges popular breed stereotypes\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Kathleen Morrill | kathleen.morrill@umassmed.edu | Researcher, UMass Chan Medical School at time of publication | 0000-0003-3856-7558 |\n| Elinor K. Karlsson | elinor.karlsson@umassmed.edu | Professor, UMass Chan; Director, Vertebrate Genomics Group, Broad Institute | 0000-0002-8405-7285 |\n\nPaper: Generation Pup: protocol for a longitudinal study of dog behaviour and health\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Jane Katherine Murray | jane.murray@dogstrust.org.uk | Researcher, Dogs Trust | 0000-0002-8525-2877 |\n| Rachel Alison Casey | rachel.casey@dogstrust.org.uk | Director of Strategy and Transformation, Dogs Trust | 0000-0002-6559-9531 |\n\nPaper: DNA methylation clocks for dogs and humans\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Steve Horvath | Not found | Professor and epigenetic clock researcher | Not found |\n| Elaine A. Ostrander | Not found | Senior Investigator, NIH NHGRI | Not found |\n\nPaper: A randomised controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Silvan R. Urfer | Not found | Acting Assistant Professor, UW Department of Laboratory Medicine and Pathology | 0000-0002-3722-0731 |\n| Matt R. Kaeberlein | kaeber@uw.edu | Professor of Pathology, University of Washington | 0000-0002-1311-3421 |",
        "structured": {
          "papers": [
            {
              "title": "An open science study of ageing in companion dogs",
              "identifier": "Source",
              "authors": [
                {
                  "name": "Kate E. Creevy",
                  "email": "kcreevy@cvm.tamu.edu",
                  "role": "Professor of Small Animal Internal Medicine, Texas A&M; Chief Veterinary Officer, Dog Aging Project",
                  "orcid": "0000-0002-5945-1519",
                  "profiles": [
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/kate-creevy-97882833"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://dogagingproject.org/leadership/kate-creevy"
                    }
                  ]
                },
                {
                  "name": "The Dog Aging Project Consortium",
                  "email": null,
                  "role": "Consortium author group",
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Daniel E. L. Promislow",
                  "email": "promislo@uw.edu",
                  "role": "Professor, Department of Biology, University of Washington",
                  "orcid": "0000-0002-4740-3708",
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://promislowlab.org/people/"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Cohort profile: The Golden Retriever Lifetime Study",
              "identifier": null,
              "authors": [
                {
                  "name": "Julia D. Labadie",
                  "email": "jdlabadie@gmail.com",
                  "role": "Researcher; affiliation listed in paper as Morris Animal Foundation, Denver, USA",
                  "orcid": "0000-0002-2472-429X",
                  "profiles": []
                },
                {
                  "name": "Janet Patterson-Kane",
                  "email": null,
                  "role": "Chief Scientific Officer, Morris Animal Foundation",
                  "orcid": "0000-0001-8212-6424",
                  "profiles": [
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/janetpatterson-kane"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Ancestry-inclusive dog genomics challenges popular breed stereotypes",
              "identifier": null,
              "authors": [
                {
                  "name": "Kathleen Morrill",
                  "email": "kathleen.morrill@umassmed.edu",
                  "role": "Researcher, UMass Chan Medical School at time of publication",
                  "orcid": "0000-0003-3856-7558",
                  "profiles": []
                },
                {
                  "name": "Elinor K. Karlsson",
                  "email": "elinor.karlsson@umassmed.edu",
                  "role": "Professor, UMass Chan; Director, Vertebrate Genomics Group, Broad Institute",
                  "orcid": "0000-0002-8405-7285",
                  "profiles": [
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/elinorkarlsson"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://umassmed.edu/karlsson"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Generation Pup: protocol for a longitudinal study of dog behaviour and health",
              "identifier": null,
              "authors": [
                {
                  "name": "Jane Katherine Murray",
                  "email": "jane.murray@dogstrust.org.uk",
                  "role": "Researcher, Dogs Trust",
                  "orcid": "0000-0002-8525-2877",
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://generationpup.ac.uk/meet-the-team/"
                    }
                  ]
                },
                {
                  "name": "Rachel Alison Casey",
                  "email": "rachel.casey@dogstrust.org.uk",
                  "role": "Director of Strategy and Transformation, Dogs Trust",
                  "orcid": "0000-0002-6559-9531",
                  "profiles": []
                }
              ]
            },
            {
              "title": "DNA methylation clocks for dogs and humans",
              "identifier": null,
              "authors": [
                {
                  "name": "Steve Horvath",
                  "email": null,
                  "role": "Professor and epigenetic clock researcher",
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Elaine A. Ostrander",
                  "email": null,
                  "role": "Senior Investigator, NIH NHGRI",
                  "orcid": null,
                  "profiles": []
                }
              ]
            },
            {
              "title": "A randomised controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs",
              "identifier": null,
              "authors": [
                {
                  "name": "Silvan R. Urfer",
                  "email": null,
                  "role": "Acting Assistant Professor, UW Department of Laboratory Medicine and Pathology",
                  "orcid": "0000-0002-3722-0731",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=QhLw-4oAAAAJ"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://dlmp.uw.edu/faculty/urfer"
                    }
                  ]
                },
                {
                  "name": "Matt R. Kaeberlein",
                  "email": "kaeber@uw.edu",
                  "role": "Professor of Pathology, University of Washington",
                  "orcid": "0000-0002-1311-3421",
                  "profiles": []
                }
              ]
            }
          ],
          "promptNotes": ""
        }
      },
      "researcherTheses": {
        "maxChars": 6501,
        "truncated": false,
        "text": "Researcher: Kate E. Creevy\nEmail: kcreevy@cvm.tamu.edu\nData publicly available: yes\nLatest publication:\n  - Title: Dog size and patterns of disease history across the canine age spectrum: Results from the Dog Aging Project\n  - Year: 2024\n  - Venue: PLOS ONE\n  - URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0295840\nPhD thesis: Not found\n\nResearcher: The Dog Aging Project Consortium\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Dog size and patterns of disease history across the canine age spectrum: Results from the Dog Aging Project\n  - Year: 2024\n  - Venue: PLOS ONE\n  - URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0295840\nPhD thesis: Not found\n\nResearcher: Daniel E. L. Promislow\nEmail: promislo@uw.edu\nData publicly available: unknown\nLatest publication:\n  - Title: Rationale and design of the Dog Aging Project precision cohort: a multi-omic resource for longitudinal research in geroscience\n  - Year: 2025\n  - Venue: GeroScience\n  - URL: https://link.springer.com/article/10.1007/s11357-025-01571-3\nPhD thesis:\n  - Title: Mortality patterns in natural populations of mammals and their consequences\n  - Year: 1990\n  - Institution: University of Oxford\n  - URL: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.256377\n\nResearcher: Julia D. Labadie\nEmail: jdlabadie@gmail.com\nData publicly available: yes\nLatest publication:\n  - Title: A splice donor variant in SLAMF1 is associated with canine atopic dermatitis\n  - Year: 2025\n  - Venue: Frontiers in Veterinary Science\n  - URL: https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2025.1550617/full\nPhD thesis:\n  - Title: Using the dog as a model to investigate environmental and genetic risk factors for mature, antigen-driven lymphoproliferative disorders\n  - Year: 2017\n  - Institution: Colorado State University\n  - URL: https://mountainscholar.org/bitstream/handle/10217/184031/Labadie_colostate_0053A_14407.pdf?sequence=1\n\nResearcher: Janet Patterson-Kane\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Cohort profile: The Golden Retriever Lifetime Study (GRLS)\n  - Year: 2022\n  - Venue: PLOS ONE\n  - URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0269425\nPhD thesis:\n  - Title: The effect of exercise on the collagen fibril morphology of the digital flexor tendons of the Thoroughbred\n  - Year: 1996\n  - Institution: Massey University\n  - URL: https://mro.massey.ac.nz/bitstreams/ecaba6be-6e0a-4597-ad3c-0406c160ea80/download\n\nResearcher: Kathleen Morrill\nEmail: kathleen.morrill@umassmed.edu\nData publicly available: unknown\nLatest publication:\n  - Title: Comparative neurogenetics of dog behavior complements efforts towards human neuropsychiatric genetics\n  - Year: 2023\n  - Venue: Human Genetics\n  - URL: https://link.springer.com/content/pdf/10.1007/s00439-023-02580-y.pdf\nPhD thesis:\n  - Title: The Genomics of Canine Behavior and its Comparative Relevance to Human\n  - Year: 2023\n  - Institution: UMass Chan Medical School\n  - URL: https://repository.escholarship.umassmed.edu/entities/publication/f3de5270-26e1-4362-87d2-bf0c2e708910\n\nResearcher: Elinor K. Karlsson\nEmail: elinor.karlsson@umassmed.edu\nData publicly available: unknown\nLatest publication:\n  - Title: Evolutionary constraint and innovation across hundreds of placental mammals\n  - Year: 2023\n  - Venue: Science\n  - URL: https://www.science.org/doi/epdf/10.1126/science.abn3943\nPhD thesis: Not found\n\nResearcher: Steve Horvath\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Universal DNA methylation age across mammalian tissues\n  - Year: 2023\n  - Venue: Nature Aging\n  - URL: https://digitalcommons.unl.edu/animalscifacpub/1274/\nPhD thesis:\n  - Title: Gauge Symmetry in the Ramond-Ramond Sector of Superstring Theory\n  - Year: 1995\n  - Institution: University of North Carolina at Chapel Hill\n  - URL: Not found\n\nResearcher: Elaine A. Ostrander\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants\n  - Year: 2023\n  - Venue: Nature Genetics\n  - URL: https://www.nature.com/articles/s41588-023-01534-4.pdf\nPhD thesis: Not found\n\nResearcher: Silvan R. Urfer\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Lifetime prevalence of malignant and benign tumours in companion dogs: Cross-sectional analysis of Dog Aging Project baseline survey\n  - Year: 2022\n  - Venue: Veterinary and Comparative Oncology\n  - URL: https://drjingma.com/assets/pdfs/papers/2022-Schwartz-cancer.pdf\nPhD thesis:\n  - Title: Lifespan and Causes of Death in the Irish Wolfhound: Medical, Genetical and Ethical Aspects\n  - Year: 2007\n  - Institution: Vetsuisse Faculty, University of Bern\n  - URL: https://www.tierschutz.vetsuisse.unibe.ch/unibe/portal/fak_vetmedizin/c_dept_dcr-vph/e_inst_tierschutz/content/e191756/e191761/e753472/e753493/Diss_Urfer_2007_ger_eng.pdf\n\nResearcher: Matt R. Kaeberlein\nEmail: kaeber@uw.edu\nData publicly available: no\nLatest publication:\n  - Title: A single-center, double-blind, randomized, placebo-controlled, two-arm study to evaluate the safety and efficacy of once-weekly sirolimus (rapamycin) on muscle strength and endurance in older adults following a 13-week exercise program\n  - Year: 2024\n  - Venue: Trials\n  - URL: https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-024-08490-2\nPhD thesis:\n  - Title: Genetic analysis of longevity in Saccharomyces cerevisiae\n  - Year: 2002\n  - Institution: Massachusetts Institute of Technology\n  - URL: https://dspace.mit.edu/handle/1721.1/8318\n\nResearcher: Jane Katherine Murray\nEmail: jane.murray@dogstrust.org.uk\nData publicly available: unknown\nLatest publication:\n  - Title: Not found\n  - Year: Not found\n  - Venue: Not found\n  - URL: Not found\nPhD thesis:\n  - Title: An epidemiological study of the risk factors associated with falls of horses and riders in the sport of eventing\n  - Year: 2004\n  - Institution: University of Liverpool\n  - URL: https://livrepository.liverpool.ac.uk/400243/1/450359.pdf\n\nResearcher: Rachel Alison Casey\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Longevity of companion dog breeds: those at risk from early death\n  - Year: 2024\n  - Venue: Scientific Reports\n  - URL: https://www.nature.com/articles/s41598-023-50458-w.pdf\nPhD thesis: Not found",
        "structured": {
          "researchers": [
            {
              "name": "Kate E. Creevy",
              "email": "kcreevy@cvm.tamu.edu",
              "latest_publication": {
                "title": "Dog size and patterns of disease history across the canine age spectrum: Results from the Dog Aging Project",
                "year": 2024,
                "venue": "PLOS ONE",
                "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0295840"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "The Dog Aging Project Consortium",
              "email": null,
              "latest_publication": {
                "title": "Dog size and patterns of disease history across the canine age spectrum: Results from the Dog Aging Project",
                "year": 2024,
                "venue": "PLOS ONE",
                "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0295840"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "Daniel E. L. Promislow",
              "email": "promislo@uw.edu",
              "latest_publication": {
                "title": "Rationale and design of the Dog Aging Project precision cohort: a multi-omic resource for longitudinal research in geroscience",
                "year": 2025,
                "venue": "GeroScience",
                "url": "https://link.springer.com/article/10.1007/s11357-025-01571-3"
              },
              "phd_thesis": {
                "title": "Mortality patterns in natural populations of mammals and their consequences",
                "year": 1990,
                "institution": "University of Oxford",
                "url": "https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.256377"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Julia D. Labadie",
              "email": "jdlabadie@gmail.com",
              "latest_publication": {
                "title": "A splice donor variant in SLAMF1 is associated with canine atopic dermatitis",
                "year": 2025,
                "venue": "Frontiers in Veterinary Science",
                "url": "https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2025.1550617/full"
              },
              "phd_thesis": {
                "title": "Using the dog as a model to investigate environmental and genetic risk factors for mature, antigen-driven lymphoproliferative disorders",
                "year": 2017,
                "institution": "Colorado State University",
                "url": "https://mountainscholar.org/bitstream/handle/10217/184031/Labadie_colostate_0053A_14407.pdf?sequence=1"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Janet Patterson-Kane",
              "email": null,
              "latest_publication": {
                "title": "Cohort profile: The Golden Retriever Lifetime Study (GRLS)",
                "year": 2022,
                "venue": "PLOS ONE",
                "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0269425"
              },
              "phd_thesis": {
                "title": "The effect of exercise on the collagen fibril morphology of the digital flexor tendons of the Thoroughbred",
                "year": 1996,
                "institution": "Massey University",
                "url": "https://mro.massey.ac.nz/bitstreams/ecaba6be-6e0a-4597-ad3c-0406c160ea80/download"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Kathleen Morrill",
              "email": "kathleen.morrill@umassmed.edu",
              "latest_publication": {
                "title": "Comparative neurogenetics of dog behavior complements efforts towards human neuropsychiatric genetics",
                "year": 2023,
                "venue": "Human Genetics",
                "url": "https://link.springer.com/content/pdf/10.1007/s00439-023-02580-y.pdf"
              },
              "phd_thesis": {
                "title": "The Genomics of Canine Behavior and its Comparative Relevance to Human",
                "year": 2023,
                "institution": "UMass Chan Medical School",
                "url": "https://repository.escholarship.umassmed.edu/entities/publication/f3de5270-26e1-4362-87d2-bf0c2e708910"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Elinor K. Karlsson",
              "email": "elinor.karlsson@umassmed.edu",
              "latest_publication": {
                "title": "Evolutionary constraint and innovation across hundreds of placental mammals",
                "year": 2023,
                "venue": "Science",
                "url": "https://www.science.org/doi/epdf/10.1126/science.abn3943"
              },
              "phd_thesis": null,
              "data_publicly_available": "unknown"
            },
            {
              "name": "Steve Horvath",
              "email": null,
              "latest_publication": {
                "title": "Universal DNA methylation age across mammalian tissues",
                "year": 2023,
                "venue": "Nature Aging",
                "url": "https://digitalcommons.unl.edu/animalscifacpub/1274/"
              },
              "phd_thesis": {
                "title": "Gauge Symmetry in the Ramond-Ramond Sector of Superstring Theory",
                "year": 1995,
                "institution": "University of North Carolina at Chapel Hill",
                "url": null
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Elaine A. Ostrander",
              "email": null,
              "latest_publication": {
                "title": "Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants",
                "year": 2023,
                "venue": "Nature Genetics",
                "url": "https://www.nature.com/articles/s41588-023-01534-4.pdf"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "Silvan R. Urfer",
              "email": null,
              "latest_publication": {
                "title": "Lifetime prevalence of malignant and benign tumours in companion dogs: Cross-sectional analysis of Dog Aging Project baseline survey",
                "year": 2022,
                "venue": "Veterinary and Comparative Oncology",
                "url": "https://drjingma.com/assets/pdfs/papers/2022-Schwartz-cancer.pdf"
              },
              "phd_thesis": {
                "title": "Lifespan and Causes of Death in the Irish Wolfhound: Medical, Genetical and Ethical Aspects",
                "year": 2007,
                "institution": "Vetsuisse Faculty, University of Bern",
                "url": "https://www.tierschutz.vetsuisse.unibe.ch/unibe/portal/fak_vetmedizin/c_dept_dcr-vph/e_inst_tierschutz/content/e191756/e191761/e753472/e753493/Diss_Urfer_2007_ger_eng.pdf"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Matt R. Kaeberlein",
              "email": "kaeber@uw.edu",
              "latest_publication": {
                "title": "A single-center, double-blind, randomized, placebo-controlled, two-arm study to evaluate the safety and efficacy of once-weekly sirolimus (rapamycin) on muscle strength and endurance in older adults following a 13-week exercise program",
                "year": 2024,
                "venue": "Trials",
                "url": "https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-024-08490-2"
              },
              "phd_thesis": {
                "title": "Genetic analysis of longevity in Saccharomyces cerevisiae",
                "year": 2002,
                "institution": "Massachusetts Institute of Technology",
                "url": "https://dspace.mit.edu/handle/1721.1/8318"
              },
              "data_publicly_available": "no"
            },
            {
              "name": "Jane Katherine Murray",
              "email": "jane.murray@dogstrust.org.uk",
              "latest_publication": {
                "title": null,
                "year": null,
                "venue": null,
                "url": null
              },
              "phd_thesis": {
                "title": "An epidemiological study of the risk factors associated with falls of horses and riders in the sport of eventing",
                "year": 2004,
                "institution": "University of Liverpool",
                "url": "https://livrepository.liverpool.ac.uk/400243/1/450359.pdf"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Rachel Alison Casey",
              "email": null,
              "latest_publication": {
                "title": "Longevity of companion dog breeds: those at risk from early death",
                "year": 2024,
                "venue": "Scientific Reports",
                "url": "https://www.nature.com/articles/s41598-023-50458-w.pdf"
              },
              "phd_thesis": null,
              "data_publicly_available": "unknown"
            }
          ],
          "promptNotes": "Compiled from all thesis discovery responses in this thread; phd_thesis is null where no thesis record was verified or linked."
        }
      },
      "patents": {
        "text": "Patent: US11632938B2\nTitle: Markers for determining the biological age of a dog\nAssignee: Mars, Incorporated\nFiling Date: 2022-06-21\nGrant Date: 2023-04-25\nAbstract: Uses a small panel of routine clinical biomarkers and modelling to estimate a dog's biological age, including size-category adjustments. Provides methods for calculating biological age and pace-of-ageing using supervised models on standard veterinary lab measures.\nOverlaps with paper claims: C2\nTechnical overlap: DAP commits to deriving predictive and prognostic ageing biomarkers from large-scale longitudinal data. The patent claims a supervised modelling framework over standard veterinary analytes to produce a biological-age metric and pace-of-ageing readout, matching DAP's plan to build biomarker-based systems models. The listed marker panels and category normalisation mirror the types of clinicopathologic features DAP will analyse.\n\nPatent: US20220064713A1\nTitle: Monitoring tools and diagnostic methods for determining a canid's microbiome age status\nAssignee: Mars, Incorporated\nFiling Date: 2020-01-20\nGrant Date: Not provided\nAbstract: Determines a canid's microbiome age status by profiling gut microbiota and comparing to reference distributions spanning life stages. Supports longitudinal monitoring of microbiome-based ageing trajectories.\nOverlaps with paper claims: C2\nTechnical overlap: DAP plans annual microbiome profiling in the Precision and TRIAD cohorts to discover ageing biomarkers. The patent operationalises this by claiming methods to compute a microbiome-derived age metric from taxa abundance profiles against age-stratified reference datasets, enabling longitudinal tracking exactly as DAP proposes. The comparative algorithmic framework validates DAP's microbiome biomarker approach.\n\nPatent: US11999995B2\nTitle: Methylome profiling in animals and uses thereof\nAssignee: The Regents of the University of California\nFiling Date: 2018-08-31\nGrant Date: 2024-06-04\nAbstract: Provides targeted bisulphite sequencing of conserved CpGs and machine-learning models to predict biological age in non-human mammals, including canines. Includes selection of syntenic CpG sites and training and validation of methylation age clocks.\nOverlaps with paper claims: C2\nTechnical overlap: DAP will generate epigenomic datasets and build predictive biomarkers of canine ageing. The patent claims a concrete pipeline-targeted bisulphite capture of conserved CpGs and ElasticNet-like models-to compute methylation-based age clocks explicitly for dogs, which aligns with DAP's planned epigenome profiling and biomarker modelling. The canine embodiments and modelling steps directly map to DAP's systems-biology objectives.\n\nPatent: WO2021124264A1\nTitle: Veterinary formulations comprising rapamycin and methods of using the same for treating animal diseases\nAssignee: Triviumvet DAC\nFiling Date: 2020-12-18\nGrant Date: Not provided\nAbstract: Discloses oral veterinary rapamycin compositions with improved bioavailability for companion animals. Claims use at non-immunosuppressive doses to improve cardiac health and mitigate effects of ageing in dogs.\nOverlaps with paper claims: C3\nTechnical overlap: DAP's TRIAD is a randomised, double-masked, placebo-controlled trial of weekly low-dose rapamycin in middle-aged, large-breed dogs with cardiac and healthspan endpoints. The patent claims veterinary rapamycin therapy at non-immunosuppressive doses to modulate mTOR signalling for cardioprotection and anti-ageing effects in dogs, validating the pharmacologic mechanism, dosing rationale, and endpoint focus embedded in TRIAD. The claimed compositions and indications match the trial's therapeutic approach.\n\nPatent: US20190284625A1\nTitle: Methods for joint low-pass and targeted sequencing\nAssignee: Gencove Inc.\nFiling Date: 2019-03-15\nGrant Date: Not provided\nAbstract: Combines low-coverage whole-genome sequencing with targeted capture in a single library to recover genome-wide variation while boosting coverage at specified loci. Enables cost-efficient genotyping for large cohorts.\nOverlaps with paper claims: C2\nTechnical overlap: DAP specifies low-coverage whole-genome sequencing with imputation across tens of thousands of dogs to power genetic discovery. The patent claims pooled low-pass sequencing workflows with barcoding and optional targeted enrichment, which is the same class of cost-efficient genotyping strategy DAP intends to deploy. This validates the scalability and technical feasibility of DAP's planned genomic pipeline.",
        "structured": {
          "patents": [
            {
              "patentNumber": "US11632938B2",
              "title": "Markers for determining the biological age of a dog",
              "assignee": "Mars, Incorporated",
              "filingDate": "2022-06-21",
              "grantDate": "2023-04-25",
              "abstract": "Uses a small panel of routine clinical biomarkers and modelling to estimate a dog's biological age, including size-category adjustments. Provides methods for calculating biological age and pace-of-ageing using supervised models on standard veterinary lab measures.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2"
                ],
                "summary": "DAP commits to deriving predictive and prognostic ageing biomarkers from large-scale longitudinal data. The patent claims a supervised modelling framework over standard veterinary analytes to produce a biological-age metric and pace-of-ageing readout, matching DAP's plan to build biomarker-based systems models. The listed marker panels and category normalisation mirror the types of clinicopathologic features DAP will analyse."
              },
              "url": null
            },
            {
              "patentNumber": "US20220064713A1",
              "title": "Monitoring tools and diagnostic methods for determining a canid's microbiome age status",
              "assignee": "Mars, Incorporated",
              "filingDate": "2020-01-20",
              "grantDate": null,
              "abstract": "Determines a canid's microbiome age status by profiling gut microbiota and comparing to reference distributions spanning life stages. Supports longitudinal monitoring of microbiome-based ageing trajectories.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2"
                ],
                "summary": "DAP plans annual microbiome profiling in the Precision and TRIAD cohorts to discover ageing biomarkers. The patent operationalises this by claiming methods to compute a microbiome-derived age metric from taxa abundance profiles against age-stratified reference datasets, enabling longitudinal tracking exactly as DAP proposes. The comparative algorithmic framework validates DAP's microbiome biomarker approach."
              },
              "url": null
            },
            {
              "patentNumber": "US11999995B2",
              "title": "Methylome profiling in animals and uses thereof",
              "assignee": "The Regents of the University of California",
              "filingDate": "2018-08-31",
              "grantDate": "2024-06-04",
              "abstract": "Provides targeted bisulphite sequencing of conserved CpGs and machine-learning models to predict biological age in non-human mammals, including canines. Includes selection of syntenic CpG sites and training and validation of methylation age clocks.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2"
                ],
                "summary": "DAP will generate epigenomic datasets and build predictive biomarkers of canine ageing. The patent claims a concrete pipeline-targeted bisulphite capture of conserved CpGs and ElasticNet-like models-to compute methylation-based age clocks explicitly for dogs, which aligns with DAP's planned epigenome profiling and biomarker modelling. The canine embodiments and modelling steps directly map to DAP's systems-biology objectives."
              },
              "url": null
            },
            {
              "patentNumber": "WO2021124264A1",
              "title": "Veterinary formulations comprising rapamycin and methods of using the same for treating animal diseases",
              "assignee": "Triviumvet DAC",
              "filingDate": "2020-12-18",
              "grantDate": null,
              "abstract": "Discloses oral veterinary rapamycin compositions with improved bioavailability for companion animals. Claims use at non-immunosuppressive doses to improve cardiac health and mitigate effects of ageing in dogs.",
              "overlapWithPaper": {
                "claimIds": [
                  "C3"
                ],
                "summary": "DAP's TRIAD is a randomised, double-masked, placebo-controlled trial of weekly low-dose rapamycin in middle-aged, large-breed dogs with cardiac and healthspan endpoints. The patent claims veterinary rapamycin therapy at non-immunosuppressive doses to modulate mTOR signalling for cardioprotection and anti-ageing effects in dogs, validating the pharmacologic mechanism, dosing rationale, and endpoint focus embedded in TRIAD. The claimed compositions and indications match the trial's therapeutic approach."
              },
              "url": null
            },
            {
              "patentNumber": "US20190284625A1",
              "title": "Methods for joint low-pass and targeted sequencing",
              "assignee": "Gencove Inc.",
              "filingDate": "2019-03-15",
              "grantDate": null,
              "abstract": "Combines low-coverage whole-genome sequencing with targeted capture in a single library to recover genome-wide variation while boosting coverage at specified loci. Enables cost-efficient genotyping for large cohorts.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2"
                ],
                "summary": "DAP specifies low-coverage whole-genome sequencing with imputation across tens of thousands of dogs to power genetic discovery. The patent claims pooled low-pass sequencing workflows with barcoding and optional targeted enrichment, which is the same class of cost-efficient genotyping strategy DAP intends to deploy. This validates the scalability and technical feasibility of DAP's planned genomic pipeline."
              },
              "url": null
            }
          ],
          "promptNotes": "The strongest validation is for C2 (biomarkers, multi-omics, and scalable genomics) and C3 (rapamycin intervention). No substantive platform-level patents were identified for C1."
        }
      },
      "verifiedClaims": {
        "text": "=== OVERALL ASSESSMENT ===\nThe paper's programme-level vision of an open, longitudinal, multi-cohort community-science resource is well supported, with curated open releases tied to environmental exposures. The multi-omic and genomics work is methodologically feasible and underway, but realised scale and completeness remain to be fully documented publicly, and most claims are best rated Partially Verified. TRIAD's RCT design is robust and independently documented; efficacy awaits results.\n\n=== VERIFIED CLAIMS ===\n\nClaim: C1\nOriginal: The DAP is a large-scale, open-data, long-term longitudinal study of ageing in tens of thousands of companion dogs, designed to identify genetic, environmental and lifestyle determinants of healthy lifespan.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] An open science study of ageing in companion dogs\n    Describes DAP as a long-term, nationwide, community-science cohort intended to discover genetic, environmental and lifestyle determinants of healthy lifespan in tens of thousands of dogs.\n\nSummary: DAP's scale, longitudinal design, open-data posture, and multi-cohort structure are documented by the paper itself and acknowledged independently. Open releases are curated rather than fully raw and much of the structural evidence is first-party, so the claim remains Partially Verified.\n\nClaim: C2\nOriginal: The project will generate large-scale genetic, multi-omic, and environmental datasets to identify determinants and biomarkers of canine ageing and build systems biology models.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] Ancestry-inclusive dog genomics challenges popular breed stereotypes\n    Shows feasibility of combining owner-reported phenotypes with low-pass whole-genome sequencing and imputation in a community-science cohort, aligning with DAP's genomics plan.\n  - [Similar Paper] DNA methylation clocks for dogs and humans\n    Demonstrates epigenome-based ageing biomarkers and cross-species models in dogs, aligning with DAP's epigenomic profiling and biomarker goals.\n  - [Patent] US11632938B2 Markers for determining the biological age of a dog\n    Claims supervised models over veterinary analytes to compute biological age and pace of ageing, supporting the feasibility of DAP's biomarker modelling.\n  - [Patent] US20220064713A1 Monitoring tools and diagnostic methods for determining a canid's microbiome age status\n    Claims microbiome-derived age metrics and longitudinal tracking, supporting DAP's plan for microbiome-based biomarkers.\n  - [Patent] US11999995B2 Methylome profiling in animals and uses thereof\n    Describes targeted methylome capture and modelling pipelines for age clocks in dogs, consistent with DAP's epigenomic objectives.\n  - [Patent] US20190284625A1 Methods for joint low-pass and targeted sequencing\n    Describes scalable low-pass sequencing with imputation and optional targeting, supporting DAP's cost-efficient genotyping strategy.\n\nSummary: There is strong methodological and ecosystem support that DAP is generating multi-omic and environmental datasets for biomarker discovery and systems models. Exact realised genomic sample size at the 10,000 level is not yet independently confirmed and sample-collection missingness is a practical constraint, so the claim is Partially Verified.\n\nClaim: C3\nOriginal: The DAP includes TRIAD, a randomised, double-masked, placebo-controlled clinical trial to test whether weekly low-dose rapamycin for one year increases lifespan and healthspan in middle-aged, large-breed dogs.\nStatus: Verified\nConfidence: High\n\nSupporting Evidence:\n  - [Similar Paper] TRIAD study design and rationale\n    Peer-reviewed description of a multicentre randomised, double-masked, placebo-controlled, once-weekly rapamycin trial embedded in DAP.\n  - [Similar Paper] A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs\n    Establishes feasibility of masked allocation, owner-administered rapamycin, and cardiac/safety endpoints used by TRIAD.\n\nContradicting Evidence:\n  - [Similar Paper] Barnett et al. (2023) masked RCT in 17 dogs\n    Reported no clinically significant cardiac changes versus placebo with different dosing and duration, tempering efficacy expectations.\n\nSummary: Multiple independent sources confirm TRIAD is a randomised, double-masked, placebo-controlled, once-weekly rapamycin study of one year within DAP, targeting lifespan and healthspan in middle-aged, large-breed dogs. Prior small RCTs establish feasibility but do not prove benefit, so the verification applies to the protocol's existence and design, not efficacy.\n",
        "structured": {
          "claims": [
            {
              "claimId": "C1",
              "originalClaim": "The DAP is a large-scale, open-data, long-term longitudinal study of ageing in tens of thousands of companion dogs, designed to identify genetic, environmental and lifestyle determinants of healthy lifespan.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "An open science study of ageing in companion dogs",
                  "relevance": "Describes DAP as a long-term, nationwide, community-science cohort intended to discover genetic, environmental and lifestyle determinants of healthy lifespan in tens of thousands of dogs."
                }
              ],
              "contradictingEvidence": [],
              "verificationSummary": "DAP's scale, longitudinal design, open-data posture, and multi-cohort structure are documented by the paper itself and acknowledged independently. Open releases are curated rather than fully raw and much of the structural evidence is first-party, so the claim remains Partially Verified.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C2",
              "originalClaim": "The project will generate large-scale genetic, multi-omic, and environmental datasets to identify determinants and biomarkers of canine ageing and build systems biology models.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Ancestry-inclusive dog genomics challenges popular breed stereotypes",
                  "relevance": "Shows feasibility of combining owner-reported phenotypes with low-pass whole-genome sequencing and imputation in a community-science cohort, aligning with DAP's genomics plan."
                },
                {
                  "source": "Similar Paper",
                  "title": "DNA methylation clocks for dogs and humans",
                  "relevance": "Demonstrates epigenome-based ageing biomarkers and cross-species models in dogs, aligning with DAP's epigenomic profiling and biomarker goals."
                },
                {
                  "source": "Patent",
                  "title": "US11632938B2 Markers for determining the biological age of a dog",
                  "relevance": "Claims supervised models over veterinary analytes to compute biological age and pace of ageing, supporting the feasibility of DAP's biomarker modelling."
                },
                {
                  "source": "Patent",
                  "title": "US20220064713A1 Monitoring tools and diagnostic methods for determining a canid's microbiome age status",
                  "relevance": "Claims microbiome-derived age metrics and longitudinal tracking, supporting DAP's plan for microbiome-based biomarkers."
                },
                {
                  "source": "Patent",
                  "title": "US11999995B2 Methylome profiling in animals and uses thereof",
                  "relevance": "Describes targeted methylome capture and modelling pipelines for age clocks in dogs, consistent with DAP's epigenomic objectives."
                },
                {
                  "source": "Patent",
                  "title": "US20190284625A1 Methods for joint low-pass and targeted sequencing",
                  "relevance": "Describes scalable low-pass sequencing with imputation and optional targeting, supporting DAP's cost-efficient genotyping strategy."
                }
              ],
              "contradictingEvidence": [],
              "verificationSummary": "There is strong methodological and ecosystem support that DAP is generating multi-omic and environmental datasets for biomarker discovery and systems models. Exact realised genomic sample size at the 10,000 level is not yet independently confirmed and sample-collection missingness is a practical constraint, so the claim is Partially Verified.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C3",
              "originalClaim": "The DAP includes TRIAD, a randomised, double-masked, placebo-controlled clinical trial to test whether weekly low-dose rapamycin for one year increases lifespan and healthspan in middle-aged, large-breed dogs.",
              "verificationStatus": "Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "TRIAD study design and rationale",
                  "relevance": "Peer-reviewed description of a multicentre randomised, double-masked, placebo-controlled, once-weekly rapamycin trial embedded in DAP."
                },
                {
                  "source": "Similar Paper",
                  "title": "A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs",
                  "relevance": "Establishes feasibility of masked allocation, owner-administered rapamycin, and cardiac/safety endpoints used by TRIAD."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Barnett et al. (2023) masked RCT in 17 dogs",
                  "relevance": "Reported no clinically significant cardiac changes versus placebo with different dosing and duration, tempering efficacy expectations."
                }
              ],
              "verificationSummary": "Multiple independent sources confirm TRIAD is a randomised, double-masked, placebo-controlled, once-weekly rapamycin study of one year within DAP, targeting lifespan and healthspan in middle-aged, large-breed dogs. Prior small RCTs establish feasibility but do not prove benefit, so the verification applies to the protocol's existence and design, not efficacy.",
              "confidenceLevel": "High"
            }
          ],
          "overallAssessment": "The paper's programme-level vision of an open, longitudinal, multi-cohort community-science resource is well supported, with curated open releases tied to environmental exposures. The multi-omic and genomics work is methodologically feasible and underway, but realised scale and completeness remain to be fully documented publicly, and most claims are best rated Partially Verified. TRIAD's RCT design is robust and independently documented; efficacy awaits results.",
          "promptNotes": "Open data are curated, de-identified releases on Terra; identifiable or trial data are withheld until completion for privacy and integrity. Public codebooks exist, but full analysis pipelines are variably shared across publications.  Strengtheners: public confirmation of realised sequencing counts at or above 10,000 with release notes; independent replications using DAP curated data for multi-omic biomarker models; TRIAD primary outcome publication with shared analysis code and datasets."
        }
      }
    },
    {
      "id": "4",
      "sourcePdf": {
        "path": "Transitional lncRNA Signatures Reveal Distinct Stages of Cancer Progression and Metastasis.pdf",
        "publicPath": "/mock-papers/4.pdf",
        "title": "Transitional lncRNA Signatures Reveal Distinct Stages of Cancer Progression and Metastasis",
        "originalFileName": "Transitional lncRNA Signatures Reveal Distinct Stages of Cancer Progression and Metastasis.pdf",
        "doi": "10.1101/2025.06.10.658949doi",
        "pages": 21
      },
      "label": "Transitional lncRNA Signatures Reveal Distinct Stages of Cancer Progression and Metastasis",
      "generatedAt": "2025-10-29T03:01:27.022Z",
      "claimsAnalysis": {
        "text": "Executive Summary   The paper defines \"transitional lncRNAs\" (Tr-lncRNAs) whose expression shifts across clinical transitions of tumour stage and metastasis using TCGA RNA-seq and stringent thresholds. Headline results: more than 70 percent of Tr-lncRNAs are cancer-type specific, only 2-4 percent are shared across 17 cancers, each cancer type shows about 30-80 Tr-lncRNAs per transition, and a small pan-cancer set of 14 Tr-lncRNAs recurs across metastatic transitions. Feature enrichment across 2,399 Tr-lncRNAs identifies longer transcripts with more exons and about twofold higher \"small-protein\" coding capacity. Overall evidence strength: Moderate.    Top 3 Claims and Evidence    C1. One-sentence claim   Most Tr-lncRNAs that mark cancer progression are cancer-type specific, with minimal sharing across cancers.    Evidence summary   Observational, computational analysis of TCGA RNA-seq across 16-17 cancer types; Tr-lncRNAs defined per transition by z-scores on log2 fold changes with a strict threshold and expression coherence filter; sharing quantified by pairwise overlap and network connectivity.    Key numbers    More than 70 percent of Tr-lncRNAs are cancer-type specific; only 2-4 percent are shared across 17 cancers; each cancer type had 30-80 Tr-lncRNAs, with more than half unique to one type (Abstract).    For T-stage EL (transition d), per cancer 20-80 Tr-lncRNAs selected from 2,500-4,500 expressed lncRNAs (Fig. 3A).    Across T-stage transitions a-d, about 220 Tr-lncRNAs per cancer on average; cancer-unique subset about 60 (Fig. 3B-C).    Across M-state transitions e-g, about 160 Tr-lncRNAs per cancer on average; cancer-unique subset about 50 (Fig. 3E-F).    Pairwise sharing for EL: typically 2-3 percent, maximum less than 10 percent for BLCA-BRCA (Fig. 4B).    Example: USEC shows 44 Tr-lncRNAs, 40 unique (Fig. 4D).    Pan-cancer M-state view lists 14 shared Tr-lncRNAs across transitions e and f (Table 1).    Source location   Abstract; Results, \"Differentially expressed transitional lncRNAs\" and \"Tr-lncRNAs connectivity map\" with Fig. 3A-F and Fig. 4B-D; Table 1.    Strength rating   Moderate. Assumes mapping harmonisation and z-score procedure are valid across uneven sample sizes and cancer types.    C2. One-sentence claim   A small pan-cancer subset of Tr-lncRNAs, notably XIST and USP9Y, shows coherent trends across metastatic transitions, with XIST exhibiting moderate cross-cancer correlation between primary growth and metastasis transitions.    Evidence summary   Pan-cancer tally of top 50 Tr-lncRNAs per metastasis transition; overlap of 14 shared Tr-lncRNAs; cross-cancer correlations of z-scores for transitions e and f; illustrative extreme z-values shown for lung cancers.    Key numbers    Fourteen Tr-lncRNAs overlap between M0-smallM0-large (e) and M0-largeM1-large (f) within the top-50 lists (Table 1).    XIST: r=0.59, p=0.02 for coherence between transitions e and f across cancer types; lung cancers show suppression with z about -15 (Fig. 5A).    USP9Y: r=0.39 across cancer types (Fig. 5B).    MIR205HG: r=0.08, indicating little coherence between e and f (Fig. 5C).    Additional recurrent pan-cancer Tr-lncRNAs across T-stage transitions include XIST, UCA1, H19, DIO3OS, MIR205HG and USP9Y; overlap across T-stage transitions a-c yields only 6 shared lncRNAs, 5 poorly characterised (Fig. 6B).    Overlap across T-stage d and M-state e and g totals 28 lncRNAs, with 10 shared among these transitions; includes several antisense lncRNAs (Fig. 6C).    Source location   Results, \"Pan-cancer view\" and Fig. 5A-C, Fig. 6A-C; Table 1.    Strength rating   Moderate. Correlations are reported, but no external validation or predictive performance metrics are provided. The magnitude and sign of z-scores are descriptive, not effect sizes.    C3. One-sentence claim   Tr-lncRNAs display distinct molecular features versus the background lncRNA set, including longer transcripts, more exons and transcripts, and about twofold higher small-protein coding capacity, with many feature differences reaching FDR significance.    Evidence summary   Feature enrichment analysis comparing 2,399 unique Tr-lncRNAs to all TCGA-mapped lncRNAs annotated in lncBook; 143 features tested with Mann-Whitney or chi-square, FDR threshold applied.    Key numbers    2,399 unique Tr-lncRNAs analysed; 143 features evaluated; 40 features meet FDR p<0.05 (Fig. 9A).    Tr-lncRNAs are longer with more exons and longer exons (Fig. 9B).    Tr-lncRNAs have substantially more transcripts per gene and more polyA sites (Fig. 9C).    About twofold higher fraction of \"small proteins\" among Tr-lncRNAs versus background (Fig. 9D).    None of the 40 subcellular localisation features are significant, and only a very few of the many conservation annotations (totaling 30) met the FDR threshold (Fig. 9A).    Additional summary: antisense fraction among Tr-lncRNAs reaches 47 percent using a relaxed definition; 13.3 percent of the 2,399 Tr-lncRNAs are predicted exosomal, suggesting liquid biopsy potential (Discussion).    Source location   Results, \"Tr-lncRNA molecular features\" with Fig. 9A-D; Discussion.    Strength rating   Moderate. Findings are statistically controlled for multiple comparisons in the feature analysis, but depend on catalogue annotations and Tr-lncRNA selection criteria.    Gaps and Limitations   Linked to C1    Uneven sample sizes across stages and cancers may bias detection of Tr-lncRNAs despite the z-score filter and coherence requirement (Supplemental Fig. S3 referenced; Results).    Bulk RNA-seq limits cell-type resolution, risking confounding by tumour microenvironment; acknowledged by authors (Discussion).    Low cross-cancer overlap may limit clinical generalisability of signatures (Abstract; Fig. 4B-D).    Linked to C2    Cross-cancer correlations for XIST and USP9Y are moderate (r=0.59, r=0.39) and reported without model adjustment for confounders (Fig. 5A-B).    Lack of diagnostic or prognostic performance metrics for the shared set of 14 Tr-lncRNAs (Table 1; Fig. 5).    Acronym inconsistencies likely from OCR, for example LAUD [UNCLEAR] vs LUAD, USEC [UNCLEAR] vs UCEC, could affect interpretation of cancer-type labels (Fig. 4D; Fig. 5).    Linked to C3    \"Small-protein\" capacity inference depends on Ribo-seq and MS annotations and may be incomplete; exact effect sizes beyond \"twofold\" are not enumerated per feature (Fig. 9D).    The analysis collapses multiple isoforms to a representative transcript, potentially missing isoform-specific features (Methods).    Antisense fraction 47 percent uses a relaxed definition and is stated in Discussion without an accompanying figure; exact testing details not shown (Discussion).    Methods Snapshot    Data: TCGA RNA-seq (HiSeq, polyA+, paired-end) processed as RSEM with log2[FPKM+1] normalisation, with clinical T-stage I-IV and M-state labels (Methods).    lncRNA harmonisation: GeneCaRNA-centred mapping across multiple catalogues; ambiguous mappings removed; final gene list 12,654; 11,667 used for feature analysis (Results, Fig. 1E).    Transitions: seven transitions defined-T-stage a: III, b: IIIII, c: IIIIV, d: Early [I+II]Late [III+IV]; M-state e: M0_smallM0_large, f: M0_largeM1_large, g: M0M1; about 20 M1_small samples excluded (Results).    Tr-lncRNA selection: require expected count at least 1.0 in at least 30 percent of samples in one stage; compute z-scores over log2 fold changes; threshold z>|3|; coherence filter across samples; tails represent about 0.015 percent each side (Results; Supplemental Fig. S4 referenced).    Visualisation: t-SNE for clustering by cancer type and stage (Fig. 2A-D).    Feature enrichment: 143 lncBook-derived features tested with FDR control (Fig. 9A-D).    Availability: code and large tables stated as available via GitHub; preprint posted 16/06/2025 (Data Availability; title page).    Risk-of-Bias and Quality Checklist    Study type: observational, secondary analysis of public RNA-seq; no experimental validation or external cohort.    Selection bias: TCGA-only, uneven stage distributions across cancers (Results; Supplemental Fig. S3 referenced).    Measurement bias: bulk RNA-seq with potential TME confounding; single transcript per gene used (Methods; Discussion).    Analysis choices: stringent z>|3| threshold reduces false positives but may under-detect down-regulated Tr-lncRNAs given minimal expression requirement (Discussion; Results).    Multiplicity: explicit FDR only for feature analysis; multiplicity across thousands of lncRNA comparisons per transition not fully detailed.    Reporting: several numeric summaries are approximate (for example \"about\", \"~\"), figures summarise without per-cancer counts in text.    Peer review: preprint, not peer reviewed as of 16/06/2025.    Open Questions and Next Steps    Validate Tr-lncRNA panels per cancer and per transition in independent cohorts with matched clinical staging, reporting AUROC and calibration.    Perform single-cell and spatial transcriptomics to localise Tr-lncRNA sources and separate tumour from microenvironment contributions.    Test functional roles of recurrent Tr-lncRNAs such as XIST, USP9Y, H19, DIO3OS in model systems across transitions e and f, quantifying phenotypic effects.    Evaluate liquid biopsy utility using the 13.3 percent predicted exosomal Tr-lncRNAs, with longitudinal sampling across EL and M0M1 transitions.    Disaggregate isoform-level dynamics to assess whether specific splice variants drive transition signals.    Standardise cancer-type labels and re-run analyses to resolve [UNCLEAR] acronyms and potential OCR artefacts.    QA Checklist    Sections present and complete per brief.    Numbers transcribed exactly from the provided text.    Each claim includes evidence, key numbers, locations, and a strength rating.    Notes on OCR artefacts and assumptions    Acronyms PADD [UNCLEAR] likely PAAD, USEC [UNCLEAR] likely UCEC, LAUD [UNCLEAR] likely LUAD, tgct [UNCLEAR] likely TGCT; analysis treats them as written.    \"xaximization\" is presumed \"expectation maximization\" in RSEM (Methods).    Where figures reference supplemental items, only their described content in the main text is used.",
        "structured": {
          "executiveSummary": [
            "Defines Tr-lncRNAs as stage- and metastasis-transition markers in TCGA using strict z-score thresholds.",
            "More than 70 percent cancer-type specificity; only 2-4 percent shared across 17 cancers; typical 30-80 Tr-lncRNAs per cancer per transition; 14 pan-cancer Tr-lncRNAs recur across metastasis transitions.",
            "Feature enrichment across 2,399 Tr-lncRNAs: longer transcripts, more exons and transcripts, about twofold higher small-protein capacity; overall evidence strength: Moderate."
          ],
          "claims": [
            {
              "id": "C1",
              "claim": "Most Tr-lncRNAs that mark cancer progression are cancer-type specific, with minimal sharing across cancers.",
              "evidenceSummary": "Observational, computational analysis of TCGA RNA-seq across 16-17 cancer types; Tr-lncRNAs defined by z-scores on log2 fold changes with z>|3| and expression coherence; sharing quantified via pairwise overlap and network connectivity.",
              "keyNumbers": [
                "More than 70 percent of Tr-lncRNAs are cancer-type specific (Abstract)",
                "2-4 percent shared across 17 cancers (Abstract)",
                "30-80 Tr-lncRNAs per cancer type per transition (Abstract; Fig. 3A)",
                "EL: 20-80 Tr-lncRNAs from 2,500-4,500 expressed lncRNAs (Fig. 3A)",
                "Average per cancer across T-stage a-d: ~220; cancer-unique ~60 (Fig. 3B-C)",
                "Average per cancer across M-state e-g: ~160; cancer-unique ~50 (Fig. 3E-F)",
                "Pairwise sharing for EL typically 2-3 percent; maximum less than 10 percent for BLCA-BRCA (Fig. 4B)",
                "USEC: 44 Tr-lncRNAs, 40 unique (Fig. 4D)",
                "14 shared Tr-lncRNAs across metastatic transitions (Table 1)"
              ],
              "source": "Abstract; Results: \"Differentially expressed transitional lncRNAs\", Fig. 3A-F; Results: \"Tr-lncRNAs connectivity map\", Fig. 4B-D; Table 1.",
              "strength": "Moderate",
              "assumptions": "Harmonised mapping and z-score procedure are valid across uneven sample sizes and cancer types; minimal expression threshold and coherence filter adequately address heterogeneity.",
              "evidenceType": "Observational computational secondary analysis of TCGA bulk RNA-seq"
            },
            {
              "id": "C2",
              "claim": "A small pan-cancer subset of Tr-lncRNAs, notably XIST and USP9Y, shows coherent trends across metastatic transitions, with XIST exhibiting moderate cross-cancer correlation between primary growth and metastasis transitions.",
              "evidenceSummary": "Pan-cancer overlap of top 50 Tr-lncRNAs per metastasis transition identifies 14 shared; cross-cancer correlations of z-scores between transitions e and f for specific lncRNAs; examples include strong XIST suppression in lung cancers.",
              "keyNumbers": [
                "14 Tr-lncRNAs overlap between transitions e and f (Table 1)",
                "XIST cross-cancer correlation r=0.59, p=0.02 (Fig. 5A)",
                "Lung cancers show XIST suppression around z-15 (Fig. 5A)",
                "USP9Y cross-cancer correlation r=0.39 (Fig. 5B)",
                "MIR205HG cross-cancer correlation r=0.08 (Fig. 5C)",
                "T-stage transitions a-c share only 6 lncRNAs (Fig. 6B)",
                "Transitions d, e, g total 28 overlapping lncRNAs; 10 shared among them (Fig. 6C)"
              ],
              "source": "Results: \"Pan-cancer view\", Fig. 5A-C; Fig. 6A-C; Table 1.",
              "strength": "Moderate",
              "assumptions": "Correlations reflect coherent biological trends without adjustment for potential confounders; cancer-type acronyms are correctly parsed despite OCR issues.",
              "evidenceType": "Observational cross-cancer correlation analysis on TCGA bulk RNA-seq"
            },
            {
              "id": "C3",
              "claim": "Tr-lncRNAs display distinct molecular features versus the background lncRNA set, including longer transcripts, more exons and transcripts, and about twofold higher small-protein coding capacity, with many feature differences reaching FDR significance.",
              "evidenceSummary": "Feature enrichment comparing 2,399 Tr-lncRNAs with all TCGA-mapped lncRNAs using 143 lncBook-derived features; Mann-Whitney or chi-square tests with FDR control.",
              "keyNumbers": [
                "2,399 unique Tr-lncRNAs; 143 features tested; 40 features with FDR p<0.05 (Fig. 9A)",
                "Longer transcripts, more exons and longer exons in Tr-lncRNAs (Fig. 9B)",
                "More transcripts per gene and more polyA sites (Fig. 9C)",
                "About twofold higher fraction of small proteins among Tr-lncRNAs (Fig. 9D)",
                "None of 40 subcellular localisation features significant; few of 30 conservation features significant (Fig. 9A)",
                "Antisense fraction 47 percent among Tr-lncRNAs [relaxed definition] (Discussion)",
                "13.3 percent of 2,399 Tr-lncRNAs predicted exosomal (Discussion)"
              ],
              "source": "Results: \"Tr-lncRNA molecular features\", Fig. 9A-D; Discussion.",
              "strength": "Moderate",
              "assumptions": "Catalogue annotations accurately reflect biology; collapsing to a single transcript per gene does not distort feature distributions.",
              "evidenceType": "Catalogue-based feature enrichment with multiple-testing control"
            }
          ],
          "gaps": [
            {
              "category": "Sampling and heterogeneity",
              "detail": "Uneven sample sizes across stages and cancers may bias Tr-lncRNA detection despite thresholds.",
              "relatedClaimIds": [
                "C1"
              ]
            },
            {
              "category": "Measurement and confounding",
              "detail": "Bulk RNA-seq lacks cell-type resolution; tumour microenvironment may confound signals.",
              "relatedClaimIds": [
                "C1",
                "C2"
              ]
            },
            {
              "category": "Generalisability",
              "detail": "Low cross-cancer overlap limits clinical generalisability of signatures.",
              "relatedClaimIds": [
                "C1"
              ]
            },
            {
              "category": "Statistics and validation",
              "detail": "Reported correlations for shared Tr-lncRNAs lack confounder adjustment and external validation.",
              "relatedClaimIds": [
                "C2"
              ]
            },
            {
              "category": "Performance metrics",
              "detail": "No diagnostic or prognostic performance metrics for the 14 shared metastasis Tr-lncRNAs.",
              "relatedClaimIds": [
                "C2"
              ]
            },
            {
              "category": "OCR/label integrity",
              "detail": "Cancer-type acronym inconsistencies [UNCLEAR] may affect interpretation.",
              "relatedClaimIds": [
                "C2"
              ]
            },
            {
              "category": "Annotation dependency",
              "detail": "Small-protein capacity and other features depend on catalogue completeness; isoform collapsing may mask differences.",
              "relatedClaimIds": [
                "C3"
              ]
            }
          ],
          "methodsSnapshot": [
            "TCGA RNA-seq (HiSeq, polyA+, paired-end) processed as RSEM with log2[FPKM+1] normalisation; clinical T-stage I-IV and M-state labels.",
            "lncRNA harmonisation via GeneCaRNA across catalogues; ambiguous mappings removed; final 12,654 genes; 11,667 for feature analysis.",
            "Seven transitions: T a III, b IIIII, c IIIIV, d Early [I+II]Late [III+IV]; M e M0_smallM0_large, f M0_largeM1_large, g M0M1; ~20 M1_small excluded.",
            "Tr-lncRNA criteria: expected count 1.0 in 30 percent of samples in one stage; z-scores on log2 fold changes with z>|3|; coherence filter; tails cover ~0.015 percent each side.",
            "t-SNE for clustering by cancer type/stage.",
            "Feature enrichment: 143 lncBook-derived features; Mann-Whitney or chi-square with FDR control.",
            "Availability: code and large tables on GitHub; preprint posted 16/06/2025."
          ],
          "riskChecklist": [
            {
              "item": "External validation or replication",
              "status": "missing",
              "note": "No external cohort or experimental validation reported."
            },
            {
              "item": "Selection bias across cancers and stages",
              "status": "partial",
              "note": "Uneven stage distributions; stringent thresholds applied."
            },
            {
              "item": "Measurement bias and confounding",
              "status": "partial",
              "note": "Bulk RNA-seq; tumour microenvironment not separable; single transcript per gene."
            },
            {
              "item": "Multiple-testing control for discovery of Tr-lncRNAs",
              "status": "unclear",
              "note": "FDR detailed for feature analysis only; discovery multiplicity across lncRNAs not fully specified."
            },
            {
              "item": "Reporting transparency",
              "status": "partial",
              "note": "Many values reported approximately; reliance on figures for exact counts."
            },
            {
              "item": "Peer review",
              "status": "missing",
              "note": "Preprint as of 16/06/2025."
            },
            {
              "item": "Code and data availability",
              "status": "met",
              "note": "GitHub and supplemental tables stated available."
            },
            {
              "item": "Isoform-level analysis",
              "status": "missing",
              "note": "Analyses collapse to a single representative transcript."
            },
            {
              "item": "Detection of down-regulated lncRNAs",
              "status": "partial",
              "note": "Minimal expression requirement may under-detect negative z-score candidates."
            }
          ],
          "openQuestions": [
            "Validate Tr-lncRNA panels per cancer and per transition in independent cohorts with AUROC and calibration.",
            "Apply single-cell and spatial transcriptomics to localise Tr-lncRNA sources and separate tumour versus microenvironment contributions.",
            "Functionally test recurrent Tr-lncRNAs (XIST, USP9Y, H19, DIO3OS) across transitions e and f in model systems with phenotypic readouts.",
            "Assess liquid biopsy utility of the 13.3 percent predicted exosomal Tr-lncRNAs with longitudinal sampling across EL and M0M1.",
            "Perform isoform-level analyses to determine whether specific splice variants drive transition signals.",
            "Standardise cancer-type labels and resolve OCR artefacts before re-analysis."
          ],
          "crossPaperComparison": []
        }
      },
      "createdAt": "2025-10-29T02:29:26.558Z",
      "updatedAt": "2025-10-29T03:47:42.167Z",
      "agent": {
        "maxChars": 10270,
        "promptNotes": ""
      },
      "sourcePaper": {
        "title": "Transitional lncRNA Signatures Reveal Distinct Stages of Cancer Progression and Metastasis",
        "summary": "Computational analysis of TCGA bulk RNA-seq across many cancers defines transitional lncRNAs (Tr-lncRNAs) that shift across stage and metastasis transitions using strict z-score thresholds and coherence filters. Results show high cancer-type specificity, a small pan-cancer subset during metastasis, and feature enrichment including longer length, more exons, and about twofold higher small-protein capacity.",
        "keyMethodSignals": [
          "TCGA polyA+ bulk RNA-seq with clinical T-stage and M-state labels",
          "Seven defined transitions spanning early-to-late stage and metastasis",
          "Tr-lncRNA selection via prevalence filter and |z|>3 on log2 fold-change",
          "Cross-cancer sharing quantified by pairwise overlap and connectivity mapping",
          "Feature enrichment of 2,399 Tr-lncRNAs using 143 lncBook features with FDR control"
        ],
        "methodComparison": {
          "sample": "TCGA bulk RNA-seq across 16-17 cancer types with clinical T-stage I-IV and M-state labels; seven transitions; very small M1_small excluded.",
          "materials": "RSEM-processed polyA+ paired-end RNA-seq with log2[FPKM+1]; lncRNA harmonisation via GeneCaRNA; 12,654 genes retained (11,667 for feature tests); 143 lncBook features including small-protein annotations.",
          "equipment": "Illumina HiSeq RNA-seq (TCGA standard) and computational pipelines for differential analysis and feature testing.",
          "procedure": "Define Tr-lncRNAs per transition using expression prevalence and |z|>3 on log2 fold-change with a coherence filter; quantify cross-cancer sharing; pan-cancer overlap of top metastasis lists; feature enrichment by Mann-Whitney or chi-square with FDR.",
          "outcomes": "More than 70 percent cancer-type specificity with 2-4 percent sharing; 14 recurrent pan-cancer Tr-lncRNAs in metastasis; Tr-lncRNAs are longer, exon-richer, and show about twofold higher small-protein capacity."
        }
      },
      "similarPapers": [
        {
          "identifier": "10.1038/ncomms13197",
          "title": "Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events",
          "authors": [
            "Ashouri et al."
          ],
          "year": 2016,
          "venue": "Nature Communications",
          "whyRelevant": "Pan-cancer TCGA RNA-seq analysis with stringent quantification mirrors the source's observational design and cross-cancer scope. Systematic overlap and association testing align with the source's sharing analyses.",
          "methodOverlap": [
            "TCGA polyA+ HiSeq 2000/2500 with at least 25M mapped fragments",
            "Genome-wide lncRNA quantification using GENCODE across 7,295 tumours",
            "Cross-cancer consistency of lncRNA associations analysed"
          ],
          "methodComparison": {
            "sample": "Nineteen TCGA cancer types; 7,295 tumours overall with a mutation-analysis subset of 4,698.",
            "materials": "RNA-seq realigned and quantified for GENCODE lncRNAs; integrated somatic mutations and copy-number alterations.",
            "equipment": "Illumina HiSeq 2000/2500 libraries with depth and quality filters.",
            "procedure": "Association testing between driver mutations and lncRNA expression with multiple controls and focused perturbation validation.",
            "outcomes": "Catalogue of lncRNAs linked to driver events; several associations reproducible across cancers and pathways."
          },
          "gaps": "Does not model clinical stage or metastasis transitions explicitly. Bulk RNA-seq confounding by microenvironment remains and patient-level covariates are limited.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1093/nar/gkx1311",
          "title": "LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations",
          "authors": [
            "Li et al."
          ],
          "year": 2018,
          "venue": "Nucleic Acids Research",
          "whyRelevant": "Uses TCGA-scale lncRNA expression with strict filters and log transforms, then quantifies cross-cancer overlap of lncRNA modulators. This parallels the source's cancer-specific versus pan-cancer overlap logic.",
          "methodOverlap": [
            "Paired lncRNA-mRNA TCGA profiles across 20 cancer types",
            "Expression filters with log2 RPKM transform and zero-handling",
            "Z-score standardisation and clustering enforce expression coherence"
          ],
          "methodComparison": {
            "sample": "TCGA and TANRIC cohorts with paired lncRNA-mRNA profiles across 20 cancers.",
            "materials": "ChIPBase TF-gene maps, hallmark gene sets, and survival labels for downstream evaluations.",
            "equipment": "TCGA RNA-seq pipelines as upstream source; computational network inference environment.",
            "procedure": "Linear-regression TF-gene filtering with multiple testing control; LncMod infers lncRNA modulators; clustering and survival analysis.",
            "outcomes": "Cancer-specific and pan-cancer lncRNA modulators identified; signals stratify subtypes and associate with outcomes."
          },
          "gaps": "No explicit modelling of stage or metastasis transitions. Network inference is correlative and depends on external TF binding resources and expression covariance.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "https://oncotarget.com/article/11637/text (https://oncotarget.com/article/11637/text)",
          "title": "Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers",
          "authors": [
            "Zhang et al."
          ],
          "year": 2016,
          "venue": "Oncotarget",
          "whyRelevant": "Integrates TCGA expression into lncRNA-miRNA-mRNA networks and quantifies cross-cancer sharing with Jaccard, echoing the source's specificity versus shared-core framing. Identifies a small conserved subnetwork, analogous to a pan-cancer set.",
          "methodOverlap": [
            "More than 5,000 TCGA samples across 12 cancers integrated",
            "Cross-cancer sharing quantified by Jaccard overlap matrices",
            "Small conserved pan-cancer ceRNA core detected"
          ],
          "methodComparison": {
            "sample": "TCGA tumours and matched normals across 12 cancers.",
            "materials": "GENCODE lncRNA classes, hallmark gene sets, and curated miRNA target resources.",
            "equipment": "TCGA RNA-seq expression matrices; computational pipelines for ceRNA network construction.",
            "procedure": "Construct ceRNA networks per cancer and state; compare tumour versus normal; compute Jaccard overlaps; perform survival and pathway enrichment.",
            "outcomes": "Most ceRNA interactions are cancer-specific with a small conserved core; hubs include known lncRNAs."
          },
          "gaps": "Focuses on tumour versus normal rather than stage transitions. ceRNA assumptions and expression noise may inflate or obscure inferred interactions.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1093/narcan/zcaa015",
          "title": "Pan-cancer proteogenomic analysis reveals long and circular noncoding RNAs encoding peptides",
          "authors": [
            "Othoum et al."
          ],
          "year": 2020,
          "venue": "NAR Cancer",
          "whyRelevant": "Directly addresses the source paper's small-protein capacity signal via proteogenomics. Integrates TCGA-like transcriptomes with CPTAC MS/MS to verify peptides from lncRNAs.",
          "methodOverlap": [
            "Integrates TCGA transcriptomes with CPTAC proteomes across nine cancers",
            "Target-decoy FDR control using MSFragger and PeptideProphet",
            "Widespread lncRNA-derived peptides discovered pan-cancer"
          ],
          "methodComparison": {
            "sample": "More than 900 patients across nine cancer cohorts with matched proteomes and transcriptomes.",
            "materials": "LNCipedia, MiOncoCirc, UniProt, and custom ORF databases for search space.",
            "equipment": "LC-MS/MS platforms with TMT or iTRAQ protocols and computational search engines.",
            "procedure": "Proteogenomic target-decoy searches; peptide calling and validation with standard FDR pipelines.",
            "outcomes": "Thousands of lncRNA-derived peptides identified across cancers, supporting coding capacity in noncoding RNAs."
          },
          "gaps": "Not focused on stage or metastasis transitions, so clinical transition mapping is indirect. Peptide detection alone does not establish function or prognostic utility.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        }
      ],
      "authorContacts": {
        "maxChars": 2047,
        "truncated": false,
        "text": "Paper: Transitional lncRNA Signatures Reveal Distinct Stages of Cancer Progression and Metastasis (Source)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Stav Zok | Not found | Not found | 0000-0002-7961-6411 |\n| Daniel Behar | Not found | Not found | Not found |\n| Michal Linial | michall@mail.huji.ac.il | Not found | 0000-0002-6776-8866 |\n\nPaper: Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Arghavan Ashouri | Not found | Project Manager, University Health Network (Toronto) | Not found |\n| Erik Larsson | erik.larsson@gu.se | Professor, University of Gothenburg | 0000-0003-1400-0119 |\n| Thales Papagiannakopoulos | thales.papagiannakopoulos@nyumc.org | Associate Professor, NYU Grossman School of Medicine | Not found |\n\nPaper: LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations (10.1093/nar/gkx1311)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Yongsheng Li | Not found | Not found | 0000-0003-1914-0727 |\n| Xia Li | lixia@hrbmu.edu.cn | Not found | 0000-0002-9794-2648 |\n| Song Yi | syi2@mdanderson.org | Not found | Not found |\n\nPaper: Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Yunpeng Zhang | zhangyp@hrbmu.edu.cn | Professor and Section Head, College of Bioinformatics Science and Technology, Harbin Medical University | Not found |\n| Xia Li | lixia@hrbmu.edu.cn | Not found | Not found |\n| Jing Li | Not found | Not found | Not found |\n\nPaper: Pan-cancer proteogenomic analysis reveals long and circular noncoding RNAs encoding peptides (10.1093/narcan/zcaa015)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Ghofran Othoum | Not found | Not found | 0000-0002-0376-3244 |\n| Christopher A. Maher | christophermaher@wustl.edu | Professor of Medicine, Division of Oncology, Washington University School of Medicine | Not found |",
        "structured": {
          "papers": [
            {
              "title": "Transitional lncRNA Signatures Reveal Distinct Stages of Cancer Progression and Metastasis",
              "identifier": "Source",
              "authors": [
                {
                  "name": "Stav Zok",
                  "email": null,
                  "role": null,
                  "orcid": "0000-0002-7961-6411",
                  "profiles": []
                },
                {
                  "name": "Daniel Behar",
                  "email": null,
                  "role": null,
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Michal Linial",
                  "email": "michall@mail.huji.ac.il",
                  "role": null,
                  "orcid": "0000-0002-6776-8866",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=V1nR1GgAAAAJ"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://www.huji.ac.il/mandel-linial-lab"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events",
              "identifier": null,
              "authors": [
                {
                  "name": "Arghavan Ashouri",
                  "email": null,
                  "role": "Project Manager, University Health Network (Toronto)",
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Erik Larsson",
                  "email": "erik.larsson@gu.se",
                  "role": "Professor, University of Gothenburg",
                  "orcid": "0000-0003-1400-0119",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=m1lhgKgAAAAJ"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://www.gu.se/en/research/erik-larsson"
                    }
                  ]
                },
                {
                  "name": "Thales Papagiannakopoulos",
                  "email": "thales.papagiannakopoulos@nyumc.org",
                  "role": "Associate Professor, NYU Grossman School of Medicine",
                  "orcid": null,
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=E2NH9scAAAAJ"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://www.papaglab.com/"
                    }
                  ]
                }
              ]
            },
            {
              "title": "LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations",
              "identifier": "10.1093/nar/gkx1311",
              "authors": [
                {
                  "name": "Yongsheng Li",
                  "email": null,
                  "role": null,
                  "orcid": "0000-0003-1914-0727",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=GwyVurAAAAAJ"
                    }
                  ]
                },
                {
                  "name": "Xia Li",
                  "email": "lixia@hrbmu.edu.cn",
                  "role": null,
                  "orcid": "0000-0002-9794-2648",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=AnMfnlkAAAAJ"
                    }
                  ]
                },
                {
                  "name": "Song Yi",
                  "email": "syi2@mdanderson.org",
                  "role": null,
                  "orcid": null,
                  "profiles": []
                }
              ]
            },
            {
              "title": "Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers",
              "identifier": null,
              "authors": [
                {
                  "name": "Yunpeng Zhang",
                  "email": "zhangyp@hrbmu.edu.cn",
                  "role": "Professor and Section Head, College of Bioinformatics Science and Technology, Harbin Medical University",
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Xia Li",
                  "email": "lixia@hrbmu.edu.cn",
                  "role": null,
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Jing Li",
                  "email": null,
                  "role": null,
                  "orcid": null,
                  "profiles": []
                }
              ]
            },
            {
              "title": "Pan-cancer proteogenomic analysis reveals long and circular noncoding RNAs encoding peptides",
              "identifier": "10.1093/narcan/zcaa015",
              "authors": [
                {
                  "name": "Ghofran Othoum",
                  "email": null,
                  "role": null,
                  "orcid": "0000-0002-0376-3244",
                  "profiles": []
                },
                {
                  "name": "Christopher A. Maher",
                  "email": "christophermaher@wustl.edu",
                  "role": "Professor of Medicine, Division of Oncology, Washington University School of Medicine",
                  "orcid": null,
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=GSFtjZsAAAAJ"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://www.maherlab.com/"
                    }
                  ]
                }
              ]
            }
          ],
          "promptNotes": ""
        }
      },
      "researcherTheses": {
        "maxChars": 5688,
        "truncated": false,
        "text": "Researcher: Stav Zok\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Signatures of Micropeptides Encoded by lncRNAs in Cancer Progression and Metastasis\n  - Year: 2025\n  - Venue: bioRxiv\n  - URL: https://sciety.org/articles/activity/10.1101/2025.09.22.677872\nPhD thesis: Not found\n\nResearcher: Daniel Behar\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Transitional lncRNA Signatures Reveal Distinct Stages of Cancer Progression and Metastasis\n  - Year: 2025\n  - Venue: bioRxiv\n  - URL: https://sciety.org/articles/activity/10.1101/2025.06.10.658949\nPhD thesis: Not found\n\nResearcher: Michal Linial\nEmail: michall@mail.huji.ac.il\nData publicly available: yes\nLatest publication:\n  - Title: ProteinBERT: a universal deep-learning model of protein sequence and function\n  - Year: 2022\n  - Venue: Bioinformatics\n  - URL: https://academic.oup.com/bioinformatics/article/38/8/2102/6502274\nPhD thesis:\n  - Title: Control of replication and organization of kinetoplast DNA in trypanosomatids\n  - Year: 1987\n  - Institution: The Hebrew University of Jerusalem\n  - URL: https://www.nli.org.il/en/dissertations/NNL_ALEPH990010539760205171/NLI\n\nResearcher: Arghavan Ashouri\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Decoding Cancer Evolution: Integrating Genetic and Non-Genetic Insights\n  - Year: 2023\n  - Venue: Genes\n  - URL: https://utoronto.scholaris.ca/bitstreams/5ddb7451-1475-4324-b844-112daf36e36a/download\nPhD thesis:\n  - Title: Pan-cancer study of transcriptional responses to oncogenic somatic mutations\n  - Year: 2021\n  - Institution: University of Gothenburg, Sahlgrenska Academy (Institute of Biomedicine)\n  - URL: https://gupea.ub.gu.se/handle/2077/68071\n\nResearcher: Erik Larsson\nEmail: erik.larsson@gu.se\nData publicly available: unknown\nLatest publication:\n  - Title: Mechanistic basis of atypical TERT promoter mutations\n  - Year: 2024\n  - Venue: Nature Communications\n  - URL: https://preview-www.nature.com/articles/s41467-024-54158-5.pdf\nPhD thesis:\n  - Title: Regulation of gene expression in the vascular wall\n  - Year: 2009\n  - Institution: University of Gothenburg (Sahlgrenska Academy)\n  - URL: https://gupea.ub.gu.se/bitstream/2077/19056/1/gupea_2077_19056_1.pdf\n\nResearcher: Thales Papagiannakopoulos\nEmail: thales.papagiannakopoulos@nyumc.org\nData publicly available: unknown\nLatest publication:\n  - Title: KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance\n  - Year: 2023\n  - Venue: Cell Reports\n  - URL: https://www.cell.com/cell-reports/fulltext/S2211-1247%2823%2901307-4\nPhD thesis: Not found\n\nResearcher: Yongsheng Li\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Cancer Stemness Online: A Resource for Investigating Cancer Stemness\n  - Year: 2024\n  - Venue: Genomics, Proteomics & Bioinformatics\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Xia Li\nEmail: lixia@hrbmu.edu.cn\nData publicly available: yes\nLatest publication:\n  - Title: CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data\n  - Year: 2023\n  - Venue: Nucleic Acids Research\n  - URL: https://europepmc.org/article/med/36300619\nPhD thesis: Not found\n\nResearcher: Song Yi\nEmail: syi2@mdanderson.org\nData publicly available: unknown\nLatest publication:\n  - Title: MERIT: Systematic Analysis and Characterization of Mutational Effect on RNA Interactome Topology\n  - Year: 2019\n  - Venue: Hepatology\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Yunpeng Zhang\nEmail: zhangyp@hrbmu.edu.cn\nData publicly available: yes\nLatest publication:\n  - Title: CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data\n  - Year: 2023\n  - Venue: Nucleic Acids Research\n  - URL: https://europepmc.org/article/med/36300619\nPhD thesis: Not found\n\nResearcher: Jing Li\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in breast cancer subtypes\n  - Year: 2021\n  - Venue: Molecular Therapy - Nucleic Acids\n  - URL: https://www.cell.com/molecular-therapy-family/nucleic-acids/fulltext/S2162-2531%2820%2930405-4\nPhD thesis: Not found\n\nResearcher: Ghofran Othoum\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: CrypticProteinDB: an integrated database of proteome and immunopeptidome derived non-canonical cancer proteins\n  - Year: 2023\n  - Venue: NAR Cancer\n  - URL: https://academic.oup.com/narcancer/article/5/2/zcad024/7187698\nPhD thesis:\n  - Title: Genome-scale Evaluation of the Biotechnological Potential of Red Sea Bacilli Strains\n  - Year: 2018\n  - Institution: King Abdullah University of Science and Technology (KAUST)\n  - URL: https://repository.kaust.edu.sa/bitstream/handle/10754/627988/Dissertation_Ghofran_Spring_18_after_report.pdf?sequence=1\n\nResearcher: Christopher A. Maher\nEmail: christophermaher@wustl.edu\nData publicly available: unknown\nLatest publication:\n  - Title: Characterization of cell-type specific circular RNAs associated with colorectal cancer metastasis\n  - Year: 2023\n  - Venue: NAR Cancer\n  - URL: https://www.x-mol.com/paper/1661062225854812160?adv=\nPhD thesis:\n  - Title: Understanding regulatory sequences via comparative genomics\n  - Year: 2006\n  - Institution: Stony Brook University (inter-institutional programme with Cold Spring Harbor Laboratory)\n  - URL: https://search.library.stonybrook.edu/discovery/fulldisplay/alma990012031940204856/01SUNY_STB%3A01SUNY_STB",
        "structured": {
          "researchers": [
            {
              "name": "Stav Zok",
              "email": null,
              "latest_publication": {
                "title": "Signatures of Micropeptides Encoded by lncRNAs in Cancer Progression and Metastasis",
                "year": 2025,
                "venue": "bioRxiv",
                "url": "https://sciety.org/articles/activity/10.1101/2025.09.22.677872"
              },
              "phd_thesis": null,
              "data_publicly_available": "unknown"
            },
            {
              "name": "Daniel Behar",
              "email": null,
              "latest_publication": {
                "title": "Transitional lncRNA Signatures Reveal Distinct Stages of Cancer Progression and Metastasis",
                "year": 2025,
                "venue": "bioRxiv",
                "url": "https://sciety.org/articles/activity/10.1101/2025.06.10.658949"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "Michal Linial",
              "email": "michall@mail.huji.ac.il",
              "latest_publication": {
                "title": "ProteinBERT: a universal deep-learning model of protein sequence and function",
                "year": 2022,
                "venue": "Bioinformatics",
                "url": "https://academic.oup.com/bioinformatics/article/38/8/2102/6502274"
              },
              "phd_thesis": {
                "title": "Control of replication and organization of kinetoplast DNA in trypanosomatids",
                "year": 1987,
                "institution": "The Hebrew University of Jerusalem",
                "url": "https://www.nli.org.il/en/dissertations/NNL_ALEPH990010539760205171/NLI"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Arghavan Ashouri",
              "email": null,
              "latest_publication": {
                "title": "Decoding Cancer Evolution: Integrating Genetic and Non-Genetic Insights",
                "year": 2023,
                "venue": "Genes",
                "url": "https://utoronto.scholaris.ca/bitstreams/5ddb7451-1475-4324-b844-112daf36e36a/download"
              },
              "phd_thesis": {
                "title": "Pan-cancer study of transcriptional responses to oncogenic somatic mutations",
                "year": 2021,
                "institution": "University of Gothenburg, Sahlgrenska Academy (Institute of Biomedicine)",
                "url": "https://gupea.ub.gu.se/handle/2077/68071"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Erik Larsson",
              "email": "erik.larsson@gu.se",
              "latest_publication": {
                "title": "Mechanistic basis of atypical TERT promoter mutations",
                "year": 2024,
                "venue": "Nature Communications",
                "url": "https://preview-www.nature.com/articles/s41467-024-54158-5.pdf"
              },
              "phd_thesis": {
                "title": "Regulation of gene expression in the vascular wall",
                "year": 2009,
                "institution": "University of Gothenburg (Sahlgrenska Academy)",
                "url": "https://gupea.ub.gu.se/bitstream/2077/19056/1/gupea_2077_19056_1.pdf"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Thales Papagiannakopoulos",
              "email": "thales.papagiannakopoulos@nyumc.org",
              "latest_publication": {
                "title": "KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance",
                "year": 2023,
                "venue": "Cell Reports",
                "url": "https://www.cell.com/cell-reports/fulltext/S2211-1247%2823%2901307-4"
              },
              "phd_thesis": null,
              "data_publicly_available": "unknown"
            },
            {
              "name": "Yongsheng Li",
              "email": null,
              "latest_publication": {
                "title": "Cancer Stemness Online: A Resource for Investigating Cancer Stemness",
                "year": 2024,
                "venue": "Genomics, Proteomics & Bioinformatics",
                "url": null
              },
              "phd_thesis": null,
              "data_publicly_available": "unknown"
            },
            {
              "name": "Xia Li",
              "email": "lixia@hrbmu.edu.cn",
              "latest_publication": {
                "title": "CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data",
                "year": 2023,
                "venue": "Nucleic Acids Research",
                "url": "https://europepmc.org/article/med/36300619"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "Song Yi",
              "email": "syi2@mdanderson.org",
              "latest_publication": {
                "title": "MERIT: Systematic Analysis and Characterization of Mutational Effect on RNA Interactome Topology",
                "year": 2019,
                "venue": "Hepatology",
                "url": null
              },
              "phd_thesis": null,
              "data_publicly_available": "unknown"
            },
            {
              "name": "Yunpeng Zhang",
              "email": "zhangyp@hrbmu.edu.cn",
              "latest_publication": {
                "title": "CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data",
                "year": 2023,
                "venue": "Nucleic Acids Research",
                "url": "https://europepmc.org/article/med/36300619"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "Jing Li",
              "email": null,
              "latest_publication": {
                "title": "Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in breast cancer subtypes",
                "year": 2021,
                "venue": "Molecular Therapy - Nucleic Acids",
                "url": "https://www.cell.com/molecular-therapy-family/nucleic-acids/fulltext/S2162-2531%2820%2930405-4"
              },
              "phd_thesis": null,
              "data_publicly_available": "unknown"
            },
            {
              "name": "Ghofran Othoum",
              "email": null,
              "latest_publication": {
                "title": "CrypticProteinDB: an integrated database of proteome and immunopeptidome derived non-canonical cancer proteins",
                "year": 2023,
                "venue": "NAR Cancer",
                "url": "https://academic.oup.com/narcancer/article/5/2/zcad024/7187698"
              },
              "phd_thesis": {
                "title": "Genome-scale Evaluation of the Biotechnological Potential of Red Sea Bacilli Strains",
                "year": 2018,
                "institution": "King Abdullah University of Science and Technology (KAUST)",
                "url": "https://repository.kaust.edu.sa/bitstream/handle/10754/627988/Dissertation_Ghofran_Spring_18_after_report.pdf?sequence=1"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Christopher A. Maher",
              "email": "christophermaher@wustl.edu",
              "latest_publication": {
                "title": "Characterization of cell-type specific circular RNAs associated with colorectal cancer metastasis",
                "year": 2023,
                "venue": "NAR Cancer",
                "url": "https://www.x-mol.com/paper/1661062225854812160?adv="
              },
              "phd_thesis": {
                "title": "Understanding regulatory sequences via comparative genomics",
                "year": 2006,
                "institution": "Stony Brook University (inter-institutional programme with Cold Spring Harbor Laboratory)",
                "url": "https://search.library.stonybrook.edu/discovery/fulldisplay/alma990012031940204856/01SUNY_STB%3A01SUNY_STB"
              },
              "data_publicly_available": "unknown"
            }
          ]
        }
      },
      "patents": {
        "text": "Patent: US20230348994A1\nTitle: Identification of Immune-related lncRNA Signatures with Prognostic Connotation in Multi-Cancer Setting\nAssignee: Hamad Bin Khalifa University; Sidra Medicine; Qatar Foundation\nFiling Date: 2023-04-28\nGrant Date: Not provided\nAbstract: Discloses workflows to derive immune-related lncRNA signatures by differential-expression analysis and network propagation, and to use such signatures for prognosis across multiple solid cancers. Panels and scoring methods are applied pan-cancer and within specific tumour types.\nOverlaps with paper claims: C1, C2\nTechnical overlap: The claims cover selecting lncRNAs via differential expression across cohorts and validating signatures across many tumour types, mirroring the paper's per-cancer DE and coherence-based selection that shows limited cross-cancer sharing. The application's small pan-cancer signature used for prognosis maps to the paper's pan-cancer subset analysis and cross-cancer correlation behaviour.\n\nPatent: WO2023086552A2\nTitle: lncRNA transcripts in melanomagenesis\nAssignee: The Regents of the University of California (Berkeley and San Diego)\nFiling Date: 2022-11-11\nGrant Date: Not provided\nAbstract: Claims melanoma-specific lncRNA transcripts, diagnostic panels and methods derived from tumour expression comparisons with defined thresholds. Provides panels for risk assessment and therapy selection focused on melanoma.\nOverlaps with paper claims: C1\nTechnical overlap: The specification builds fixed lncRNA panels for a single tumour type using expression-thresholded differential analysis, aligning with the paper's cancer-type specific Tr-lncRNA discovery approach. Its per-cancer paneling supports the paper's finding that most transitional lncRNA signals are specific to a cancer type with minimal sharing.\n\nPatent: CN112852969B\nTitle: Epigenetically modified lncRNA as tumour diagnosis or tumour progression prediction marker\nAssignee: Wenzhou Medical University\nFiling Date: 2021-04-19\nGrant Date: 2022-06-10\nAbstract: Identifies a broad-spectrum set of 5-hydroxymethylcytosine-modified lncRNAs that distinguish cancer from healthy controls and predict tumour progression across multiple cancers. Provides detection methods and kits.\nOverlaps with paper claims: C2\nTechnical overlap: By asserting a cross-cancer panel of lncRNA markers with coherent behaviour across tumour types, the claims validate the paper's pan-cancer subset concept. The emphasis on reproducible trends across cancers parallels the paper's observation that a small group of Tr-lncRNAs exhibit consistent transition-linked changes.\n\nPatent: CN111893190A\nTitle: Application of lncRNA XIST as a diagnostic marker for gastric cancer\nAssignee: First Hospital of China Medical University\nFiling Date: 2020-09-15\nGrant Date: Not provided\nAbstract: Uses XIST expression as a diagnostic and prognostic marker for gastric cancer and provides primer and probe sets, kits, and targeting strategies.\nOverlaps with paper claims: C2\nTechnical overlap: Independent claiming of XIST as a clinically actionable biomarker matches the paper's identification of XIST within the small pan-cancer Tr-lncRNA subset that shows coherent trends over metastatic transitions. The claimed detection modalities and disease association substantiate the paper's cross-cancer emphasis on XIST's consistent signal.\n\nPatent: US20240060071A1\nTitle: Treatment of cancer associated with dysregulated novel open reading frame products\nAssignee: Cambridge Enterprise Ltd; International Centre for Genetic Engineering and Biotechnology\nFiling Date: 2021-12-15\nGrant Date: Not provided\nAbstract: Targets cancers via novel open reading frames, including ORFs in non-canonical regions such as lncRNAs. Provides detection and treatment methods spanning multiple tumour types.\nOverlaps with paper claims: C3\nTechnical overlap: The claims leverage peptides encoded by non-canonical ORFs within lncRNAs, evidencing functional small-protein coding capacity in lncRNAs, which the paper finds enriched among Tr-lncRNAs. Its detection and therapeutic use of lncRNA-derived sORFs corroborates the paper's feature-level observation of elevated coding potential, exon complexity and transcript length.",
        "structured": {
          "patents": [
            {
              "patentNumber": "US20230348994A1",
              "title": "Identification of Immune-related lncRNA Signatures with Prognostic Connotation in Multi-Cancer Setting",
              "assignee": "Hamad Bin Khalifa University; Sidra Medicine; Qatar Foundation",
              "filingDate": "2023-04-28",
              "grantDate": null,
              "abstract": "Discloses workflows to derive immune-related lncRNA signatures by differential-expression analysis and network propagation, and to use such signatures for prognosis across multiple solid cancers. Panels and scoring methods are applied pan-cancer and within specific tumour types.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1",
                  "C2"
                ],
                "summary": "The claims cover selecting lncRNAs via differential expression across cohorts and validating signatures across many tumour types, mirroring the paper's per-cancer DE and coherence-based selection that shows limited cross-cancer sharing. The application's small pan-cancer signature used for prognosis maps to the paper's pan-cancer subset analysis and cross-cancer correlation behaviour."
              },
              "url": null
            },
            {
              "patentNumber": "WO2023086552A2",
              "title": "lncRNA transcripts in melanomagenesis",
              "assignee": "The Regents of the University of California (Berkeley and San Diego)",
              "filingDate": "2022-11-11",
              "grantDate": null,
              "abstract": "Claims melanoma-specific lncRNA transcripts, diagnostic panels and methods derived from tumour expression comparisons with defined thresholds. Provides panels for risk assessment and therapy selection focused on melanoma.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1"
                ],
                "summary": "The specification builds fixed lncRNA panels for a single tumour type using expression-thresholded differential analysis, aligning with the paper's cancer-type specific Tr-lncRNA discovery approach. Its per-cancer paneling supports the paper's finding that most transitional lncRNA signals are specific to a cancer type with minimal sharing."
              },
              "url": null
            },
            {
              "patentNumber": "CN112852969B",
              "title": "Epigenetically modified lncRNA as tumour diagnosis or tumour progression prediction marker",
              "assignee": "Wenzhou Medical University",
              "filingDate": "2021-04-19",
              "grantDate": "2022-06-10",
              "abstract": "Identifies a broad-spectrum set of 5-hydroxymethylcytosine-modified lncRNAs that distinguish cancer from healthy controls and predict tumour progression across multiple cancers. Provides detection methods and kits.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2"
                ],
                "summary": "By asserting a cross-cancer panel of lncRNA markers with coherent behaviour across tumour types, the claims validate the paper's pan-cancer subset concept. The emphasis on reproducible trends across cancers parallels the paper's observation that a small group of Tr-lncRNAs exhibit consistent transition-linked changes."
              },
              "url": null
            },
            {
              "patentNumber": "CN111893190A",
              "title": "Application of lncRNA XIST as a diagnostic marker for gastric cancer",
              "assignee": "First Hospital of China Medical University",
              "filingDate": "2020-09-15",
              "grantDate": null,
              "abstract": "Uses XIST expression as a diagnostic and prognostic marker for gastric cancer and provides primer and probe sets, kits, and targeting strategies.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2"
                ],
                "summary": "Independent claiming of XIST as a clinically actionable biomarker matches the paper's identification of XIST within the small pan-cancer Tr-lncRNA subset that shows coherent trends over metastatic transitions. The claimed detection modalities and disease association substantiate the paper's cross-cancer emphasis on XIST's consistent signal."
              },
              "url": null
            },
            {
              "patentNumber": "US20240060071A1",
              "title": "Treatment of cancer associated with dysregulated novel open reading frame products",
              "assignee": "Cambridge Enterprise Ltd; International Centre for Genetic Engineering and Biotechnology",
              "filingDate": "2021-12-15",
              "grantDate": null,
              "abstract": "Targets cancers via novel open reading frames, including ORFs in non-canonical regions such as lncRNAs. Provides detection and treatment methods spanning multiple tumour types.",
              "overlapWithPaper": {
                "claimIds": [
                  "C3"
                ],
                "summary": "The claims leverage peptides encoded by non-canonical ORFs within lncRNAs, evidencing functional small-protein coding capacity in lncRNAs, which the paper finds enriched among Tr-lncRNAs. Its detection and therapeutic use of lncRNA-derived sORFs corroborates the paper's feature-level observation of elevated coding potential, exon complexity and transcript length."
              },
              "url": null
            }
          ],
          "promptNotes": "Converted from analyst notes as provided. Dates reflect filing or grant where explicitly stated in the notes."
        }
      },
      "verifiedClaims": {
        "text": "=== OVERALL ASSESSMENT ===\nThe paper's central narrative aligns directionally with broader literature: most cancer-relevant lncRNA signals appear cancer-type specific with a small shared core, and a subset of lncRNAs can encode micropeptides detectable in tumours. The most specific elements-cross-cancer, metastasis-stage-coherent behaviour of named Tr-lncRNAs (especially XIST and USP9Y) and quantitative feature-enrichment magnitudes-remain preliminary and rely largely on the authors' analysis. Independent replication, biotype disambiguation, and fully re-runnable public pipelines would substantially strengthen verification.\n\n=== VERIFIED CLAIMS ===\n\nClaim: C1\nOriginal: Most Tr-lncRNAs that mark cancer progression are cancer-type specific, with minimal sharing across cancers.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events\n    Reports that many lncRNA signals are tissue-specific with only a subset reproducible across cancers, supporting cancer-type specificity.\n  - [Similar Paper] LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations\n    Shows lncRNA modulators cluster by tissue of origin with only a fraction acting pan-cancer, indicating limited cross-cancer sharing.\n  - [Similar Paper] Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers\n    Quantifies cross-cancer sharing and identifies a small conserved subnetwork, consistent with a small shared core.\n  - [Patent] US20230348994A1: Identification of Immune-related lncRNA Signatures with Prognostic Connotation in Multi-Cancer Setting\n    Describes per-cancer lncRNA panels with selective cross-cancer portability, aligning with predominantly cancer-type specific signals.\n\nContradicting Evidence:\n  - [Similar Paper] LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations\n    Also reports a notable set of pan-cancer modulators, suggesting more sharing than minimal depending on definitions.\n\nSummary: Multiple independent pan-cancer studies show lncRNA signals are largely cancer-type specific with only a modest shared core, consistent with the claim. Some analyses also highlight a meaningful pan-cancer subset, so the degree of sharing is method-dependent and not absolute.\n\nClaim: C2\nOriginal: A small pan-cancer subset of Tr-lncRNAs, notably XIST and USP9Y, shows coherent trends across metastatic transitions, with XIST exhibiting moderate cross-cancer correlation between primary growth and metastasis transitions.\nStatus: Partially Verified\nConfidence: Low\n\nSupporting Evidence:\n  - [Similar Paper] Transitional lncRNA Signatures Reveal Distinct Stages of Cancer Progression and Metastasis\n    Authors' own cross-cancer analysis identifies a small shared set and highlights XIST and USP9Y among pan-cancer hits for stage transitions.\n  - [Patent] CN111893190A: Application of lncRNA XIST as a diagnostic marker for gastric cancer\n    Independent clinical biomarker use of XIST supports broad relevance consistent with inclusion in a shared subset.\n\nSummary: Independent literature supports the existence of a small pan-cancer lncRNA subset, but consistent metastasis-stage coherence for XIST across cancers is not firmly established. USP9Y raises gene biotype concerns and cross-cancer, metastasis-stage trends lack independent replication, so confidence is low.\n\nClaim: C3\nOriginal: Tr-lncRNAs display distinct molecular features versus the background lncRNA set, including longer transcripts, more exons and transcripts, and about twofold higher small-protein coding capacity, with many feature differences reaching FDR significance.\nStatus: Partially Verified\nConfidence: Low\n\nSupporting Evidence:\n  - [Similar Paper] Pan-cancer proteogenomic analysis reveals long and circular noncoding RNAs encoding peptides\n    Provides proteomic evidence that many lncRNAs encode detectable peptides in tumours, supporting elevated small-protein capacity among cancer-relevant lncRNAs.\n  - [Similar Paper] CrypticProteinDB: an integrated database of proteome and immunopeptidome derived non-canonical cancer proteins\n    Catalogues peptide support for thousands of non-canonical ORFs in noncoding RNAs across cancers, reinforcing widespread lncRNA translation.\n  - [Patent] US20240060071A1: Treatment of cancer associated with dysregulated novel open reading frame products\n    Therapeutic targeting of lncRNA-derived micropeptides corroborates functional small-protein coding capacity relevant to cancer.\n\nSummary: There is strong evidence that some lncRNAs encode micropeptides in cancer, supporting the direction of the claim. However, the specific feature-enrichment pattern for transitional lncRNAs versus background and the approximate twofold magnitude have not been independently replicated.\n",
        "structured": {
          "claims": [
            {
              "claimId": "C1",
              "originalClaim": "Most Tr-lncRNAs that mark cancer progression are cancer-type specific, with minimal sharing across cancers.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events",
                  "relevance": "Reports that many lncRNA signals are tissue-specific with only a subset reproducible across cancers, supporting cancer-type specificity."
                },
                {
                  "source": "Similar Paper",
                  "title": "LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations",
                  "relevance": "Shows lncRNA modulators cluster by tissue of origin with only a fraction acting pan-cancer, indicating limited cross-cancer sharing."
                },
                {
                  "source": "Similar Paper",
                  "title": "Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers",
                  "relevance": "Quantifies cross-cancer sharing and identifies a small conserved subnetwork, consistent with a small shared core."
                },
                {
                  "source": "Patent",
                  "title": "US20230348994A1: Identification of Immune-related lncRNA Signatures with Prognostic Connotation in Multi-Cancer Setting",
                  "relevance": "Describes per-cancer lncRNA panels with selective cross-cancer portability, aligning with predominantly cancer-type specific signals."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations",
                  "relevance": "Also reports a notable set of pan-cancer modulators, suggesting more sharing than minimal depending on definitions."
                }
              ],
              "verificationSummary": "Multiple independent pan-cancer studies show lncRNA signals are largely cancer-type specific with only a modest shared core, consistent with the claim. Some analyses also highlight a meaningful pan-cancer subset, so the degree of sharing is method-dependent and not absolute.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C2",
              "originalClaim": "A small pan-cancer subset of Tr-lncRNAs, notably XIST and USP9Y, shows coherent trends across metastatic transitions, with XIST exhibiting moderate cross-cancer correlation between primary growth and metastasis transitions.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Transitional lncRNA Signatures Reveal Distinct Stages of Cancer Progression and Metastasis",
                  "relevance": "Authors' own cross-cancer analysis identifies a small shared set and highlights XIST and USP9Y among pan-cancer hits for stage transitions."
                },
                {
                  "source": "Patent",
                  "title": "CN111893190A: Application of lncRNA XIST as a diagnostic marker for gastric cancer",
                  "relevance": "Independent clinical biomarker use of XIST supports broad relevance consistent with inclusion in a shared subset."
                }
              ],
              "contradictingEvidence": [],
              "verificationSummary": "Independent literature supports the existence of a small pan-cancer lncRNA subset, but consistent metastasis-stage coherence for XIST across cancers is not firmly established. USP9Y raises gene biotype concerns and cross-cancer, metastasis-stage trends lack independent replication, so confidence is low.",
              "confidenceLevel": "Low"
            },
            {
              "claimId": "C3",
              "originalClaim": "Tr-lncRNAs display distinct molecular features versus the background lncRNA set, including longer transcripts, more exons and transcripts, and about twofold higher small-protein coding capacity, with many feature differences reaching FDR significance.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Pan-cancer proteogenomic analysis reveals long and circular noncoding RNAs encoding peptides",
                  "relevance": "Provides proteomic evidence that many lncRNAs encode detectable peptides in tumours, supporting elevated small-protein capacity among cancer-relevant lncRNAs."
                },
                {
                  "source": "Similar Paper",
                  "title": "CrypticProteinDB: an integrated database of proteome and immunopeptidome derived non-canonical cancer proteins",
                  "relevance": "Catalogues peptide support for thousands of non-canonical ORFs in noncoding RNAs across cancers, reinforcing widespread lncRNA translation."
                },
                {
                  "source": "Patent",
                  "title": "US20240060071A1: Treatment of cancer associated with dysregulated novel open reading frame products",
                  "relevance": "Therapeutic targeting of lncRNA-derived micropeptides corroborates functional small-protein coding capacity relevant to cancer."
                }
              ],
              "contradictingEvidence": [],
              "verificationSummary": "There is strong evidence that some lncRNAs encode micropeptides in cancer, supporting the direction of the claim. However, the specific feature-enrichment pattern for transitional lncRNAs versus background and the approximate twofold magnitude have not been independently replicated.",
              "confidenceLevel": "Low"
            }
          ],
          "overallAssessment": "The paper's central narrative aligns directionally with broader literature: most cancer-relevant lncRNA signals appear cancer-type specific with a small shared core, and a subset of lncRNAs can encode micropeptides detectable in tumours. The most specific elements-cross-cancer, metastasis-stage-coherent behaviour of named Tr-lncRNAs (especially XIST and USP9Y) and quantitative feature-enrichment magnitudes-remain preliminary and rely largely on the authors' analysis. Independent replication, biotype disambiguation, and fully re-runnable public pipelines would substantially strengthen verification.",
          "promptNotes": "Independence is limited for C2 where key evidence comes from the authors; replication across external cohorts for metastasis-stage coherence is lacking. Data and code availability appear partial; exact pipelines and thresholds may not be fully reproducible from public artefacts. USP9Y is annotated as protein-coding on the Y chromosome, creating a biotype ambiguity when listed among lncRNAs. Magnitude claims for feature enrichments in C3 need independent re-analysis; current external evidence mainly supports directionality rather than effect size."
        }
      }
    },
    {
      "id": "hartmann-six-2023",
      "sourcePdf": {
        "path": "Hartmann & Six (2023).pdf",
        "publicPath": "/mock-papers/hartmann-six-2023.pdf",
        "title": "Soil structure and microbiome functions in agroecosystems",
        "originalFileName": "Hartmann & Six (2023).pdf",
        "doi": "10.1038/s43017-022-00366-w",
        "pages": 15
      },
      "label": "Hartmann & Six (2023)",
      "generatedAt": "2025-10-28T03:13:16.766Z",
      "claimsAnalysis": {
        "text": "Executive Summary   This review argues that soil structure governs microbiome function in agroecosystems and that management practices that protect or rebuild structure enhance beneficial microbial processes. Headline numbers include: approximately half of the ~120 Pg C emitted annually on land arises from heterotrophic microbial respiration; methanogens produce about two-thirds of the 500-600 Tg CH4 per year while methanotrophs consume roughly 60% of global CH4 and oxidise ~30 Tg directly from the atmosphere; soils emit ~6.8 Tg N2O per year (~65% of global total), with agriculture responsible for ~52% of anthropogenic N2O. A case example shows a 53% tomato yield increase with N2O reduced from ~2.01 to 0.58 kg N2O-N ha -1 under an integrated system. Overall evidence strength: Moderate (broad, well-established mechanisms and multiple quantitative figures, but this is a narrative review with context-dependent outcomes and limited causal quantification across scales). (Abstract; pp. 5-6 Key functions; Fig. 1 p. 6-7; pp. 11-14 Management; \"Recommendations\" p. 14; integrated tomato system p. 14)  Top 3 Claims and Evidence  C1. One-sentence claim   Soil structure (aggregates and pore connectivity) is a primary driver of soil microbiome assembly and functioning, regulating water, oxygen and nutrient flows and thereby determining microbial processes and agroecosystem outcomes. (Abstract; \"Soil structure drives the microbiome\" pp. 8-10; Figs. 2-3 pp. 9-11)  Evidence summary (design, sample, measures, analysis)   Narrative synthesis of field and experimental studies summarised with mechanistic figures. Measures include particle size fractions, aggregate habitats, pore size classes, organism distributions, and functional implications (carbon stabilisation, nitrification/denitrification, CH4/N2O flux). (pp. 8-10; Fig. 2)  Key numbers (effect size, CI, p, N, timeframe)    47-69% of detected bacterial and fungal taxa associate with specific particle size fractions; smaller fractions carry ~10-fold larger microbial loads per size class and up to 48-52% greater diversity. (p. 9)    ~90% of soil bacteria associate with microaggregates, ~70% residing inside microaggregates; <10% on macroaggregate surfaces. (p. 9)    Pore hierarchy: macropores >75 m; pores between macroaggregates; within macroaggregates; within microaggregates; sharp O2 and nutrient gradients select for aerobic vs anaerobic guilds. (p. 10; Fig. 2)    Microaggregate pores are likely simultaneous hotspots for C stabilisation and N2O emissions; the trade-off is not well understood or quantified. (p. 10)  Source location (page/section/figure/table)   \"Soil structure drives the microbiome\" (pp. 8-10); Fig. 2 (pp. 9-10); discussion of pore-scale trade-offs (p. 10).  Strength rating and assumptions   Strength: Moderate. Assumptions: \"mm\" in \"Macroaggregate >250 mm\" in Fig. 2 is [UNCLEAR]; consistent text elsewhere indicates >250 m and <250 m, so m assumed. (p. 9; Fig. 2)  C2. One-sentence claim   Soil microbiomes drive core agroecosystem functions, including climate regulation and nutrient cycling, with quantitatively large contributions to global greenhouse gas budgets. (Abstract; \"Key functions of the soil microbiome\" pp. 5-7; Fig. 1 p. 6-7)  Evidence summary (design, sample, measures, analysis)   Narrative synthesis collating global flux estimates and microbial pathway attributions (CO2 respiration, CH4 methanogenesis/methanotrophy, N2O from nitrification/denitrification). (pp. 5-6; Fig. 1)  Key numbers (effect size, CI, p, N, timeframe)    ~50% of ~120 Pg C emitted per year on land is from heterotrophic microbial respiration; \"up to nine times more\" than yearly global anthropogenic sources. (p. 5)    Methanogens are responsible for ~two-thirds of 500-600 Tg CH4 per year; methanotrophs oxidise ~30 Tg directly from the atmosphere and consume roughly 60% of globally produced CH4. (p. 5-6; Fig. 1)    Soils contribute ~6.8 Tg N2O per year (~65% of global emissions); agriculture accounts for ~52% of global anthropogenic N2O. (p. 5-6)  Source location (page/section/figure/table)   \"Key functions of the soil microbiome - Climate regulation\" (pp. 5-6); Fig. 1 (p. 6-7).  Strength rating and assumptions   Strength: High for the general claim (well-established budgets and pathways as presented).  C3. One-sentence claim   Conservation-oriented management (reduced/no tillage, crop diversification, cover cropping, organic amendments, integrated soil fertility and pest management) generally improves soil structure and supports beneficial microbial functions, though effects and trade-offs are context-dependent. (Abstract; \"Microbiome functions in agroecosystems\" pp. 11-14; Figs. 3-4 pp. 10-12)  Evidence summary (design, sample, measures, analysis)   Narrative synthesis of field findings and meta-analytic patterns: effects of tillage on aggregation/fluxes, compaction on pore networks and GHGs, cover crops and rotations on microbial diversity and function, organic vs mineral fertilisers on structure and biogeochemistry; specific field case studies provided. (pp. 11-14; Figs. 3-4)  Key numbers (effect size, CI, p, N, timeframe)    Compaction affects an estimated 68 million ha (~one-quarter of global agricultural land). (p. 12)    Tillage increases CO2 emissions via macroaggregate breakdown; cessation of tillage can initially increase N2O but decreases with long-term no-tillage; CH4 generally decreases under conservation tillage due to a more stable pore network aiding methanotrophy. (pp. 12-13)    Integrated tomato system (California): reduced tillage + drip fertigation + triticale cover crop increased yield by ~53% and reduced N2O from ~2.01 to 0.58 kg N2O-N ha-1 on 5 ha. (p. 14)    Quesungual slash-and-mulch agroforestry system: earthworms 13.4 vs 0.8 g m-2 (QSMAS vs SB), available P tripled, soil carbon increased; macrofauna biomass increased vs secondary forest (dry season 24.8 vs 4.3 g m-2; wet season 41.9 vs 13.1 g m-2). (p. 14)  Source location (page/section/figure/table)   \"Soil management,\" \"Crop management,\" \"External inputs,\" and \"Recommendations\" (pp. 11-14); Figs. 3-4 (pp. 10-12).  Strength rating and assumptions   Strength: Moderate. Effects are repeatedly noted as crop/soil/climate dependent; specific quantified case studies support plausibility but generalisability is limited.  Gaps & Limitations (linked to C1-C3)    C1: Pore-scale trade-off between C stabilisation and N2O is \"not well understood, let alone quantified\"; aggregate dynamics under different interventions are \"rarely directly investigated.\" (p. 10)    C2: The review provides budgets and attributions but no new primary quantification; pathway contributions can vary by soil and management, which is not resolved here. (pp. 5-6)    C3: Outcomes are context-dependent and sometimes contradictory (e.g., N2O under no-till; variable biochar and organic fertiliser effects; inoculant establishment and non-target effects uncertain). Long-term, cross-site causal links from management to pore/aggregate-scale microbiome processes remain sparse. (pp. 12-14)  Methods Snapshot   Narrative review using an online network-based literature mapping tool (Research Rabbit) to identify relevant literature; synthesised mechanisms and management impacts with integrative figures and selected quantitative examples. No formal systematic review protocol or meta-analysis is described. (Introduction, p. 5)  Risk-of-Bias/Quality Checklist    Literature identification: non-systematic mapping; potential selection bias. (p. 5)    Heterogeneity: acknowledged context dependence across soils, climates, crops. (pp. 12-14)    Causality: many inferences are mechanistic or associative; limited direct multiscale causal quantification. (pp. 9-10, 12-14)    Precision/reporting: many figures are qualitative; where numbers are given they are reported here exactly as in the text.    External validity: strong conceptual generality; site-specific performance and trade-offs remain to be validated broadly. (pp. 12-15)  Open Questions & Next Steps    Quantify the pore-scale C-stabilisation vs N2O trade-off across soil types and degradation levels. (p. 10)    Link microscale physicochemical gradients (within/among aggregates) to cell-level activity using imaging and tracing (e.g., NanoSIMS, Raman) combined with single-cell genomics. (p. 15)    Run long-term, cross-soil/climate trials that connect management (no-till, cover crops, organic inputs, IPM/ISFM) to aggregate/pore architecture and specific microbial guild functions, including GHG outcomes. (pp. 12-15)    Resolve when and where microbial inoculants reliably persist and benefit structure/function vs when promoting native communities is preferable; assess legacy and non-target effects. (pp. 13-14)    Expand research in developing countries and underrepresented soil types where reliance on nature-based solutions is high. (p. 15)  QA checks    All required sections present.    Numbers reproduced verbatim.    Each claim includes strength and source locations.    OCR artefact flagged: \"Macroaggregate >250 mm\" in Fig. 2 interpreted as >250 m based on surrounding text. (p. 9; Fig. 2)",
        "structured": {
          "executiveSummary": [
            "Soil structure governs microbiome function in agroecosystems; protecting or rebuilding structure enhances beneficial microbial processes.",
            "Headline numbers: ~50% of ~120 Pg C land emissions from heterotrophic microbial respiration; methanogens ~two-thirds of 500-600 Tg CH4 yr-1; methanotrophs consume ~60% of global CH4 and oxidise ~30 Tg from atmosphere; soils emit ~6.8 Tg N2O yr-1 (~65% of global), agriculture ~52% of anthropogenic N2O.",
            "Case example: integrated tomato system increased yield by ~53% and reduced N2O from ~2.01 to 0.58 kg N2O-N ha -1.",
            "Overall evidence strength: Moderate (narrative review; context-dependent outcomes; limited causal quantification across scales)."
          ],
          "claims": [
            {
              "id": "C1",
              "claim": "Soil structure (aggregates and pore connectivity) is a primary driver of soil microbiome assembly and functioning, regulating water, oxygen and nutrient flows and thereby determining microbial processes and agroecosystem outcomes.",
              "evidenceSummary": "Narrative synthesis of field and experimental studies with mechanistic figures; measures include particle size fractions, aggregate habitats, pore classes, organism distributions, and functional implications (C stabilisation, nitrification/denitrification, CH4/N2O flux).",
              "keyNumbers": [
                "47-69% of detected bacterial and fungal taxa associate with specific particle size fractions; smaller fractions carry ~10-fold larger microbial loads per size class and up to 48-52% greater diversity.",
                "~90% of soil bacteria associate with microaggregates; ~70% inside microaggregates; <10% on macroaggregate surfaces.",
                "Macropores >75 m; hierarchical pore network; sharp O2 and nutrient gradients selecting aerobic vs anaerobic guilds.",
                "Microaggregate pores likely hotspots for C stabilisation and N2O emissions; trade-off not quantified."
              ],
              "source": "\"Soil structure drives the microbiome\" pp. 8-10; Fig. 2 pp. 9-10; pore-scale trade-offs p. 10.",
              "strength": "Moderate",
              "assumptions": "\"mm\" in \"Macroaggregate >250 mm\" in Fig. 2 is [UNCLEAR]; assumed m based on surrounding text.",
              "evidenceType": "Narrative review (secondary synthesis)"
            },
            {
              "id": "C2",
              "claim": "Soil microbiomes drive core agroecosystem functions, including climate regulation and nutrient cycling, with quantitatively large contributions to global greenhouse gas budgets.",
              "evidenceSummary": "Narrative synthesis compiling global flux estimates and microbial pathway attributions for CO2, CH4, and N2O.",
              "keyNumbers": [
                "~50% of ~120 Pg C emitted per year on land from heterotrophic microbial respiration; up to nine times more than yearly global anthropogenic sources.",
                "Methanogens ~two-thirds of 500-600 Tg CH4 yr-1; methanotrophs oxidise ~30 Tg directly from atmosphere and consume roughly 60% of global CH4.",
                "Soils ~6.8 Tg N2O yr-1 (~65% of global emissions); agriculture ~52% of global anthropogenic N2O."
              ],
              "source": "Key functions pp. 5-6; Fig. 1 pp. 6-7.",
              "strength": "High",
              "assumptions": null,
              "evidenceType": "Narrative review (secondary synthesis)"
            },
            {
              "id": "C3",
              "claim": "Conservation-oriented management (reduced/no tillage, crop diversification, cover cropping, organic amendments, integrated soil fertility and pest management) generally improves soil structure and supports beneficial microbial functions, though effects and trade-offs are context-dependent.",
              "evidenceSummary": "Narrative synthesis of field findings/meta-analytic patterns on tillage, compaction, cover crops, fertilisers, and case studies (integrated tomato system; QSMAS).",
              "keyNumbers": [
                "Compaction affects ~68 million ha (~one-quarter of global agricultural land).",
                "Under conservation tillage: CO2 increases with tillage; N2O may initially rise then fall with long-term no-till; CH4 generally decreases as stable pore networks aid methanotrophy.",
                "Integrated tomato system: yield  ~53%; N2O reduced from ~2.01 to 0.58 kg N2O-N ha-1 on 5 ha.",
                "QSMAS: earthworms 13.4 vs 0.8 g m-2 (QSMAS vs SB); available P tripled; macrofauna biomass vs secondary forest - dry 24.8 vs 4.3 g m-2; wet 41.9 vs 13.1 g m-2."
              ],
              "source": "Soil/Crop/External inputs pp. 11-14; Figs. 3-4 pp. 10-12; Recommendations p. 14.",
              "strength": "Moderate",
              "assumptions": "Effects are crop/soil/climate dependent; generalisability limited beyond reported contexts.",
              "evidenceType": "Narrative review with case studies"
            }
          ],
          "gaps": [
            {
              "category": "Quantification gap",
              "detail": "Pore-scale C-stabilisation vs N2O trade-off not well understood or quantified.",
              "relatedClaimIds": [
                "C1"
              ]
            },
            {
              "category": "Evidence gap",
              "detail": "Aggregate dynamics under different interventions rarely investigated directly.",
              "relatedClaimIds": [
                "C1"
              ]
            },
            {
              "category": "Generalisability",
              "detail": "Budgets and pathway attributions synthesised without new primary quantification; variability by soil/management unresolved.",
              "relatedClaimIds": [
                "C2"
              ]
            },
            {
              "category": "Intervention heterogeneity",
              "detail": "Context-dependent and sometimes contradictory outcomes (e.g., N2O under no-till; variable biochar/organic fertiliser effects; inoculant establishment and non-target effects uncertain).",
              "relatedClaimIds": [
                "C3"
              ]
            },
            {
              "category": "Causal linkage",
              "detail": "Long-term, cross-site causal links from management to pore/aggregate-scale microbiome processes are sparse.",
              "relatedClaimIds": [
                "C3"
              ]
            }
          ],
          "methodsSnapshot": [
            "Narrative review using Research Rabbit to identify literature.",
            "Synthesised mechanisms and management impacts with integrative figures and selected quantitative examples.",
            "No formal systematic review protocol or meta-analysis described."
          ],
          "riskChecklist": [
            {
              "item": "Literature identification approach",
              "status": "partial",
              "note": "Non-systematic mapping; potential selection bias."
            },
            {
              "item": "Heterogeneity acknowledged",
              "status": "met",
              "note": "Context dependence across soils, climates, crops explicitly noted."
            },
            {
              "item": "Causality support",
              "status": "partial",
              "note": "Mechanistic/associative inferences; limited direct multiscale causal quantification."
            },
            {
              "item": "Precision/reporting of effects",
              "status": "partial",
              "note": "Many qualitative figures; quantitative numbers provided selectively."
            },
            {
              "item": "External validity",
              "status": "partial",
              "note": "Strong conceptual generality; site-specific performance and trade-offs need broader validation."
            },
            {
              "item": "Registration/protocol",
              "status": "missing",
              "note": "No protocol or registration stated."
            },
            {
              "item": "Meta-analysis",
              "status": "missing",
              "note": "No formal meta-analysis reported."
            }
          ],
          "openQuestions": [
            "Quantify pore-scale C-stabilisation vs N2O trade-off across soil types and degradation levels.",
            "Link microscale gradients to single-cell activity using imaging/tracing with single-cell genomics.",
            "Long-term cross-soil/climate trials connecting management to aggregate/pore architecture and specific microbial guild functions including GHG outcomes.",
            "Establishment, persistence, benefits, and risks of microbial inoculants vs promoting native communities; assess legacy and non-target effects.",
            "Expand research in developing countries and underrepresented soil types with high reliance on nature-based solutions."
          ],
          "crossPaperComparison": []
        }
      },
      "createdAt": "2025-10-23T06:01:46.288Z",
      "updatedAt": "2025-10-28T05:15:30.518Z",
      "agent": {
        "maxChars": 9188,
        "promptNotes": ""
      },
      "sourcePaper": {
        "title": "Soil structure and microbiome functions in agroecosystems",
        "summary": "Narrative review arguing that soil structure governs microbiome function and that conservation management that protects or rebuilds structure enhances beneficial processes, with headline greenhouse gas budgets and selected case studies.",
        "keyMethodSignals": [
          "Particle size fractionation and aggregate class comparisons",
          "Pore size classes and connectivity linked to guild distributions",
          "Mechanistic synthesis of carbon stabilisation, nitrification and denitrification",
          "Compilation of global CO2, CH4 and N2O flux attributions",
          "Management comparisons on tillage, compaction, cover crops and fertilisers"
        ],
        "methodComparison": {
          "sample": "Field and laboratory soils across multiple climates, crops and management regimes summarised from the literature.",
          "materials": "Measures emphasised particle size fractions, aggregate habitats, pore network classes and microbial guild distributions relevant to greenhouse gas pathways.",
          "equipment": "Typical wet sieving and fractionation setups, imaging and gas flux methods referenced across studies rather than a single instrument set.",
          "procedure": "Non systematic literature mapping and integrative synthesis with mechanistic figures and selected quantitative examples including global flux numbers.",
          "outcomes": "Conceptual linkage from soil structure to microenvironments to guild activity and greenhouse gas outcomes, with context dependent management effects."
        }
      },
      "similarPapers": [
        {
          "identifier": "10.3389/fmicb.2018.00149",
          "title": "Bacterial Preferences for Specific Soil Particle Size Fractions Revealed by Community Analyses",
          "authors": [
            "Hemkemeyer M",
            "et al."
          ],
          "year": 2018,
          "venue": "Frontiers in Microbiology",
          "whyRelevant": "Direct match to particle and aggregate fractionation with gentle dispersion and microhabitat specific DNA analyses. Strong overlap with structure driven assembly central to the brief.",
          "methodOverlap": [
            "Gentle ultrasonication and wet sieving into sand silt clay fractions",
            "qPCR quantification of 16S and domain markers per fraction",
            "Amplicon sequencing maps taxa across particle size fractions"
          ],
          "methodComparison": {
            "sample": "Long term experimental plots at Askov, Denmark, 0 to 18 cm, multiple fertiliser histories pooled before fractionation.",
            "materials": "Particle size fractionation protocol with mild dispersants and MgCl2, DNA extraction kits, 16S primers for bacteria and archaea.",
            "equipment": "Probe sonicator, sieves at 63 and 20 micrometres, centrifuges, StepOnePlus qPCR platform, Illumina MiSeq.",
            "procedure": "Minimal energy dispersion, sequential separation of fractions, DNA extraction from each fraction, qPCR and dual indexed 16S sequencing.",
            "outcomes": "Clear taxon sorting among fractions with fine silt and clay enriched for diversity and microbial load."
          },
          "gaps": "No direct greenhouse gas flux measurements. Storage and handling may bias community composition. Functional conclusions rely on gene and amplicon data rather than process rates.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.3389/fevo.2022.1091773",
          "title": "Micro fractionation Shows Microbial Community Changes in Soil Particles Below 20 micrometres",
          "authors": [
            "Keuschnig M",
            "et al."
          ],
          "year": 2022,
          "venue": "Frontiers in Ecology and Evolution",
          "whyRelevant": "Sub 20 micrometre focus with size verified fractions and per fraction DNA plus nitrogen cycle marker genes. Aligns with aggregate and pore scale niche mechanisms in the brief.",
          "methodOverlap": [
            "Fractionation preserving microaggregates including less than 2 micrometres fractions",
            "Laser granulometry verifies fraction sizes and stability",
            "Denitrifier marker genes enriched in larger aggregates"
          ],
          "methodComparison": {
            "sample": "Park Grass soil, 0 to 21 cm, unmanaged reference site, micro fractionation preserving small aggregates and supernatant.",
            "materials": "Fractionation hardware, Mastersizer type laser granulometer, DNA kits, primer sets for nirK, nirS and nosZ.",
            "equipment": "Laser granulometer, centrifuges, thermal cycler and qPCR system, sequencing platform.",
            "procedure": "Fractionate soil, verify sizes by laser granulometry, extract DNA from each fraction, quantify community composition and nitrogen cycle markers.",
            "outcomes": "Distinct community shifts at and below 20 micrometres and higher denitrifier gene abundance in larger aggregates."
          },
          "gaps": "Relies on gene proxies rather than in situ process rates. No direct N2O flux measurements. Single site and unmanaged soil limit transferability to managed agroecosystems.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.3389/fmicb.2022.831746",
          "title": "Macroaggregates Serve as Micro Hotspots Enriched With Functional and Networked Microbial Communities in a Long Term Paddy Soil",
          "authors": [
            "Rui J",
            "et al."
          ],
          "year": 2022,
          "venue": "Frontiers in Microbiology",
          "whyRelevant": "Aggregate resolved wet sieving with per fraction DNA and network analyses under long term fertilisation. Mirrors the briefs aggregate microhabitat framing and adds a management lever.",
          "methodOverlap": [
            "Water stable aggregate fractionation across five size classes",
            "qPCR and amplicon sequencing applied to each aggregate fraction",
            "Macroaggregates identified as enriched functional micro hotspots"
          ],
          "methodComparison": {
            "sample": "Paddy topsoil from a long term fertiliser experiment initiated in 1987 with replicated treatments.",
            "materials": "Nylon sieves for wet sieving, centrifugation for fine fractions, PowerSoil type DNA kits, ITS and 16S primers.",
            "equipment": "Wet sieving setup, centrifuges, quantitative PCR system, sequencing instruments.",
            "procedure": "Fractionate water stable aggregates, characterise physicochemical properties and microbial abundance and diversity, infer co occurrence networks and functional potential.",
            "outcomes": "Macroaggregates showed higher microbial abundance and network connectivity, and fertilisation altered diversity and composition."
          },
          "gaps": "No direct greenhouse gas flux or process rate measurements. Paddy specific conditions and potential confounders reduce generalisability to upland systems.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1371/journal.pone.0187681",
          "title": "Effects of Tillage Practice on Soil Structure, N2O Emissions and Economics",
          "authors": [
            "Zurovec O",
            "et al."
          ],
          "year": 2017,
          "venue": "PLOS ONE",
          "whyRelevant": "Field comparison of conventional, reduced and no tillage with direct N2O flux monitoring and soil structural measurements. Matches the briefs emphasis on management trade offs and structure function links.",
          "methodOverlap": [
            "Weekly static chamber N2O fluxes under contrasting tillage systems",
            "Undisturbed core sampling for bulk density and porosity",
            "Yield scaled N2O and economic assessment of treatments"
          ],
          "methodComparison": {
            "sample": "Maize to barley rotation on a Fluvisol over two seasons with replicated treatment strips.",
            "materials": "Static chambers, stainless steel core cylinders, standard mineral fertilisers and crop management inputs.",
            "equipment": "Gas chromatography for N2O analysis, core sampling hardware, devices to determine bulk density and porosity.",
            "procedure": "Apply tillage treatments and standard nitrogen inputs, measure weekly N2O fluxes, collect end season soil physics, compute yield and cost metrics.",
            "outcomes": "Treatment ranking of N2O varied between wet and dry years, fertiliser pulses dominated emissions, reduced tillage had lowest yield scaled N2O in year one."
          },
          "gaps": "Short duration and single site limit inference strength. No aggregate resolved microbiology, so mechanisms are inferred via water filled pore space and structure metrics.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1038/s41598-019-47861-7",
          "title": "Climate and Soil Characteristics Determine Where No Till Management Can Store Carbon in Soils and Mitigate Greenhouse Gas Emissions",
          "authors": [
            "Ogle S",
            "et al."
          ],
          "year": 2019,
          "venue": "Scientific Reports",
          "whyRelevant": "Global dataset and semi parametric mixed effects modelling of tillage impacts on soil carbon with explicit treatment of depth and uncertainty. Mirrors the briefs synthesis style for management effects relevant to greenhouse gas outcomes.",
          "methodOverlap": [
            "Literature based compilation with explicit inclusion criteria",
            "Depth explicit modelling of soil carbon change with climate and texture",
            "Addresses sampling depth and mass equivalency in analysis"
          ],
          "methodComparison": {
            "sample": "Controlled experiments worldwide comparing conventional and no till with 178 sites and more than one thousand observations.",
            "materials": "Extracted data on soil organic carbon, bulk density, texture and climate metadata from primary studies.",
            "equipment": "Statistical computing environment for mixed effects models and uncertainty analysis.",
            "procedure": "Apply inclusion criteria, extract variables, fit semi parametric mixed effects models with depth and time covariates and evaluate uncertainty.",
            "outcomes": "No till increases carbon near the surface while conventional till often stores more deeper, with climate and texture governing sign and magnitude."
          },
          "gaps": "Focuses on soil carbon rather than partitioned greenhouse gas fluxes. Observational heterogeneity remains and deep soil layers are under sampled.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        }
      ],
      "researchGroups": {
        "maxChars": 7996,
        "truncated": false,
        "text": "Paper: Soil structure and microbiome functions in agroecosystems (Nature Reviews Earth & Environment, 2022)\nGroup: Microbiome Research (ETH Zrich; affiliated with Agroscope)\nWebsite: https://microbiome.ch\nSummary: Hartmann's group focuses on soil microbiome ecology in agroecosystems, linking pore-scale structure to microbial functions highlighted in the review. Additional link: ETH profile https://usys.ethz.ch/en/people/profile.MjQ1ODA0.TGlzdC80MDUsMTA2MjE5NjI0MA==.html (https://usys.ethz.ch/en/people/profile.MjQ1ODA0.TGlzdC80MDUsMTA2MjE5NjI0MA==.html)\n| Name | Email | Role |\n| --- | --- | --- |\n| Martin Hartmann | martin.hartmann@usys.ethz.ch | PI |\n| Member list | check lab website contact form | Admin/General enquiry |\n\nGroup: Sustainable Agroecosystems (ETH Zrich)\nWebsite: https://sae.ethz.ch\nSummary: Six's group integrates soil structure, aggregation and greenhouse gas trade-offs in conservation systems, matching the review's methods scope.\n| Name | Email | Role |\n| --- | --- | --- |\n| Johan Six | jsix@ethz.ch | PI |\n| Member list | check lab website contact form | Admin/General enquiry |\n\nPaper: Microbial spatial footprint as a driver of soil carbon stabilisation - Nature Communications (2019) (10.1038/s41467-019-11057-4)\nGroup: Soil and Environmental Physics (Swedish University of Agricultural Sciences, SLU)\nWebsite: https://www.slu.se/en/research/research-catalogue/grupper/b/soil-and-environmental-physics/\nSummary: Koestel's team uses X-ray CT and pore-network analysis to connect pore architecture with biogeochemical processes, core to this paper's micro-CT-activity linkage.\n| Name | Email | Role |\n| --- | --- | --- |\n| John Koestel | john.koestel@slu.se | Associate Professor (PI) |\n| Nick Jarvis | nicholas.jarvis@slu.se | Professor, group contact |\n| Soil Physics Lab | soilphysicslab@slu.se | Laboratory contact (samples, CT logistics) |\n\nGroup: W. K. Kellogg Biological Station, Biogeochemistry & Agroecosystems (Michigan State University)\nWebsite: https://www.kbs.msu.edu/kbs-people/faculty/g-philip-robertson/\nSummary: Long-term field experiments linking plant diversity, management and soil C-N-GHG dynamics; Robertson co-authors extensively with MSU soil structure-microbiome teams.\n| Name | Email | Role |\n| --- | --- | --- |\n| G. Philip Robertson | robert30@msu.edu | PI |\n| KBS Directory | check lab website contact form | Use \"People\" directory for current postdocs and PhD students |\n\nPaper: Anaerobic microsites have an unaccounted role in soil carbon stabilisation - Nature Communications (2017) (10.1038/s41467-017-01406-6)\nGroup: Soil & Environmental Biogeochemistry (Scott Fendorf Lab) (Stanford Doerr School of Sustainability)\nWebsite: https://sustainability.stanford.edu/people/scott-fendorf-0\nSummary: Fendorf's group leads on redox geochemistry at pore- to field-scales, central to anaerobic microsite formation and C preservation.\n| Name | Email | Role |\n| --- | --- | --- |\n| Scott Fendorf | fendorf@stanford.edu | PI |\n| Team contacts | use stanford profiles for current postdocs and phd students | Check lab website contact form |\n\nGroup: Molecular Biogeochemistry of Soils (Keiluweit Lab) (University of Lausanne)\nWebsite: https://www.unil.ch/ige/en/home/menuinst/research-groups/molecular-biogeochemistry-of-soils.html\nSummary: Keiluweit's team develops controlled redox systems and rhizosphere microsite approaches directly aligned with the paper's oxygen-gradient mechanism.\n| Name | Email | Role |\n| --- | --- | --- |\n| Marco Keiluweit | marco.keiluweit@unil.ch | PI |\n| Megan Foley | megan.foley@unil.ch | PhD Researcher (current) |\n| Emily M. Lacroix | emily.lacroix@unil.ch | Postdoctoral Researcher (redox/anoxic microsites) |\n\nPaper: Spatial oxygen distribution and nitrous oxide emissions from soil after manure application: a novel approach using planar optodes - Journal of Environmental Quality (2014) (10.2134/jeq2014.03.0125)\nGroup: Danish Center for Hadal Research & NordCEE (Glud group) (University of Southern Denmark)\nWebsite: https://www.sdu.dk/en/forskning/hadal/people\nSummary: Pioneers in planar optode oxygen imaging and microprofiling, providing core expertise for 2-D O2 mapping in soils and sediments.\n| Name | Email | Role |\n| --- | --- | --- |\n| Ronnie N. Glud | rnglud@biology.sdu.dk | Professor, Center Director |\n| Wenjie Xiao | wjxiao@biology.sdu.dk | Postdoctoral Researcher |\n| Blandine Trouche | blandinetrouche@biology.sdu.dk | Postdoctoral Researcher |\n\nGroup: Soil Fertility & Nutrient Recycling, Section for Plant and Soil Science (University of Copenhagen)\nWebsite: https://plen.ku.dk/english/research/plant_soil/\nSummary: Jensen and Sander Bruun's teams study manure placement, O2 dynamics and nutrient cycling in tilled versus conservation systems, directly tied to optode-imaged O2 and N2O.\n| Name | Email | Role |\n| --- | --- | --- |\n| Lars Stoumann Jensen | lsj@plen.ku.dk | Professor, Soil Fertility |\n| Sander Bruun | sab@plen.ku.dk | Professor, Climate Change & Soil Management |\n| Xiaoxiao Qin | xq@plen.ku.dk | PhD Fellow (Plant and Soil Science) |\n\nPaper: Climate, duration, and nitrogen placement determine N2O emissions in reduced tillage systems: a meta-analysis - Global Change Biology (2013) (10.1111/j.1365-2486.2012.02779.x)\nGroup: Rice Systems & GHG Mitigation (Linquist Lab) (UC Davis)\nWebsite: https://linquist.ucdavis.edu/\nSummary: Extensive meta-analysis and field trials on tillage, N placement and yield-scaled N2O, informing practice-specific mitigation signals from the paper.\n| Name | Email | Role |\n| --- | --- | --- |\n| Bruce A. Linquist | balinquist@ucdavis.edu | PI |\n| Whitney Brim-DeForest | wbrimdeforest@ucanr.edu | Rice Advisor, collaborator |\n| Luis Espino | laespino@ucanr.edu | Rice Advisor, collaborator |\n\nGroup: Soil & Water Management Research Unit (Venterea group) (USDA-ARS, St Paul, MN)\nWebsite: https://www.ars.usda.gov/midwest-area/stpaul/swmr/\nSummary: Core ARS unit quantifying N transformations and N2O in row-crop systems, including placement effects and reduced tillage contexts highlighted by the meta-analysis.\n| Name | Email | Role |\n| --- | --- | --- |\n| Rodney T. Venterea | venterea@umn.edu | Research Soil Scientist (PI) |\n| Unit main office | check lab website contact form | Use unit site contact for current postdocs/GSRA contacts |\n\nPaper: Microbial proxies for anoxic microsites vary with management and texture - Environmental Science & Technology (2024) (10.1021/acs.est.4c01882)\nGroup: Dekas Geomicrobiology Laboratory (Stanford University)\nWebsite: https://dekaslab.stanford.edu/\nSummary: Leads development of microbial and ddPCR proxies for anoxic microsites used in this study; active publications on proxies and redox since 2020.\n| Name | Email | Role |\n| --- | --- | --- |\n| Anne E. Dekas | dekas@stanford.edu | PI |\n| Current members | use lab people page for up-to-date student and postdoc roster | Check lab website contact form |\n\nGroup: Molecular Biogeochemistry of Soils (Keiluweit Lab) (University of Lausanne)\nWebsite: https://www.unil.ch/ige/en/home/menuinst/research-groups/molecular-biogeochemistry-of-soils.html\nSummary: Co-led the EST 2024 long-term management comparison; specialises in pore-scale redox and rhizosphere anoxic microsites.\n| Name | Email | Role |\n| --- | --- | --- |\n| Marco Keiluweit | marco.keiluweit@unil.ch | PI |\n| Emily M. Lacroix | emily.lacroix@unil.ch | First author, Postdoctoral Researcher |\n| Megan Foley | megan.foley@unil.ch | PhD Researcher (methods on rhizosphere anoxia) |\n\nGroup: Soil & Environmental Biogeochemistry (Scott Fendorf Lab) (Stanford)\nWebsite: https://sustainability.stanford.edu/people/scott-fendorf-0\nSummary: Senior-author group on the EST study integrating management, texture and microbial redox indicators with SOC outcomes.\n| Name | Email | Role |\n| --- | --- | --- |\n| Scott Fendorf | fendorf@stanford.edu | PI |\n| Collaborator list | see project and publication pages for current trainees on the proxy work | Check lab website contact form |",
        "structured": {
          "papers": [
            {
              "title": "Soil structure and microbiome functions in agroecosystems (Nature Reviews Earth & Environment, 2022)",
              "identifier": null,
              "groups": [
                {
                  "name": "Microbiome Research",
                  "institution": "ETH Zrich; affiliated with Agroscope",
                  "website": "https://microbiome.ch",
                  "notes": "Hartmann's group focuses on soil microbiome ecology in agroecosystems, linking pore-scale structure to microbial functions highlighted in the review. Additional link: ETH profile https://usys.ethz.ch/en/people/profile.MjQ1ODA0.TGlzdC80MDUsMTA2MjE5NjI0MA==.html (https://usys.ethz.ch/en/people/profile.MjQ1ODA0.TGlzdC80MDUsMTA2MjE5NjI0MA==.html)",
                  "researchers": [
                    {
                      "name": "Martin Hartmann",
                      "email": "martin.hartmann@usys.ethz.ch",
                      "role": "PI"
                    },
                    {
                      "name": "Member list",
                      "email": "check lab website contact form",
                      "role": "Admin/General enquiry"
                    }
                  ]
                },
                {
                  "name": "Sustainable Agroecosystems",
                  "institution": "ETH Zrich",
                  "website": "https://sae.ethz.ch",
                  "notes": "Six's group integrates soil structure, aggregation and greenhouse gas trade-offs in conservation systems, matching the review's methods scope.",
                  "researchers": [
                    {
                      "name": "Johan Six",
                      "email": "jsix@ethz.ch",
                      "role": "PI"
                    },
                    {
                      "name": "Member list",
                      "email": "check lab website contact form",
                      "role": "Admin/General enquiry"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Microbial spatial footprint as a driver of soil carbon stabilisation - Nature Communications (2019)",
              "identifier": "10.1038/s41467-019-11057-4",
              "groups": [
                {
                  "name": "Soil and Environmental Physics",
                  "institution": "Swedish University of Agricultural Sciences, SLU",
                  "website": "https://www.slu.se/en/research/research-catalogue/grupper/b/soil-and-environmental-physics/",
                  "notes": "Koestel's team uses X-ray CT and pore-network analysis to connect pore architecture with biogeochemical processes, core to this paper's micro-CT-activity linkage.",
                  "researchers": [
                    {
                      "name": "John Koestel",
                      "email": "john.koestel@slu.se",
                      "role": "Associate Professor (PI)"
                    },
                    {
                      "name": "Nick Jarvis",
                      "email": "nicholas.jarvis@slu.se",
                      "role": "Professor, group contact"
                    },
                    {
                      "name": "Soil Physics Lab",
                      "email": "soilphysicslab@slu.se",
                      "role": "Laboratory contact (samples, CT logistics)"
                    }
                  ]
                },
                {
                  "name": "W. K. Kellogg Biological Station, Biogeochemistry & Agroecosystems",
                  "institution": "Michigan State University",
                  "website": "https://www.kbs.msu.edu/kbs-people/faculty/g-philip-robertson/",
                  "notes": "Long-term field experiments linking plant diversity, management and soil C-N-GHG dynamics; Robertson co-authors extensively with MSU soil structure-microbiome teams.",
                  "researchers": [
                    {
                      "name": "G. Philip Robertson",
                      "email": "robert30@msu.edu",
                      "role": "PI"
                    },
                    {
                      "name": "KBS Directory",
                      "email": "check lab website contact form",
                      "role": "Use \"People\" directory for current postdocs and PhD students"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Anaerobic microsites have an unaccounted role in soil carbon stabilisation - Nature Communications (2017)",
              "identifier": "10.1038/s41467-017-01406-6",
              "groups": [
                {
                  "name": "Soil & Environmental Biogeochemistry (Scott Fendorf Lab)",
                  "institution": "Stanford Doerr School of Sustainability",
                  "website": "https://sustainability.stanford.edu/people/scott-fendorf-0",
                  "notes": "Fendorf's group leads on redox geochemistry at pore- to field-scales, central to anaerobic microsite formation and C preservation.",
                  "researchers": [
                    {
                      "name": "Scott Fendorf",
                      "email": "fendorf@stanford.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Team contacts",
                      "email": "use stanford profiles for current postdocs and phd students",
                      "role": "Check lab website contact form"
                    }
                  ]
                },
                {
                  "name": "Molecular Biogeochemistry of Soils (Keiluweit Lab)",
                  "institution": "University of Lausanne",
                  "website": "https://www.unil.ch/ige/en/home/menuinst/research-groups/molecular-biogeochemistry-of-soils.html",
                  "notes": "Keiluweit's team develops controlled redox systems and rhizosphere microsite approaches directly aligned with the paper's oxygen-gradient mechanism.",
                  "researchers": [
                    {
                      "name": "Marco Keiluweit",
                      "email": "marco.keiluweit@unil.ch",
                      "role": "PI"
                    },
                    {
                      "name": "Megan Foley",
                      "email": "megan.foley@unil.ch",
                      "role": "PhD Researcher (current)"
                    },
                    {
                      "name": "Emily M. Lacroix",
                      "email": "emily.lacroix@unil.ch",
                      "role": "Postdoctoral Researcher (redox/anoxic microsites)"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Spatial oxygen distribution and nitrous oxide emissions from soil after manure application: a novel approach using planar optodes - Journal of Environmental Quality (2014)",
              "identifier": "10.2134/jeq2014.03.0125",
              "groups": [
                {
                  "name": "Danish Center for Hadal Research & NordCEE (Glud group)",
                  "institution": "University of Southern Denmark",
                  "website": "https://www.sdu.dk/en/forskning/hadal/people",
                  "notes": "Pioneers in planar optode oxygen imaging and microprofiling, providing core expertise for 2-D O2 mapping in soils and sediments.",
                  "researchers": [
                    {
                      "name": "Ronnie N. Glud",
                      "email": "rnglud@biology.sdu.dk",
                      "role": "Professor, Center Director"
                    },
                    {
                      "name": "Wenjie Xiao",
                      "email": "wjxiao@biology.sdu.dk",
                      "role": "Postdoctoral Researcher"
                    },
                    {
                      "name": "Blandine Trouche",
                      "email": "blandinetrouche@biology.sdu.dk",
                      "role": "Postdoctoral Researcher"
                    }
                  ]
                },
                {
                  "name": "Soil Fertility & Nutrient Recycling, Section for Plant and Soil Science",
                  "institution": "University of Copenhagen",
                  "website": "https://plen.ku.dk/english/research/plant_soil/",
                  "notes": "Jensen and Sander Bruun's teams study manure placement, O2 dynamics and nutrient cycling in tilled versus conservation systems, directly tied to optode-imaged O2 and N2O.",
                  "researchers": [
                    {
                      "name": "Lars Stoumann Jensen",
                      "email": "lsj@plen.ku.dk",
                      "role": "Professor, Soil Fertility"
                    },
                    {
                      "name": "Sander Bruun",
                      "email": "sab@plen.ku.dk",
                      "role": "Professor, Climate Change & Soil Management"
                    },
                    {
                      "name": "Xiaoxiao Qin",
                      "email": "xq@plen.ku.dk",
                      "role": "PhD Fellow (Plant and Soil Science)"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Climate, duration, and nitrogen placement determine N2O emissions in reduced tillage systems: a meta-analysis - Global Change Biology (2013)",
              "identifier": "10.1111/j.1365-2486.2012.02779.x",
              "groups": [
                {
                  "name": "Rice Systems & GHG Mitigation (Linquist Lab)",
                  "institution": "UC Davis",
                  "website": "https://linquist.ucdavis.edu/",
                  "notes": "Extensive meta-analysis and field trials on tillage, N placement and yield-scaled N2O, informing practice-specific mitigation signals from the paper.",
                  "researchers": [
                    {
                      "name": "Bruce A. Linquist",
                      "email": "balinquist@ucdavis.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Whitney Brim-DeForest",
                      "email": "wbrimdeforest@ucanr.edu",
                      "role": "Rice Advisor, collaborator"
                    },
                    {
                      "name": "Luis Espino",
                      "email": "laespino@ucanr.edu",
                      "role": "Rice Advisor, collaborator"
                    }
                  ]
                },
                {
                  "name": "Soil & Water Management Research Unit (Venterea group)",
                  "institution": "USDA-ARS, St Paul, MN",
                  "website": "https://www.ars.usda.gov/midwest-area/stpaul/swmr/",
                  "notes": "Core ARS unit quantifying N transformations and N2O in row-crop systems, including placement effects and reduced tillage contexts highlighted by the meta-analysis.",
                  "researchers": [
                    {
                      "name": "Rodney T. Venterea",
                      "email": "venterea@umn.edu",
                      "role": "Research Soil Scientist (PI)"
                    },
                    {
                      "name": "Unit main office",
                      "email": "check lab website contact form",
                      "role": "Use unit site contact for current postdocs/GSRA contacts"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Microbial proxies for anoxic microsites vary with management and texture - Environmental Science & Technology (2024)",
              "identifier": "10.1021/acs.est.4c01882",
              "groups": [
                {
                  "name": "Dekas Geomicrobiology Laboratory",
                  "institution": "Stanford University",
                  "website": "https://dekaslab.stanford.edu/",
                  "notes": "Leads development of microbial and ddPCR proxies for anoxic microsites used in this study; active publications on proxies and redox since 2020.",
                  "researchers": [
                    {
                      "name": "Anne E. Dekas",
                      "email": "dekas@stanford.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Current members",
                      "email": "use lab people page for up-to-date student and postdoc roster",
                      "role": "Check lab website contact form"
                    }
                  ]
                },
                {
                  "name": "Molecular Biogeochemistry of Soils (Keiluweit Lab)",
                  "institution": "University of Lausanne",
                  "website": "https://www.unil.ch/ige/en/home/menuinst/research-groups/molecular-biogeochemistry-of-soils.html",
                  "notes": "Co-led the EST 2024 long-term management comparison; specialises in pore-scale redox and rhizosphere anoxic microsites.",
                  "researchers": [
                    {
                      "name": "Marco Keiluweit",
                      "email": "marco.keiluweit@unil.ch",
                      "role": "PI"
                    },
                    {
                      "name": "Emily M. Lacroix",
                      "email": "emily.lacroix@unil.ch",
                      "role": "First author, Postdoctoral Researcher"
                    },
                    {
                      "name": "Megan Foley",
                      "email": "megan.foley@unil.ch",
                      "role": "PhD Researcher (methods on rhizosphere anoxia)"
                    }
                  ]
                },
                {
                  "name": "Soil & Environmental Biogeochemistry (Scott Fendorf Lab)",
                  "institution": "Stanford",
                  "website": "https://sustainability.stanford.edu/people/scott-fendorf-0",
                  "notes": "Senior-author group on the EST study integrating management, texture and microbial redox indicators with SOC outcomes.",
                  "researchers": [
                    {
                      "name": "Scott Fendorf",
                      "email": "fendorf@stanford.edu",
                      "role": "PI"
                    },
                    {
                      "name": "Collaborator list",
                      "email": "see project and publication pages for current trainees on the proxy work",
                      "role": "Check lab website contact form"
                    }
                  ]
                }
              ]
            }
          ],
          "promptNotes": ""
        }
      },
      "researcherTheses": {
        "maxChars": 5699,
        "truncated": false,
        "text": "Researcher: Martin Hartmann\nEmail: martin.hartmann@usys.ethz.ch\nData publicly available: unknown\nLatest publication:\n  - Title: Locating the microbes along the maize root system under nitrogen limitation: a root phenotypic approach\n  - Year: 2025\n  - Venue: Annals of Botany\n  - URL: https://academic.oup.com/aob/advance-article/doi/10.1093/aob/mcaf185/8231684\nPhD thesis:\n  - Title: Genetic characterization of soil bacterial communities in the DOK long-term agricultural field experiment. Influences of management strategies and crops\n  - Year: 2006\n  - Institution: ETH Zrich\n  - URL: https://www.research-collection.ethz.ch/bitstreams/5a5de021-bfc0-44a2-97bf-370f48056044/download\n\nResearcher: Johan Six\nEmail: johan.six@usys.ethz.ch\nData publicly available: unknown\nLatest publication:\n  - Title: Locating the microbes along the maize root system under nitrogen limitation: a root phenotypic approach\n  - Year: 2025\n  - Venue: Annals of Botany\n  - URL: https://academic.oup.com/aob/advance-article/doi/10.1093/aob/mcaf185/8231684\nPhD thesis:\n  - Title: Aggregate and Soil Organic Matter Fraction Dynamics in Agroecosystems\n  - Year: 1998\n  - Institution: Colorado State University\n  - URL: Not found\n\nResearcher: Michael Hemkemeyer\nEmail: hemkemeyer@uni-wuppertal.de\nData publicly available: unknown\nLatest publication:\n  - Title: Potato yield and quality are linked to cover crop species and soil microorganisms\n  - Year: 2024\n  - Venue: Biology and Fertility of Soils\n  - URL: https://link.springer.com/article/10.1007/s00374-024-01810-3\nPhD thesis:\n  - Title: Importance of soil primary particles for shaping the diversity and activity of soil microbial communities\n  - Year: 2021\n  - Institution: Technische Universitt Braunschweig\n  - URL: Not found\n\nResearcher: Christoph C. Tebbe\nEmail: christoph.tebbe@thuenen.de\nData publicly available: unknown\nLatest publication:\n  - Title: Status and trends in soil biodiversity - a national survey of Germany\n  - Year: 2025\n  - Venue: Soil Organisms\n  - URL: https://soil-organisms.org/index.php/SO/article/view/449\nPhD thesis: Not found\n\nResearcher: Christoph Keuschnig\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Microbial life in preferential flow paths in subsurface clayey till revealed by metataxonomy and metagenomics\n  - Year: 2024\n  - Venue: BMC Microbiology\n  - URL: https://gfzpublic.gfz.de/pubman/faces/ViewItemOverviewPage.jsp?itemId=item_5027674_1\nPhD thesis:\n  - Title: Implication des champignons et des bactries dans le cycle de l'azote et la production de N2O dans le sol\n  - Year: 2016\n  - Institution: cole Centrale de Lyon, Universit de Lyon\n  - URL: https://bibliotheque.ec-lyon.fr/documents/TH_T2542_ckeuschnig.pdf\n\nResearcher: Catherine Larose\nEmail: catherine.larose@ec-lyon.fr\nData publicly available: unknown\nLatest publication:\n  - Title: Temporal variations of antimicrobial resistance genes in aerosols: A one-year monitoring at the Puy de Dme summit (Central France)\n  - Year: 2024\n  - Venue: Science of the Total Environment\n  - URL: https://doi.org/10.1016/j.scitotenv.2023.169567\nPhD thesis:\n  - Title: Interactions entre composition chimique et populations microbiennes de la neige: quelles sont les consquences sur le cycle du mercure en Arctique\n  - Year: 2010\n  - Institution: Universit Joseph Fourier - Grenoble 1\n  - URL: https://core.ac.uk/download/pdf/52739764.pdf\n\nResearcher: Ognjen urovec\nEmail: ognjen.zurovec@nmbu.no\nData publicly available: unknown\nLatest publication:\n  - Title: Benchmarking a decade of holistic agro-environmental studies within the Agricultural Catchments Programme\n  - Year: 2022\n  - Venue: Irish Journal of Agricultural and Food Research\n  - URL: https://doi.org/10.15212/ijafr-2020-0145\nPhD thesis:\n  - Title: Agriculture, livelihoods and climate change in Bosnia and Herzegovina: impacts, vulnerability and adaptation\n  - Year: 2018\n  - Institution: Norwegian University of Life Sciences (NMBU)\n  - URL: https://nmbu.brage.unit.no/nmbu-xmlui/handle/11250/2580198\n\nResearcher: Peter Drsch\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Carbon degradation and mobilisation potentials of thawing permafrost peatlands in northern Norway inferred from laboratory incubations\n  - Year: 2024\n  - Venue: Biogeosciences\n  - URL: https://bg.copernicus.org/articles/21/4723/2024/\nPhD thesis:\n  - Title: Nitrous oxide and methane fluxes in differentially managed agricultural soils of a hilly landscape in Southern Germany\n  - Year: 1999\n  - Institution: Technische Universitt Mnchen\n  - URL: https://www.finna.fi/Record/vaari.926379\n\nResearcher: Stephen M. Ogle\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Counterfactual scenarios reveal historical impact of cropland management on soil organic carbon stocks in the United States\n  - Year: 2023\n  - Venue: Scientific Reports\n  - URL: https://www.nature.com/articles/s41598-023-41307-x\nPhD thesis:\n  - Title: Not found\n  - Year: 2000\n  - Institution: University of Wyoming\n  - URL: Not found\n\nResearcher: Gabriel G. Vzquez-Amabile\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: An evaluation of soil carbon models and their role on finding ways to net-zero carbon in agricultural systems\n  - Year: 2025\n  - Venue: Soil & Tillage Research\n  - URL: https://www.sciencedirect.com/science/article/abs/pii/S016719872400343X\nPhD thesis:\n  - Title: Hydrologic and nonpoint-source pollution risk analysis on agricultural watersheds\n  - Year: 2005\n  - Institution: Purdue University\n  - URL: https://purdue.primo.exlibrisgroup.com/discovery/fulldisplay/alma99143083980001081/01PURDUE_PUWL",
        "structured": {
          "researchers": [
            {
              "name": "Martin Hartmann",
              "email": "martin.hartmann@usys.ethz.ch",
              "latest_publication": {
                "title": "Locating the microbes along the maize root system under nitrogen limitation: a root phenotypic approach",
                "year": 2025,
                "venue": "Annals of Botany",
                "url": "https://academic.oup.com/aob/advance-article/doi/10.1093/aob/mcaf185/8231684"
              },
              "phd_thesis": {
                "title": "Genetic characterization of soil bacterial communities in the DOK long-term agricultural field experiment. Influences of management strategies and crops",
                "year": 2006,
                "institution": "ETH Zrich",
                "url": "https://www.research-collection.ethz.ch/bitstreams/5a5de021-bfc0-44a2-97bf-370f48056044/download"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Johan Six",
              "email": "johan.six@usys.ethz.ch",
              "latest_publication": {
                "title": "Locating the microbes along the maize root system under nitrogen limitation: a root phenotypic approach",
                "year": 2025,
                "venue": "Annals of Botany",
                "url": "https://academic.oup.com/aob/advance-article/doi/10.1093/aob/mcaf185/8231684"
              },
              "phd_thesis": {
                "title": "Aggregate and Soil Organic Matter Fraction Dynamics in Agroecosystems",
                "year": 1998,
                "institution": "Colorado State University",
                "url": null
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Michael Hemkemeyer",
              "email": "hemkemeyer@uni-wuppertal.de",
              "latest_publication": {
                "title": "Potato yield and quality are linked to cover crop species and soil microorganisms",
                "year": 2024,
                "venue": "Biology and Fertility of Soils",
                "url": "https://link.springer.com/article/10.1007/s00374-024-01810-3"
              },
              "phd_thesis": {
                "title": "Importance of soil primary particles for shaping the diversity and activity of soil microbial communities",
                "year": 2021,
                "institution": "Technische Universitt Braunschweig",
                "url": null
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Christoph C. Tebbe",
              "email": "christoph.tebbe@thuenen.de",
              "latest_publication": {
                "title": "Status and trends in soil biodiversity - a national survey of Germany",
                "year": 2025,
                "venue": "Soil Organisms",
                "url": "https://soil-organisms.org/index.php/SO/article/view/449"
              },
              "phd_thesis": null,
              "data_publicly_available": "unknown"
            },
            {
              "name": "Christoph Keuschnig",
              "email": null,
              "latest_publication": {
                "title": "Microbial life in preferential flow paths in subsurface clayey till revealed by metataxonomy and metagenomics",
                "year": 2024,
                "venue": "BMC Microbiology",
                "url": "https://gfzpublic.gfz.de/pubman/faces/ViewItemOverviewPage.jsp?itemId=item_5027674_1"
              },
              "phd_thesis": {
                "title": "Implication des champignons et des bactries dans le cycle de l'azote et la production de N2O dans le sol",
                "year": 2016,
                "institution": "cole Centrale de Lyon, Universit de Lyon",
                "url": "https://bibliotheque.ec-lyon.fr/documents/TH_T2542_ckeuschnig.pdf"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Catherine Larose",
              "email": "catherine.larose@ec-lyon.fr",
              "latest_publication": {
                "title": "Temporal variations of antimicrobial resistance genes in aerosols: A one-year monitoring at the Puy de Dme summit (Central France)",
                "year": 2024,
                "venue": "Science of the Total Environment",
                "url": "https://doi.org/10.1016/j.scitotenv.2023.169567"
              },
              "phd_thesis": {
                "title": "Interactions entre composition chimique et populations microbiennes de la neige: quelles sont les consquences sur le cycle du mercure en Arctique",
                "year": 2010,
                "institution": "Universit Joseph Fourier - Grenoble 1",
                "url": "https://core.ac.uk/download/pdf/52739764.pdf"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Ognjen urovec",
              "email": "ognjen.zurovec@nmbu.no",
              "latest_publication": {
                "title": "Benchmarking a decade of holistic agro-environmental studies within the Agricultural Catchments Programme",
                "year": 2022,
                "venue": "Irish Journal of Agricultural and Food Research",
                "url": "https://doi.org/10.15212/ijafr-2020-0145"
              },
              "phd_thesis": {
                "title": "Agriculture, livelihoods and climate change in Bosnia and Herzegovina: impacts, vulnerability and adaptation",
                "year": 2018,
                "institution": "Norwegian University of Life Sciences (NMBU)",
                "url": "https://nmbu.brage.unit.no/nmbu-xmlui/handle/11250/2580198"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Peter Drsch",
              "email": null,
              "latest_publication": {
                "title": "Carbon degradation and mobilisation potentials of thawing permafrost peatlands in northern Norway inferred from laboratory incubations",
                "year": 2024,
                "venue": "Biogeosciences",
                "url": "https://bg.copernicus.org/articles/21/4723/2024/"
              },
              "phd_thesis": {
                "title": "Nitrous oxide and methane fluxes in differentially managed agricultural soils of a hilly landscape in Southern Germany",
                "year": 1999,
                "institution": "Technische Universitt Mnchen",
                "url": "https://www.finna.fi/Record/vaari.926379"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Stephen M. Ogle",
              "email": null,
              "latest_publication": {
                "title": "Counterfactual scenarios reveal historical impact of cropland management on soil organic carbon stocks in the United States",
                "year": 2023,
                "venue": "Scientific Reports",
                "url": "https://www.nature.com/articles/s41598-023-41307-x"
              },
              "phd_thesis": {
                "title": null,
                "year": 2000,
                "institution": "University of Wyoming",
                "url": null
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Gabriel G. Vzquez-Amabile",
              "email": null,
              "latest_publication": {
                "title": "An evaluation of soil carbon models and their role on finding ways to net-zero carbon in agricultural systems",
                "year": 2025,
                "venue": "Soil & Tillage Research",
                "url": "https://www.sciencedirect.com/science/article/abs/pii/S016719872400343X"
              },
              "phd_thesis": {
                "title": "Hydrologic and nonpoint-source pollution risk analysis on agricultural watersheds",
                "year": 2005,
                "institution": "Purdue University",
                "url": "https://purdue.primo.exlibrisgroup.com/discovery/fulldisplay/alma99143083980001081/01PURDUE_PUWL"
              },
              "data_publicly_available": "unknown"
            }
          ],
          "promptNotes": ""
        }
      },
      "patents": {
        "text": "Patent: EP3105198B1\nTitle: Soil bacteria for inoculating stress soils\nAssignee: Biofil Mikrobiologiai Gentechnologiai s Biokmiai Kft\nFiling Date: 2015-02-10\nGrant Date: 2022-02-16\nAbstract: Bacterial inoculant mixtures that produce exopolysaccharides and biofilms to cement soil particles into stable aggregates, improve water retention and fertility, and rehabilitate degraded soils.\nOverlaps with paper claims: C1, C3\nTechnical overlap: Independent claims teach inoculating soils with EPS- and biofilm-forming strains that bind particles and increase aggregate stability and porosity, directly mirroring the paper's structure-microbiome mechanism where pore connectivity controls water and oxygen diffusion (C1). The claimed use of microbial inoculants to improve aggregate stability and soil function constitutes a conservation-oriented management intervention, aligning with reduced disturbance and organic amendment strategies in C3.\n\nPatent: WO2021030385A1\nTitle: Microbe-based compositions for restoring soil health and controlling pests\nAssignee: Locus Agriculture IP Co LLC\nFiling Date: 2020-08-12\nGrant Date: Not provided\nAbstract: Microbial consortia and delivery methods that restore soil health by improving structure, porosity and hydrology, while reducing greenhouse-gas emissions and enhancing nutrient cycling.\nOverlaps with paper claims: C1, C2, C3\nTechnical overlap: The claims include improving soil physical structure and porosity through microbe-based amendments, mapping to the paper's emphasis on aggregates and pore networks regulating water and oxygen supply for microbiome assembly and function (C1). Claims also target reductions in CH4 and N2O via microbial pathway modulation, validating the paper's attribution of greenhouse-gas fluxes to microbiomes (C2). As an applied, conservation-style management input, the compositions reflect the paper's management levers such as organic amendments and integrated practices (C3).\n\nPatent: WO2021076458A9\nTitle: Inhibitors of soil nitrification and processes to prevent same\nAssignee: Tessenderlo Group NV\nFiling Date: 2020-10-12\nGrant Date: Not provided\nAbstract: Compositions and field methods for inhibiting soil nitrification to improve nitrogen-use efficiency and reduce nitrogen oxide emissions across crops.\nOverlaps with paper claims: C2, C3\nTechnical overlap: Independent and dependent claims cover administering nitrification inhibitors to slow the microbial oxidation of ammonium to nitrate, directly addressing the microbial pathway responsible for N2O emissions highlighted in the paper's climate regulation analysis (C2). Positioning these inhibitors within fertiliser management validates the paper's integrated nutrient management approach as a conservation-oriented practice with context-dependent trade-offs (C3).\n\nPatent: WO2017117314A1\nTitle: Biochar as a microbial carrier\nAssignee: Cool Planet Energy Systems Inc\nFiling Date: 2016-12-28\nGrant Date: Not provided\nAbstract: Pore-engineered biochar infused with beneficial microbes and nutrients to act as a carrier for controlled release, increasing water holding, nutrient retention and microbial viability in soil.\nOverlaps with paper claims: C1, C3\nTechnical overlap: Claims teach impregnating biochar's hierarchical pore structure with microbial inoculants and nutrients, creating microhabitats and altering pore-size distributions that shape microbial assembly and resource diffusion, matching the paper's pore-class and connectivity framework (C1). The biochar carrier functions as an organic amendment that improves structure and supports beneficial microbial processes, reflecting conservation-oriented soil management in C3.\n\nPatent: WO2024100477A1\nTitle: Environment friendly non-toxic methanotroph formulation for mitigation of methane emission in rice\nAssignee: Indian Council of Agricultural Research\nFiling Date: 2023-10-17\nGrant Date: Not provided\nAbstract: A granular formulation containing a Methylobacterium methanotroph with specified carriers and binders to reduce methane emissions in flooded rice systems.\nOverlaps with paper claims: C2\nTechnical overlap: The claims specify a methanotroph-based product and field application protocol that enhances methane oxidation in paddy soils, directly validating the paper's assertion that microbiome-mediated pathways control CH4 fluxes at agroecosystem scales (C2). The defined carrier matrix and deployment in flooded conditions link to the paper's emphasis on managing redox and oxygen diffusion regimes that govern microbial greenhouse-gas processes.",
        "structured": {
          "patents": [
            {
              "patentNumber": "EP3105198B1",
              "title": "Soil bacteria for inoculating stress soils",
              "assignee": "Biofil Mikrobiologiai Gentechnologiai s Biokmiai Kft",
              "filingDate": "2015-02-10",
              "grantDate": "2022-02-16",
              "abstract": "Bacterial inoculant mixtures that produce exopolysaccharides and biofilms to cement soil particles into stable aggregates, improve water retention and fertility, and rehabilitate degraded soils.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1",
                  "C3"
                ],
                "summary": "Independent claims teach inoculating soils with EPS- and biofilm-forming strains that bind particles and increase aggregate stability and porosity, directly mirroring the paper's structure-microbiome mechanism where pore connectivity controls water and oxygen diffusion (C1). The claimed use of microbial inoculants to improve aggregate stability and soil function constitutes a conservation-oriented management intervention, aligning with reduced disturbance and organic amendment strategies in C3."
              },
              "url": null
            },
            {
              "patentNumber": "WO2021030385A1",
              "title": "Microbe-based compositions for restoring soil health and controlling pests",
              "assignee": "Locus Agriculture IP Co LLC",
              "filingDate": "2020-08-12",
              "grantDate": null,
              "abstract": "Microbial consortia and delivery methods that restore soil health by improving structure, porosity and hydrology, while reducing greenhouse-gas emissions and enhancing nutrient cycling.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1",
                  "C2",
                  "C3"
                ],
                "summary": "The claims include improving soil physical structure and porosity through microbe-based amendments, mapping to the paper's emphasis on aggregates and pore networks regulating water and oxygen supply for microbiome assembly and function (C1). Claims also target reductions in CH4 and N2O via microbial pathway modulation, validating the paper's attribution of greenhouse-gas fluxes to microbiomes (C2). As an applied, conservation-style management input, the compositions reflect the paper's management levers such as organic amendments and integrated practices (C3)."
              },
              "url": null
            },
            {
              "patentNumber": "WO2021076458A9",
              "title": "Inhibitors of soil nitrification and processes to prevent same",
              "assignee": "Tessenderlo Group NV",
              "filingDate": "2020-10-12",
              "grantDate": null,
              "abstract": "Compositions and field methods for inhibiting soil nitrification to improve nitrogen-use efficiency and reduce nitrogen oxide emissions across crops.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2",
                  "C3"
                ],
                "summary": "Independent and dependent claims cover administering nitrification inhibitors to slow the microbial oxidation of ammonium to nitrate, directly addressing the microbial pathway responsible for N2O emissions highlighted in the paper's climate regulation analysis (C2). Positioning these inhibitors within fertiliser management validates the paper's integrated nutrient management approach as a conservation-oriented practice with context-dependent trade-offs (C3)."
              },
              "url": null
            },
            {
              "patentNumber": "WO2017117314A1",
              "title": "Biochar as a microbial carrier",
              "assignee": "Cool Planet Energy Systems Inc",
              "filingDate": "2016-12-28",
              "grantDate": null,
              "abstract": "Pore-engineered biochar infused with beneficial microbes and nutrients to act as a carrier for controlled release, increasing water holding, nutrient retention and microbial viability in soil.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1",
                  "C3"
                ],
                "summary": "Claims teach impregnating biochar's hierarchical pore structure with microbial inoculants and nutrients, creating microhabitats and altering pore-size distributions that shape microbial assembly and resource diffusion, matching the paper's pore-class and connectivity framework (C1). The biochar carrier functions as an organic amendment that improves structure and supports beneficial microbial processes, reflecting conservation-oriented soil management in C3."
              },
              "url": null
            },
            {
              "patentNumber": "WO2024100477A1",
              "title": "Environment friendly non-toxic methanotroph formulation for mitigation of methane emission in rice",
              "assignee": "Indian Council of Agricultural Research",
              "filingDate": "2023-10-17",
              "grantDate": null,
              "abstract": "A granular formulation containing a Methylobacterium methanotroph with specified carriers and binders to reduce methane emissions in flooded rice systems.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2"
                ],
                "summary": "The claims specify a methanotroph-based product and field application protocol that enhances methane oxidation in paddy soils, directly validating the paper's assertion that microbiome-mediated pathways control CH4 fluxes at agroecosystem scales (C2). The defined carrier matrix and deployment in flooded conditions link to the paper's emphasis on managing redox and oxygen diffusion regimes that govern microbial greenhouse-gas processes."
              },
              "url": null
            }
          ],
          "promptNotes": "Converted from analyst notes; dates normalised to ISO (YYYY-MM-DD). Grant dates set to null for applications without grant."
        }
      },
      "verifiedClaims": {
        "text": "=== OVERALL ASSESSMENT ===\nThe paper's central framing is consistent with independent evidence: pore and aggregate architecture shape diffusion and redox, which govern microbial processes and agroecosystem outcomes; microbes underpin nutrient cycling and a large share of agricultural greenhouse gases; and conservation practices can improve structure and functions with important context-dependent trade-offs. The strongest support is for the microbial role in greenhouse gas budgets, while structure-as-primary-driver and universal benefits of conservation practices are supported with notable caveats about scale and local conditions.\n\n=== VERIFIED CLAIMS ===\n\nClaim: C1\nOriginal: Soil structure (aggregates and pore connectivity) is a primary driver of soil microbiome assembly and functioning, regulating water, oxygen and nutrient flows and thereby determining microbial processes and agroecosystem outcomes.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] Bacterial Preferences for Specific Soil Particle Size Fractions Revealed by Community Analyses\n    Distinct bacterial communities across particle-size and aggregate fractions indicate habitat filtering by structure.\n  - [Similar Paper] Macroaggregates Serve as Micro Hotspots Enriched With Functional and Networked Microbial Communities in a Long Term Paddy Soil\n    Macroaggregates host functional microbial hotspots linking aggregate habitats to community function.\n  - [Research Group] Anaerobic microsites have an unaccounted role in soil carbon stabilisation (2017)\n    Restricted oxygen diffusion creates anaerobic microsites that shift microbial metabolism and stabilise carbon, a pore-scale structural control.\n  - [Research Group] Microbial spatial footprint as a driver of soil carbon stabilisation (2019)\n    X-ray micro-CT shows pore architecture mediates oxygen access and decomposition, linking structure to microbial function.\n  - [Research Group] Spatial oxygen distribution and nitrous oxide emissions from soil after manure application: a novel approach using planar optodes (2014)\n    Planar optode imaging mapped oxygen heterogeneity aligned with N2O hotspots, demonstrating structure controls oxygen availability.\n  - [Patent] EP3105198B1: Soil bacteria for inoculating stress soils\n    Inoculants promoting EPS and biofilms increase aggregate stability and porosity, consistent with structure-mediated water and oxygen control.\n  - [Patent] WO2017117314A1: Biochar as a microbial carrier\n    Biochar's hierarchical pores host microbes and alter pore-size distributions, shaping microbial assembly and activity.\n\nSummary: Multiple independent studies support structure-driven assembly and function via diffusion and redox control at micro- to mesoscales. However, across broader gradients soil chemistry such as pH can dominate community composition, so the claim holds with important scale and context caveats.\n\nClaim: C2\nOriginal: Soil microbiomes drive core agroecosystem functions, including climate regulation and nutrient cycling, with quantitatively large contributions to global greenhouse gas budgets.\nStatus: Verified\nConfidence: High\n\nSupporting Evidence:\n  - [Similar Paper] Global Nitrous Oxide Budget (2024)\n    Attributes a large share of anthropogenic N2O to agriculture, linking emissions to microbially mediated nitrification and denitrification.\n  - [Similar Paper] Global Methane Budget (2024-2025)\n    Reports major methane sources from agriculture and waste with microbial origins, including rice system emissions and oxidation dynamics.\n  - [Patent] WO2024100477A1: Environment friendly non-toxic methanotroph formulation for mitigation of methane emission in rice\n    Field application of methanotrophs reduces CH4 by enhancing microbial oxidation pathways, operationalising microbial control of fluxes.\n  - [Patent] WO2021076458A9: Inhibitors of soil nitrification and processes to prevent same\n    Targets microbial ammonia oxidation to reduce N2O, reinforcing the microbial basis of agricultural greenhouse gas emissions.\n\nSummary: The microbial origin of soil N2O and CH4 and the large agricultural share in global budgets are established by repeated global syntheses and mechanistic studies. Interventions and patents that manipulate microbial pathways further reinforce causality, with uncertainties mainly in magnitude estimates rather than direction.\n\nClaim: C3\nOriginal: Conservation-oriented management (reduced/no tillage, crop diversification, cover cropping, organic amendments, integrated soil fertility and pest management) generally improves soil structure and supports beneficial microbial functions, though effects and trade-offs are context-dependent.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] Climate and Soil Characteristics Determine Where No Till Management Can Store Carbon in Soils and Mitigate Greenhouse Gas Emissions\n    Shows that mitigation and SOC benefits of no-till depend on climate, soil and depth, highlighting context-dependence.\n  - [Research Group] Microbial spatial footprint as a driver of soil carbon stabilisation (2019)\n    Demonstrates that plant-induced changes to pore architecture under conservation practices influence microbial processes and carbon outcomes.\n  - [Research Group] Anaerobic microsites have an unaccounted role in soil carbon stabilisation (2017)\n    Indicates that management altering oxygen diffusion can shift microbial functions, linking structure changes to functional outcomes.\n\nContradicting Evidence:\n  - [Similar Paper] Climate, duration, and nitrogen placement determine N2O emissions in reduced tillage systems: a meta-analysis (2013)\n    Reports conditions under which reduced tillage increases N2O, emphasising climate and nitrogen placement as critical modifiers.\n  - [Similar Paper] Effects of Tillage Practice on Soil Structure, N2O Emissions and Economics\n    Field comparison highlights that structural benefits may not align with short-term economics and may require adapted nutrient management.\n\nSummary: Conservation practices often improve structure and support beneficial microbial functions, but responses are heterogeneous and can increase N2O or fail to build SOC depending on climate, texture, depth and practice details. The claim is directionally correct, with the context-dependent caveat essential to avoid overgeneralisation.\n",
        "structured": {
          "claims": [
            {
              "claimId": "C1",
              "originalClaim": "Soil structure (aggregates and pore connectivity) is a primary driver of soil microbiome assembly and functioning, regulating water, oxygen and nutrient flows and thereby determining microbial processes and agroecosystem outcomes.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Bacterial Preferences for Specific Soil Particle Size Fractions Revealed by Community Analyses",
                  "relevance": "Distinct bacterial communities across particle-size and aggregate fractions indicate habitat filtering by structure."
                },
                {
                  "source": "Similar Paper",
                  "title": "Macroaggregates Serve as Micro Hotspots Enriched With Functional and Networked Microbial Communities in a Long Term Paddy Soil",
                  "relevance": "Macroaggregates host functional microbial hotspots linking aggregate habitats to community function."
                },
                {
                  "source": "Research Group",
                  "title": "Anaerobic microsites have an unaccounted role in soil carbon stabilisation (2017)",
                  "relevance": "Restricted oxygen diffusion creates anaerobic microsites that shift microbial metabolism and stabilise carbon, a pore-scale structural control."
                },
                {
                  "source": "Research Group",
                  "title": "Microbial spatial footprint as a driver of soil carbon stabilisation (2019)",
                  "relevance": "X-ray micro-CT shows pore architecture mediates oxygen access and decomposition, linking structure to microbial function."
                },
                {
                  "source": "Research Group",
                  "title": "Spatial oxygen distribution and nitrous oxide emissions from soil after manure application: a novel approach using planar optodes (2014)",
                  "relevance": "Planar optode imaging mapped oxygen heterogeneity aligned with N2O hotspots, demonstrating structure controls oxygen availability."
                },
                {
                  "source": "Patent",
                  "title": "EP3105198B1: Soil bacteria for inoculating stress soils",
                  "relevance": "Inoculants promoting EPS and biofilms increase aggregate stability and porosity, consistent with structure-mediated water and oxygen control."
                },
                {
                  "source": "Patent",
                  "title": "WO2017117314A1: Biochar as a microbial carrier",
                  "relevance": "Biochar's hierarchical pores host microbes and alter pore-size distributions, shaping microbial assembly and activity."
                }
              ],
              "contradictingEvidence": [],
              "verificationSummary": "Multiple independent studies support structure-driven assembly and function via diffusion and redox control at micro- to mesoscales. However, across broader gradients soil chemistry such as pH can dominate community composition, so the claim holds with important scale and context caveats.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C2",
              "originalClaim": "Soil microbiomes drive core agroecosystem functions, including climate regulation and nutrient cycling, with quantitatively large contributions to global greenhouse gas budgets.",
              "verificationStatus": "Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Global Nitrous Oxide Budget (2024)",
                  "relevance": "Attributes a large share of anthropogenic N2O to agriculture, linking emissions to microbially mediated nitrification and denitrification."
                },
                {
                  "source": "Similar Paper",
                  "title": "Global Methane Budget (2024-2025)",
                  "relevance": "Reports major methane sources from agriculture and waste with microbial origins, including rice system emissions and oxidation dynamics."
                },
                {
                  "source": "Patent",
                  "title": "WO2024100477A1: Environment friendly non-toxic methanotroph formulation for mitigation of methane emission in rice",
                  "relevance": "Field application of methanotrophs reduces CH4 by enhancing microbial oxidation pathways, operationalising microbial control of fluxes."
                },
                {
                  "source": "Patent",
                  "title": "WO2021076458A9: Inhibitors of soil nitrification and processes to prevent same",
                  "relevance": "Targets microbial ammonia oxidation to reduce N2O, reinforcing the microbial basis of agricultural greenhouse gas emissions."
                }
              ],
              "contradictingEvidence": [],
              "verificationSummary": "The microbial origin of soil N2O and CH4 and the large agricultural share in global budgets are established by repeated global syntheses and mechanistic studies. Interventions and patents that manipulate microbial pathways further reinforce causality, with uncertainties mainly in magnitude estimates rather than direction.",
              "confidenceLevel": "High"
            },
            {
              "claimId": "C3",
              "originalClaim": "Conservation-oriented management (reduced/no tillage, crop diversification, cover cropping, organic amendments, integrated soil fertility and pest management) generally improves soil structure and supports beneficial microbial functions, though effects and trade-offs are context-dependent.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Climate and Soil Characteristics Determine Where No Till Management Can Store Carbon in Soils and Mitigate Greenhouse Gas Emissions",
                  "relevance": "Shows that mitigation and SOC benefits of no-till depend on climate, soil and depth, highlighting context-dependence."
                },
                {
                  "source": "Research Group",
                  "title": "Microbial spatial footprint as a driver of soil carbon stabilisation (2019)",
                  "relevance": "Demonstrates that plant-induced changes to pore architecture under conservation practices influence microbial processes and carbon outcomes."
                },
                {
                  "source": "Research Group",
                  "title": "Anaerobic microsites have an unaccounted role in soil carbon stabilisation (2017)",
                  "relevance": "Indicates that management altering oxygen diffusion can shift microbial functions, linking structure changes to functional outcomes."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Climate, duration, and nitrogen placement determine N2O emissions in reduced tillage systems: a meta-analysis (2013)",
                  "relevance": "Reports conditions under which reduced tillage increases N2O, emphasising climate and nitrogen placement as critical modifiers."
                },
                {
                  "source": "Similar Paper",
                  "title": "Effects of Tillage Practice on Soil Structure, N2O Emissions and Economics",
                  "relevance": "Field comparison highlights that structural benefits may not align with short-term economics and may require adapted nutrient management."
                }
              ],
              "verificationSummary": "Conservation practices often improve structure and support beneficial microbial functions, but responses are heterogeneous and can increase N2O or fail to build SOC depending on climate, texture, depth and practice details. The claim is directionally correct, with the context-dependent caveat essential to avoid overgeneralisation.",
              "confidenceLevel": "Moderate"
            }
          ],
          "overallAssessment": "The paper's central framing is consistent with independent evidence: pore and aggregate architecture shape diffusion and redox, which govern microbial processes and agroecosystem outcomes; microbes underpin nutrient cycling and a large share of agricultural greenhouse gases; and conservation practices can improve structure and functions with important context-dependent trade-offs. The strongest support is for the microbial role in greenhouse gas budgets, while structure-as-primary-driver and universal benefits of conservation practices are supported with notable caveats about scale and local conditions.",
          "promptNotes": "Independence: Evidence spans multiple groups and continents, plus unrelated patents.  Data availability: Global budgets are open; several studies have data supplements but analysis code is not always fully public.  Replication and rigour: Greenhouse gas findings are repeatedly synthesised; structure-function mechanisms are reproduced across methods, but effect sizes vary with context and some pipelines remain bespoke."
        }
      },
      "authorContacts": {
        "maxChars": 2349,
        "truncated": false,
        "text": "Paper: Soil structure and microbiome functions in agroecosystems (Source)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Martin Hartmann | martin.hartmann@usys.ethz.ch | Scientist, Sustainable Agroecosystems, ETH Zrich | 0000-0001-8069-5284 |\n| Johan Six | johan.six@usys.ethz.ch | Professor, ETH Zrich (Sustainable Agroecosystems) | 0000-0001-9336-4185 |\n\nPaper: Bacterial Preferences for Specific Soil Particle Size Fractions Revealed by Community Analyses\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Michael Hemkemeyer | hemkemeyer@uni-wuppertal.de | Academic councillor, Department of Soil & Groundwater Management, University of Wuppertal | 0000-0002-2554-2231 |\n| Christoph C. Tebbe | christoph.tebbe@thuenen.de | Scientist, Thnen Institute of Biodiversity | 0000-0003-4861-0214 |\n\nPaper: Micro-fractionation shows microbial community changes in soil particles below 20 m\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Christoph Keuschnig | Not found | MSCA Postdoctoral Fellow, GFZ German Research Centre for Geosciences (Potsdam) | 0000-0002-5246-2640 |\n| Catherine Larose | catherine.larose@ec-lyon.fr | Environmental Microbial Genomics, cole Centrale de Lyon, Universit de Lyon | 0000-0001-5641-0701 |\n\nPaper: Effects of Tillage Practice on Soil Structure, N2O Emissions and Economics\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Ognjen urovec | ognjen.zurovec@nmbu.no | Department of International Environment and Development Studies, NMBU (s, Norway) | Not found |\n| Peter Drsch | Not found | Faculty of Environmental Sciences and Natural Resource Management, NMBU | Not found |\n\nPaper: Climate and Soil Characteristics Determine Where No-Till Management Can Store Carbon in Soils and Mitigate Greenhouse Gas Emissions\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Stephen M. Ogle | Not found | Not found | Not found |\n| Gabriel G. Vzquez-Amabile | Not found | Not found | Not found |\n\nPaper: Soil structure and microbiome functions in agroecosystems (Source)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Martin Hartmann | martin.hartmann@usys.ethz.ch | Scientist, Sustainable Agroecosystems, ETH Zrich | 0000-0001-8069-5284 |\n| Johan Six | johan.six@usys.ethz.ch | Professor, ETH Zrich (Sustainable Agroecosystems) | 0000-0001-9336-4185 |",
        "structured": {
          "papers": [
            {
              "title": "Soil structure and microbiome functions in agroecosystems",
              "identifier": "Source",
              "authors": [
                {
                  "name": "Martin Hartmann",
                  "email": "martin.hartmann@usys.ethz.ch",
                  "role": "Scientist, Sustainable Agroecosystems, ETH Zrich",
                  "orcid": "0000-0001-8069-5284",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=G5wlvxYAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/martin-hartmann-microbiome/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://microbiome.ch"
                    }
                  ]
                },
                {
                  "name": "Johan Six",
                  "email": "johan.six@usys.ethz.ch",
                  "role": "Professor, ETH Zrich (Sustainable Agroecosystems)",
                  "orcid": "0000-0001-9336-4185",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=tknRgfkAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/johan-six-eth/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://johansix.ethz.ch/en/johan.html"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Bacterial Preferences for Specific Soil Particle Size Fractions Revealed by Community Analyses",
              "identifier": null,
              "authors": [
                {
                  "name": "Michael Hemkemeyer",
                  "email": "hemkemeyer@uni-wuppertal.de",
                  "role": "Academic councillor, Department of Soil & Groundwater Management, University of Wuppertal",
                  "orcid": "0000-0002-2554-2231",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=YNHGIpMAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/hemkemeyer/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://www.boden.uni-wuppertal.de/en/home-1/dr-michael-hemkemeyer/"
                    }
                  ]
                },
                {
                  "name": "Christoph C. Tebbe",
                  "email": "christoph.tebbe@thuenen.de",
                  "role": "Scientist, Thnen Institute of Biodiversity",
                  "orcid": "0000-0003-4861-0214",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=a14fbqMAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/christophtebbe/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://www.thuenen.de/en/institutes/biodiversity/staff/christoph-tebbe"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Micro-fractionation shows microbial community changes in soil particles below 20 m",
              "identifier": null,
              "authors": [
                {
                  "name": "Christoph Keuschnig",
                  "email": null,
                  "role": "MSCA Postdoctoral Fellow, GFZ German Research Centre for Geosciences (Potsdam)",
                  "orcid": "0000-0002-5246-2640",
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://www.gfz.de/en/staff/christoph.keuschnig"
                    }
                  ]
                },
                {
                  "name": "Catherine Larose",
                  "email": "catherine.larose@ec-lyon.fr",
                  "role": "Environmental Microbial Genomics, cole Centrale de Lyon, Universit de Lyon",
                  "orcid": "0000-0001-5641-0701",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=NCuGHZgAAAAJ"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Effects of Tillage Practice on Soil Structure, N2O Emissions and Economics",
              "identifier": null,
              "authors": [
                {
                  "name": "Ognjen urovec",
                  "email": "ognjen.zurovec@nmbu.no",
                  "role": "Department of International Environment and Development Studies, NMBU (s, Norway)",
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Peter Drsch",
                  "email": null,
                  "role": "Faculty of Environmental Sciences and Natural Resource Management, NMBU",
                  "orcid": null,
                  "profiles": []
                }
              ]
            },
            {
              "title": "Climate and Soil Characteristics Determine Where No-Till Management Can Store Carbon in Soils and Mitigate Greenhouse Gas Emissions",
              "identifier": null,
              "authors": [
                {
                  "name": "Stephen M. Ogle",
                  "email": null,
                  "role": null,
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Gabriel G. Vzquez-Amabile",
                  "email": null,
                  "role": null,
                  "orcid": null,
                  "profiles": []
                }
              ]
            },
            {
              "title": "Soil structure and microbiome functions in agroecosystems",
              "identifier": "Source",
              "authors": [
                {
                  "name": "Martin Hartmann",
                  "email": "martin.hartmann@usys.ethz.ch",
                  "role": "Scientist, Sustainable Agroecosystems, ETH Zrich",
                  "orcid": "0000-0001-8069-5284",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=G5wlvxYAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/martin-hartmann-microbiome/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://microbiome.ch"
                    }
                  ]
                },
                {
                  "name": "Johan Six",
                  "email": "johan.six@usys.ethz.ch",
                  "role": "Professor, ETH Zrich (Sustainable Agroecosystems)",
                  "orcid": "0000-0001-9336-4185",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=tknRgfkAAAAJ"
                    },
                    {
                      "platform": "LinkedIn",
                      "url": "https://www.linkedin.com/in/johan-six-eth/"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://johansix.ethz.ch/en/johan.html"
                    }
                  ]
                }
              ]
            }
          ],
          "promptNotes": ""
        }
      }
    },
    {
      "id": "3",
      "sourcePdf": {
        "path": "SCALING LARGE LANGUAGE MODELS FOR NEXT-GENERATION SINGLE-CELL ANALYSIS.pdf",
        "publicPath": "/mock-papers/3.pdf",
        "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
        "originalFileName": "SCALING LARGE LANGUAGE MODELS FOR NEXT-GENERATION SINGLE-CELL ANALYSIS.pdf",
        "doi": "10.1101/2025.04.14.648850doi",
        "pages": 29
      },
      "label": "SCALING LARGE LANGUAGE MODELS FOR NEXT-GENERATION SINGLE-CELL ANALYSIS",
      "generatedAt": "2025-10-25T03:44:22.763Z",
      "claimsAnalysis": {
        "text": "# Executive Summary **Main findings:**   1) The authors present C2S-Scale, an LLM family up to 27B parameters trained on \"cell sentences\" and text, claiming broad state-of-the-art performance across predictive, generative, and natural-language single-cell tasks. 2) Performance scales with model and data size, and reinforcement learning (GRPO) improves perturbation response prediction, including a reported 16% reduction in scFID on interferon genes. 3) A dual-context virtual screen nominates silmitasertib as an interferon-conditional amplifier of antigen presentation, validated in two human cell models with consistent MHC-I increases only in the presence of interferon.  **Headline numbers:** 95.43% cell-type annotation accuracy on an immune dataset (vs scGPT 93.1% and Geneformer 94.0%). GRPO gains: Kendall's  +9.2% and Pearson's r +6.6% for a 410M model on L1000;  +4.9% and r +3.6% for a 1B model; scFID on interferon-related genes -16%. Silmitasertib validation: MHC-I MFI increases of 13.6% at 10 nM and 34.9% at 1000 nM with IFN-; 24.9% at 10 nM and 37.3% at 300 nM with IFN-; 17.1% at 10 nM and 28.1% at 100 nM in a second cell model.  **Overall evidence strength:** **Moderate.** The work reports consistent cross-task improvements and gives key numeric gains and wet-lab validation, but many evaluations are summarised without full statistics, several benchmarks rely on text metrics or internal datasets, and some details are confined to figures or Supplements not fully visible in the extract.  ---  # Top 3 Claims and Evidence  ## C1. C2S-Scale outperforms or matches specialised single-cell models and general LLMs across predictive, generative, and natural-language single-cell tasks. **Evidence summary:** Multi-task benchmarking shows higher or comparable performance to scGPT and Geneformer on traditional single-cell tasks, plus superior natural-language interpretation and QA vs general LLMs. Example given: immune tissue dataset cell-type annotation at 95.43% accuracy, slightly better than scGPT and Geneformer. Also reports outperforming GPT-4o in natural-language QA by 3% BERTScore and leading cluster captioning and dataset-level interpretation benchmarks. Evidence type: computational benchmarking on held-out cells, clusters, datasets; language metrics (BERTScore) for text tasks.   **Key numbers:** 95.43% accuracy vs scGPT 93.1% and Geneformer 94.0% on immune data; QA BERTScore +3% vs GPT-4o.   **Source location:** Section 2.2 and Fig. 3; Section 2.4 and Fig. 5C-E; lines detailing 95.43% and the 3% QA margin in Section 2.2.   **Strength:** **Moderate.** Assumes fair, comparable fine-tuning; exact dataset sizes, CIs, and formal statistical tests are not reported in text. Language metrics may not fully capture biological correctness.   **Assumptions/conditions:** Comparisons are as described in the text; figures not directly inspectable here. No external validation set beyond those described.  ## C2. Scaling model and data size improves performance, and GRPO reinforcement learning further boosts perturbation predictions. **Evidence summary:** Scaling from 410M to 27B parameters yields consistent gains across tasks; similar trends hold for LoRA-based fine-tuning and as training data grows. For perturbation response prediction, C2S-Scale beats scGen, scGPT, and CellOT on MMD, Wasserstein, and scFID. GRPO with biologically targeted rewards improves L1000 and cytokine-stimulation tasks, including a 16% scFID reduction on interferon-related genes. Evidence type: computational scaling studies and held-out perturbation benchmarks; embedding-space distributional metrics; RL ablations.   **Key numbers:** Parameter range 410M to 27B; scFID on interferon-related genes -16% with GRPO; L1000 gains: Kendall's  +9.2% and Pearson's r +6.6% for 410M,  +4.9% and r +3.6% for 1B; outperforms baselines across MMD, Wasserstein, scFID.   **Source location:** Section 2.3 and Fig. 4C-E; Section 2.7 and Fig. 8E-G.   **Strength:** **Moderate.** Clear directional effects with specific improvements reported, but full numeric baselines, confidence intervals, and dataset sizes per metric are not provided in text.   **Assumptions/conditions:** Benchmarks and metrics are as summarised; scFID uses scGPT embeddings; task mixes are comparable between models.  ## C3. A virtual screen identifies silmitasertib as an interferon-conditional amplifier of antigen presentation, validated experimentally in two unseen human cell models. **Evidence summary:** Dual-context in-silico screen predicted a context split for silmitasertib, with strong MHC-I increases only under low-level interferon signalling. Interferon activity in screen contexts differed strongly (****, P < 0.0001, Wilcoxon). Wet-lab validation showed no effect of silmitasertib alone but marked HLA-A,B,C surface increases with low-dose IFN- and IFN- in Merkel-origin cells, replicated in a pulmonary model. Evidence type: computational prediction followed by experimental validation with flow cytometry.   **Key numbers:** IFN context difference: ****, P < 0.0001. Merkel model with IFN-: MHC-I MFI +13.6% at 10 nM, +34.9% at 1000 nM. With IFN-: +24.9% at 10 nM, +37.3% at 300 nM. Pulmonary model: +17.1% at 10 nM and +28.1% at 100 nM. n = 3 independent experiments; two-sided tests with multiple-comparison correction.   **Source location:** Section 2.8 and Fig. 9B-H; Methods 4.8-4.9.   **Strength:** **Moderate.** Replicated across two models with coherent dose responses, but small n, absence of exact p-values for MFI changes in text, and limited cell-type diversity.   **Assumptions/conditions:** The IFN-conditional effect is defined by increases in MHC-I MFI under stated IFN doses; training did not include these cell models.  ---  # Gaps & Limitations (linked to C1-C3) - **Benchmark transparency and statistics (C1, C2):** Many results are summarised without full sample sizes, confidence intervals, or p-values in text. Several outcomes rely on BERTScore rather than biological ground truth for text tasks. Source: Sections 2.2, 2.4; Fig. 3, Fig. 5.   - **Potential evaluation bias and metric dependence (C2):** scFID depends on embeddings from another model (scGPT), which may bias comparisons. Distributional metrics are reported without detailed uncertainty. Source: Section 2.7 and 4.7; Fig. 8E-G.   - **Small-scale wet-lab validation (C3):** n = 3 experiments per condition, two cell models only, no in vivo validation, and no exact p-values for MFI changes in text. Source: Section 2.8; Fig. 9F-H; Methods 4.9.   - **Model architecture caveats and hallucination risk (C1, C2):** Authors note unidirectional causal attention limitations and LLM hallucinations for open-ended tasks. Source: Supplementary 7.1.1-7.1.2.   - **OCR/visibility constraints:** Figures and tables are referenced but not viewable here; some spacing artefacts in numbers and units are present [UNCLEAR].  ---  # Methods Snapshot - **Design:** Develop LLMs that encode scRNA-seq profiles as ranked \"cell sentences\" and jointly train on multimodal corpus with text and metadata. Two-phase training: large-scale self-supervision plus task-specific fine-tuning, with optional GRPO reinforcement learning. Introduces scFID for generative evaluation.   - **Data:** >50 million human and mouse single cells from CELLxGENE and Human Cell Atlas with associated text; additional datasets for tasks including CosMx liver spatial data, Dong et al. cytokine perturbations, and L1000 bulk landmark genes. Source: Sections 2.1, 4.1-4.3, 4.6-4.8.   - **Models:** Decoder-only Transformer backbones up to 27B parameters; input is tokenised gene names with positional encodings preserving rank order; LoRA used for parameter-efficient tuning. Source: Sections 2.1, 4.3-4.5.   - **Analyses:** Benchmarks across classification, generation, embedding, spatial reasoning, NL interpretation, QA, and perturbation prediction; metrics include BERTScore, overlap, MMD, Wasserstein, scFID. Source: Sections 2.2-2.7; 4.4-4.7.  ---  # Risk-of-Bias and Quality Checklist - **Clear primary outcomes and metrics specified:** Partially. Several metrics named, but full numeric details often in figures or Supplement.   - **Comparators appropriate and described:** Yes, named baselines include scGPT, Geneformer, scGen, CellOT, Llama, GPT-4o, etc., but configuration details are brief.   - **Train-test separation and OOD tests:** Claimed for several tasks, including unseen studies and perturbations. Details are summarised, not fully enumerated.   - **Statistical reporting:** Limited in text; few confidence intervals or exact p-values beyond the **** P < 0.0001 IFN context contrast.   - **External validation:** Wet-lab validation for one discovery across two cell models; broader external validations not reported in text.   - **Risk of leakage or overfitting controls:** Not fully detailed; authors note held-out partitions and OOD sets; some training data used to generate language targets with GPT models.   - **Limitations acknowledged by authors:** Yes, causal attention constraints and hallucination risks.   Overall quality: **Moderate**, chiefly due to summarised reporting and reliance on internal metrics without full statistical detail in the text.  ---  # Open Questions and Next Steps 1) **Generalisation of IFN-conditional amplification:** Test silmitasertib across additional tissues, primary cells, and IFN dose-response curves, including mechanistic assays for CK2-STAT1/IRF1 pathway modulation. Source link: Section 2.8; Fig. 9E-H.   2) **Robustness of scFID and embedding-metric conclusions:** Compare scFID using alternative embedding models and report variance and CIs to assess metric sensitivity. Source: Sections 2.7, 4.7.   3) **Benchmark transparency:** Release full per-task numeric tables with N, effect sizes, and uncertainty; include pre-registered evaluation splits. Source: Sections 2.2-2.7; Fig. 3-6, 8.   4) **Mitigating hallucination in NL tasks:** Add constrained decoding or fact-checking against curated gene and pathway KBs for dataset interpretation and cluster captioning. Source: Supplementary 7.1.2.   5) **Architectural exploration:** Evaluate hybrid attention or order-invariance strategies to address causal attention limitations and quantify gains on biologically causal tasks. Source: Supplementary 7.1.1.  ---  ## QA Check - All required sections present.   - Numbers match the provided text exactly.   - Each of C1-C3 includes a strength rating and specific source locations.   - Missing figure values are acknowledged where precise numbers are not visible.",
        "structured": {
          "executiveSummary": [
            "C2S-Scale (up to 27B parameters) trained on \"cell sentences\" and text shows broad state-of-the-art performance across predictive, generative, and natural-language tasks.",
            "Scaling and GRPO improve performance; reported scFID -16% on interferon genes; L1000 gains in Kendall's  and Pearson's r.",
            "Virtual screen plus wet-lab validation identifies silmitasertib as an interferon-conditional amplifier of antigen presentation.",
            "Overall evidence strength: Moderate."
          ],
          "claims": [
            {
              "id": "C1",
              "claim": "C2S-Scale outperforms or matches specialised single-cell models and general LLMs across predictive, generative, and natural-language single-cell tasks.",
              "evidenceSummary": "Multi-task benchmarking on held-out single-cell tasks and natural-language interpretation shows higher or comparable performance to scGPT and Geneformer, and improved NL interpretation and QA vs general LLMs; example immune dataset cell-type annotation reaches 95.43% accuracy.",
              "keyNumbers": [
                "95.43% accuracy vs scGPT 93.1% and Geneformer 94.0% (immune dataset)",
                "QA BERTScore +3% vs GPT-4o"
              ],
              "source": "Section 2.2; Fig. 3. Section 2.4; Fig. 5C-E.",
              "strength": "Moderate",
              "assumptions": "Assumes comparable fine-tuning and evaluation across models; figures not directly inspectable; language metrics may not fully reflect biological correctness.",
              "evidenceType": "Computational benchmarking on held-out datasets (classification, generation, NL interpretation, QA)."
            },
            {
              "id": "C2",
              "claim": "Scaling model and data size improves performance, and GRPO reinforcement learning further boosts perturbation predictions.",
              "evidenceSummary": "Performance improves from 410M to 27B parameters and with more data; LoRA shows similar trends. Perturbation prediction benchmarks show superiority over scGen, scGPT, CellOT on MMD, Wasserstein, scFID; GRPO yields a 16% scFID reduction on interferon genes and gains on L1000.",
              "keyNumbers": [
                "Model size: 410M-27B",
                "scFID on interferon-related genes -16% with GRPO",
                "L1000: Kendall's  +9.2% and Pearson's r +6.6% (410M)",
                "L1000: Kendall's  +4.9% and Pearson's r +3.6% (1B)"
              ],
              "source": "Section 2.3; Fig. 4C-E. Section 2.7; Fig. 8E-G.",
              "strength": "Moderate",
              "assumptions": "scFID computed in scGPT embedding space; baselines and task mixes as summarised.",
              "evidenceType": "Computational scaling study and perturbation benchmarks with RL ablations."
            },
            {
              "id": "C3",
              "claim": "A virtual screen identifies silmitasertib as an interferon-conditional amplifier of antigen presentation, validated experimentally in two unseen human cell models.",
              "evidenceSummary": "Dual-context screen predicts strong MHC-I increases only under low-level interferon signalling; IFN activity differs significantly across contexts. Flow cytometry shows no effect of silmitasertib alone but marked HLA-A,B,C increases with low-dose IFN- and IFN- in a Merkel-origin model, replicated in a pulmonary model.",
              "keyNumbers": [
                "IFN context difference: ****, P < 0.0001 (Wilcoxon)",
                "Merkel model + IFN-: MHC-I MFI +13.6% (10 nM), +34.9% (1000 nM)",
                "Merkel model + IFN-: +24.9% (10 nM), +37.3% (300 nM)",
                "Pulmonary model: +17.1% (10 nM), +28.1% (100 nM)",
                "n = 3 independent experiments; two-sided tests with multiple-comparison correction"
              ],
              "source": "Section 2.8; Fig. 9B-H. Methods 4.8-4.9.",
              "strength": "Moderate",
              "assumptions": "IFN-conditional effect defined by MHC-I MFI increases under stated IFN doses; cell models were unseen during training.",
              "evidenceType": "Computational virtual screening plus experimental validation (flow cytometry)."
            }
          ],
          "gaps": [
            {
              "category": "Benchmark transparency and statistics",
              "detail": "Results often summarised without full Ns, confidence intervals, or p-values; reliance on BERTScore for some tasks.",
              "relatedClaimIds": [
                "C1",
                "C2"
              ]
            },
            {
              "category": "Metric dependence and potential bias",
              "detail": "scFID depends on scGPT embeddings; uncertainty estimates not provided.",
              "relatedClaimIds": [
                "C2"
              ]
            },
            {
              "category": "Wet-lab validation scope",
              "detail": "Small n (3), two cell models, no in vivo validation; exact p-values for MFI changes not reported in text.",
              "relatedClaimIds": [
                "C3"
              ]
            },
            {
              "category": "Model limitations and hallucination risk",
              "detail": "Causal attention unidirectionality and LLM hallucinations noted by authors.",
              "relatedClaimIds": [
                "C1",
                "C2"
              ]
            },
            {
              "category": "Figure/text visibility",
              "detail": "Figures referenced but not viewable here; possible OCR artefacts [UNCLEAR].",
              "relatedClaimIds": [
                "C1",
                "C2",
                "C3"
              ]
            }
          ],
          "methodsSnapshot": [
            "Develop decoder-only LLMs that encode scRNA-seq as ranked \"cell sentences\", trained on a multimodal corpus with text and metadata.",
            "Two-phase training: large-scale self-supervision plus task-specific fine-tuning; optional GRPO reinforcement learning.",
            "Data include >50M cells (CELLxGENE, HCA) and task-specific datasets (CosMx liver spatial, Dong et al., L1000).",
            "Analyses span classification, generation, embedding, spatial reasoning, NL interpretation, QA, perturbation prediction; metrics include BERTScore, overlap, MMD, Wasserstein, scFID."
          ],
          "riskChecklist": [
            {
              "item": "Clear primary outcomes and metrics specified",
              "status": "partial",
              "note": "Metrics named, but many numeric details only in figures/Supplement."
            },
            {
              "item": "Comparators appropriate and described",
              "status": "met",
              "note": "Baselines named (scGPT, Geneformer, scGen, CellOT, Llama, GPT-4o)."
            },
            {
              "item": "Train-test separation and OOD tests",
              "status": "partial",
              "note": "Held-out and OOD described, but details summarised."
            },
            {
              "item": "Statistical reporting",
              "status": "missing",
              "note": "Few CIs or exact p-values reported in text beyond IFN context comparison."
            },
            {
              "item": "External validation",
              "status": "partial",
              "note": "Wet-lab validation for one discovery in two cell models."
            },
            {
              "item": "Risk of leakage or overfitting controls",
              "status": "unclear",
              "note": "Not fully detailed; some prompts/targets involve GPT-generated text."
            },
            {
              "item": "Limitations acknowledged by authors",
              "status": "met",
              "note": "Causal attention and hallucination risks noted."
            }
          ],
          "openQuestions": [
            "Generalisation of IFN-conditional amplification: test silmitasertib across more tissues and IFN dose-responses; probe CK2-STAT1/IRF1 mechanisms.",
            "Robustness of scFID: evaluate alternative embedding models and report variance/CIs.",
            "Benchmark transparency: release per-task tables with N, effect sizes, uncertainty and pre-registered splits.",
            "Mitigating hallucination in NL tasks: add constrained decoding or biological fact-checking.",
            "Architectural exploration: test hybrid attention or order-invariance to address causal attention limits."
          ],
          "crossPaperComparison": []
        }
      },
      "createdAt": "2025-10-23T21:49:02.191Z",
      "updatedAt": "2025-10-27T20:42:33.510Z",
      "agent": {
        "maxChars": 10579,
        "promptNotes": ""
      },
      "sourcePaper": {
        "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
        "summary": "C2S-Scale (up to 27B parameters) trained on \"cell sentences\" plus text shows broad SOTA across predictive, generative, and natural-language single-cell tasks; scaling and GRPO improve perturbation prediction; a virtual screen with wet-lab validation identifies silmitasertib as an interferon-conditional MHC-I amplifier.",
        "keyMethodSignals": [
          "Decoder-only Transformers on ranked gene-token \"cell sentences\" with text",
          "Two-phase training with task-specific fine-tuning and optional GRPO",
          "Benchmarks across annotation, generation, embedding, spatial reasoning, NL QA",
          "Metrics include BERTScore, MMD, Wasserstein, and scFID",
          "Virtual screen followed by flow-cytometry validation under IFN context"
        ],
        "methodComparison": {
          "sample": ">50 million cells from CELLxGENE and HCA, plus task-specific sets (CosMx liver spatial, cytokine perturbations, L1000).",
          "materials": "Decoder-only LLMs up to 27B; LoRA variants; multimodal corpus combining \"cell sentences\" and text; GRPO for perturbation tasks; compounds including silmitasertib.",
          "equipment": "GPU clusters for training and fine-tuning; flow cytometer for HLA-A,B,C surface assays with IFN- or IFN-.",
          "procedure": "Self-supervised pretraining on \"cell sentences\" followed by task-specific fine-tuning; optional GRPO; multi-task benchmarking; dual-context virtual screen and targeted flow-cytometry validation.",
          "outcomes": "SOTA or parity vs scGPT/Geneformer; scaling gains 410M27B; GRPO boosts L1000  and r and reduces interferon-gene scFID by 16 percent; silmitasertib increases MHC-I only with low-dose IFN."
        }
      },
      "similarPapers": [
        {
          "identifier": "10.1038/s41592-024-02201-0",
          "title": "scGPT: toward building a foundation model for single-cell multi-omics using generative AI",
          "authors": [
            "Cui et al."
          ],
          "year": 2024,
          "venue": "Nature Methods",
          "whyRelevant": "Foundation Transformer trained on tens of millions of single cells across tasks. Directly comparable baselines and datasets overlap the brief.",
          "methodOverlap": [
            "Large-scale pretraining on CELLxGENE Census cells",
            "Perturbation prediction with CRISPR Perturb-seq datasets",
            "Multi-task benchmarks including annotation and integration"
          ],
          "methodComparison": {
            "sample": "33M+ cells for pretraining; multiple public evaluation sets including PBMC multiome and CRISPR Perturb-seq.",
            "materials": "Generative pretrained Transformer; public code and processed datasets.",
            "equipment": "GPU compute; standard single-cell preprocessing pipelines for dataset preparation.",
            "procedure": "Domain pretraining on cells, then task-specific fine-tuning across annotation, perturbation, integration and GRN analysis.",
            "outcomes": "SOTA or competitive results across tasks; public splits and data release."
          },
          "gaps": "Reporting is figure-heavy; several details are in Supplement. Perturbation metrics emphasise correlations and MMD-style distances rather than scFID.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "arXiv:2310.01436",
          "title": "xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data",
          "authors": [
            "Gong et al."
          ],
          "venue": "NeurIPS",
          "whyRelevant": "Pretrained Transformer for scRNA-seq with masking on gene tokens. Reports scaling behaviour and strong perturbation prediction performance.",
          "methodOverlap": [
            "Asymmetric encoder-decoder Transformer for sparse scRNA-seq",
            "Pretrained on large gene-token corpus with masking",
            "Downstream tasks include perturbation and drug prediction"
          ],
          "methodComparison": {
            "sample": "Curated multi-study scRNA-seq spanning ~19,264 genes and a large token corpus.",
            "materials": "Auto-discretised value embeddings with gene-token embeddings; masking regression objective.",
            "equipment": "GPU compute; no wet-lab components.",
            "procedure": "Pretrain with biased masking on non-zeros; fine-tune for annotation, perturb-seq and drug tasks.",
            "outcomes": "Scaling improves accuracy; SOTA or competitive on annotation and perturbation prediction."
          },
          "gaps": "Limited disclosure of per-task Ns and uncertainty. Evaluation emphasises accuracy and correlation without generative distributional scores like scFID.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "arXiv:2210.14330",
          "title": "A single-cell gene expression language model (Exceiver)",
          "authors": [
            "Connell",
            "Khan",
            "Keiser"
          ],
          "year": 2022,
          "venue": "NeurIPS Workshop",
          "whyRelevant": "Language-model framing with masking and set-like tokenisation. Explores order-invariant design relevant to causal-attention ordering caveat.",
          "methodOverlap": [
            "Self-supervised masking over gene tokens and counts",
            "Perceiver-IO to handle unordered, long gene inputs",
            "Transfer learning to downstream classification tasks"
          ],
          "methodComparison": {
            "sample": "Pretrained on Tabula Sapiens (~500k cells, 24 organs) with a 70/30 split.",
            "materials": "Learnable gene embeddings scaled by counts; discrete-noise masking objective.",
            "equipment": "GPU compute; open-source codebase.",
            "procedure": "Self-supervised regression masking with optional tissue label; evaluate on new datasets and prediction tasks.",
            "outcomes": "Latent representations align with tissues; transfer improves downstream accuracy."
          },
          "gaps": "Smaller scale than 27B-class models; limited perturbation evaluation and no RL. Uncertainty quantification is minimal.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1038/s41592-023-01969-x",
          "title": "Learning single-cell perturbation responses using neural optimal transport (CellOT)",
          "authors": [
            "Bunne et al."
          ],
          "year": 2023,
          "venue": "Nature Methods",
          "whyRelevant": "Direct comparator for perturbation prediction with distributional metrics. Uses unpaired mapping of control to treated single-cell states.",
          "methodOverlap": [
            "Predicts perturbation effects from unpaired single-cell data",
            "Benchmarks with MMD and correlation against scGen",
            "Evaluates scRNA-seq and 4i multiplexed proteomics"
          ],
          "methodComparison": {
            "sample": "Melanoma cell-line multiplexed proteomics and scRNA-seq drug panels; patient biopsies and cross-species LPS.",
            "materials": "Input-convex neural networks parameterise optimal transport potentials.",
            "equipment": "scRNA-seq and multiplexed imaging datasets; GPU training.",
            "procedure": "Learn OT maps per perturbation from control to treated distributions; test OOD on new patients and species.",
            "outcomes": "Outperforms scGen and others on MMD and r; captures higher moments of treated distributions."
          },
          "gaps": "Not an LLM and relies on latent autoencoder features. Distributional improvements reported without comprehensive uncertainty bands.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        },
        {
          "identifier": "10.1038/s41592-019-0494-8",
          "title": "scGen predicts single-cell perturbation responses",
          "authors": [
            "Lotfollahi",
            "Wolf",
            "Theis"
          ],
          "year": 2019,
          "venue": "Nature Methods",
          "whyRelevant": "Canonical perturbation-prediction baseline with VAE latent vector arithmetic. Demonstrates cross-study and cross-species generalisation.",
          "methodOverlap": [
            "VAE latent-space shifts to model perturbations",
            "Cross-study and cross-species OOD tests",
            "Public code and reproducibility repository"
          ],
          "methodComparison": {
            "sample": "Multiple scRNA-seq datasets across tissues and species, including infection and drug responses.",
            "materials": "Variational autoencoder with linear latent manipulations; public code and reproducibility resources.",
            "equipment": "Standard single-cell sequencing datasets; GPU training.",
            "procedure": "Train VAE, infer perturbation via latent vector arithmetic; evaluate across studies and species.",
            "outcomes": "Accurate out-of-sample predictions and batch integration capabilities."
          },
          "gaps": "Linear latent shifts can miss complex distributional changes. Uncertainty reporting is limited in the original work.",
          "overlapHighlights": [
            "Not reported",
            "Not reported",
            "Not reported"
          ],
          "clusterLabel": "Sample and model",
          "gapsOrUncertainties": null
        }
      ],
      "authorContacts": {
        "maxChars": 2002,
        "truncated": false,
        "text": "Paper: Scaling Large Language Models for Next-Generation Single-Cell Analysis (Source)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Syed Asad Rizvi | syed.rizvi@yale.edu | PhD Student, Yale University, Computer Science | Not found |\n| David van Dijk | Not found | Faculty, Yale School of Medicine; Corresponding author on this paper | 0000-0003-3911-9925 |\n\nPaper: scGPT: toward building a foundation model for single-cell multi-omics using generative AI\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Haotian Cui | Not found | Not found | 0000-0001-8119-9485 |\n| Bo Wang | bo.wang@uhn.ca | Canada Research Chair, Assistant Professor, U of T; Vector Institute Faculty Affiliate | 0000-0002-9620-3413 |\n\nPaper: xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Jing Gong | gongjing@biomap.com | Researcher, BioMap Research (per author affiliations) | Not found |\n| Le Song | songle@biomap.com | Professor, MBZUAI; CTO, GenBio AI | 0000-0003-0345-9899 |\n| Xingyi Cheng | xingyi@biomap.com | Principal Researcher, BioMap (per OpenReview profile) | 0009-0002-6403-048X |\n\nPaper: A single-cell gene expression language model (Exceiver)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| William Connell | Not found | Graduate researcher, Keiser Lab, UCSF (per lab page) | Not found |\n| Michael J. Keiser | Not found | Not found | Not found |\n\nPaper: Learning single-cell perturbation responses using neural optimal transport (CellOT)\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Charlotte Bunne | Not found | Not found | Not found |\n| Gunnar Rtsch | gunnar.raetsch@inf.ethz.ch | Not found | Not found |\n\nPaper: scGen predicts single-cell perturbation responses\n| Name | Email | Role | ORCID |\n| --- | --- | --- | --- |\n| Mohammad Lotfollahi | Not found | Not found | 0000-0001-6858-7985 |\n| Fabian J. Theis | Not found | Not found | 0000-0002-2419-1943 |",
        "structured": {
          "papers": [
            {
              "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
              "identifier": "Source",
              "authors": [
                {
                  "name": "Syed Asad Rizvi",
                  "email": "syed.rizvi@yale.edu",
                  "role": "PhD Student, Yale University, Computer Science",
                  "orcid": null,
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=3nspJ4QAAAAJ"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://syedarizvi.com"
                    }
                  ]
                },
                {
                  "name": "David van Dijk",
                  "email": null,
                  "role": "Faculty, Yale School of Medicine; Corresponding author on this paper",
                  "orcid": "0000-0003-3911-9925",
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://vandijklab.org"
                    }
                  ]
                }
              ]
            },
            {
              "title": "scGPT: toward building a foundation model for single-cell multi-omics using generative AI",
              "identifier": null,
              "authors": [
                {
                  "name": "Haotian Cui",
                  "email": null,
                  "role": null,
                  "orcid": "0000-0001-8119-9485",
                  "profiles": []
                },
                {
                  "name": "Bo Wang",
                  "email": "bo.wang@uhn.ca",
                  "role": "Canada Research Chair, Assistant Professor, U of T; Vector Institute Faculty Affiliate",
                  "orcid": "0000-0002-9620-3413",
                  "profiles": []
                }
              ]
            },
            {
              "title": "xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data",
              "identifier": null,
              "authors": [
                {
                  "name": "Jing Gong",
                  "email": "gongjing@biomap.com",
                  "role": "Researcher, BioMap Research (per author affiliations)",
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Le Song",
                  "email": "songle@biomap.com",
                  "role": "Professor, MBZUAI; CTO, GenBio AI",
                  "orcid": "0000-0003-0345-9899",
                  "profiles": [
                    {
                      "platform": "Google Scholar",
                      "url": "https://scholar.google.com/citations?user=OQqQLbMAAAAJ"
                    },
                    {
                      "platform": "Personal Website",
                      "url": "https://dasongle.github.io"
                    }
                  ]
                },
                {
                  "name": "Xingyi Cheng",
                  "email": "xingyi@biomap.com",
                  "role": "Principal Researcher, BioMap (per OpenReview profile)",
                  "orcid": "0009-0002-6403-048X",
                  "profiles": []
                }
              ]
            },
            {
              "title": "A single-cell gene expression language model (Exceiver)",
              "identifier": null,
              "authors": [
                {
                  "name": "William Connell",
                  "email": null,
                  "role": "Graduate researcher, Keiser Lab, UCSF (per lab page)",
                  "orcid": null,
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://wconnell.github.io/research"
                    }
                  ]
                },
                {
                  "name": "Michael J. Keiser",
                  "email": null,
                  "role": null,
                  "orcid": null,
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://keiserlab.org"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Learning single-cell perturbation responses using neural optimal transport (CellOT)",
              "identifier": null,
              "authors": [
                {
                  "name": "Charlotte Bunne",
                  "email": null,
                  "role": null,
                  "orcid": null,
                  "profiles": []
                },
                {
                  "name": "Gunnar Rtsch",
                  "email": "gunnar.raetsch@inf.ethz.ch",
                  "role": null,
                  "orcid": null,
                  "profiles": []
                }
              ]
            },
            {
              "title": "scGen predicts single-cell perturbation responses",
              "identifier": null,
              "authors": [
                {
                  "name": "Mohammad Lotfollahi",
                  "email": null,
                  "role": null,
                  "orcid": "0000-0001-6858-7985",
                  "profiles": [
                    {
                      "platform": "Personal Website",
                      "url": "https://m0hammadl.github.io/publication/scgen"
                    }
                  ]
                },
                {
                  "name": "Fabian J. Theis",
                  "email": null,
                  "role": null,
                  "orcid": "0000-0002-2419-1943",
                  "profiles": []
                }
              ]
            }
          ],
          "promptNotes": "Converted strictly from analyst notes. Unknown fields set to null."
        }
      },
      "researcherTheses": {
        "maxChars": 6053,
        "truncated": false,
        "text": "Researcher: Syed Asad Rizvi\nEmail: [syed.rizvi@yale.edu](mailto:syed.rizvi@yale.edu)\nData publicly available: yes\nLatest publication:\n  - Title: BrainLM: A foundation model for brain activity recordings\n  - Year: 2024\n  - Venue: ICLR 2024\n  - URL: https://openreview.net/pdf?id=RwI7ZEfR27\nPhD thesis: Not found\n\nResearcher: David van Dijk\nEmail: [david.vandijk@yale.edu](mailto:david.vandijk@yale.edu)\nData publicly available: yes\nLatest publication:\n  - Title: Intelligence at the Edge of Chaos\n  - Year: 2025\n  - Venue: ICLR 2025\n  - URL: https://arxiv.org/abs/2410.02536\nPhD thesis:\n  - Title: The Symphony of Gene Regulation\n  - Year: 2013\n  - Institution: University of Amsterdam\n  - URL: https://pure.uva.nl/ws/files/1692458/126481_02.pdf\n\nResearcher: Haotian Cui\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: scGPT: toward building a foundation model for single-cell multi-omics using generative AI\n  - Year: 2024\n  - Venue: Nature Methods\n  - URL: https://www.nature.com/articles/s41592-024-02201-0.pdf\nPhD thesis:\n  - Title: Foundation Model for Single-Cell Omics\n  - Year: 2024\n  - Institution: University of Toronto\n  - URL: https://utoronto.scholaris.ca/items/6a05cbf8-663b-4c27-b82e-4e799aa4d0dd/full\n\nResearcher: Bo Wang\nEmail: [bo.wang@uhn.ca](mailto:bo.wang@uhn.ca)\nData publicly available: yes\nLatest publication:\n  - Title: scGPT: toward building a foundation model for single-cell multi-omics using generative AI\n  - Year: 2024\n  - Venue: Nature Methods\n  - URL: https://www.nature.com/articles/s41592-024-02201-0.pdf\nPhD thesis:\n  - Title: Visualization and analysis of single-cell RNA-seq data by kernel-based similarity learning\n  - Year: 2017\n  - Institution: Stanford University\n  - URL: https://purl.stanford.edu/cc855fh0112\n\nResearcher: Jing Gong\nEmail: [gongjing@biomap.com](mailto:gongjing@biomap.com)\nData publicly available: yes\nLatest publication:\n  - Title: Training Compute-Optimal Protein Language Models\n  - Year: 2024\n  - Venue: NeurIPS 2024\n  - URL: https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf\nPhD thesis:\n  - Title: RNA\n  - Year: 2020\n  - Institution: Tsinghua University, School of Life Sciences\n  - URL: https://newetds.lib.tsinghua.edu.cn/qh/paper/summary?dbCode=ETDQH&sysId=264093\n\nResearcher: Le Song\nEmail: [songle@biomap.com](mailto:songle@biomap.com)\nData publicly available: yes\nLatest publication:\n  - Title: Training Compute-Optimal Protein Language Models\n  - Year: 2024\n  - Venue: NeurIPS 2024\n  - URL: https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf\nPhD thesis: Not found\n\nResearcher: Xingyi Cheng\nEmail: [xingyi@biomap.com](mailto:xingyi@biomap.com)\nData publicly available: yes\nLatest publication:\n  - Title: Training Compute-Optimal Protein Language Models\n  - Year: 2024\n  - Venue: NeurIPS 2024\n  - URL: https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf\nPhD thesis: Not found\n\nResearcher: William Thomas Connell\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Learning chemical sensitivity reveals mechanisms of cellular response\n  - Year: 2024\n  - Venue: Communications Biology\n  - URL: https://www.nature.com/articles/s42003-024-06865-4.pdf\nPhD thesis:\n  - Title: Learning Chemical Sensitivity to Understand Disease Mechanisms\n  - Year: 2022\n  - Institution: University of California, San Francisco\n  - URL: https://escholarship.org/uc/item/0321d4q3\n\nResearcher: Michael James Keiser\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Retrieval Augmented Docking Using Hierarchical Navigable Small Worlds\n  - Year: 2024\n  - Venue: Journal of Chemical Information and Modeling\n  - URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jcim.4c00683\nPhD thesis:\n  - Title: Relating protein pharmacology by ligand chemistry\n  - Year: 2009\n  - Institution: University of California, San Francisco\n  - URL: https://escholarship.org/uc/item/5vp5h8g4\n\nResearcher: Charlotte Bunne\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Learning single-cell perturbation responses using neural optimal transport\n  - Year: 2023\n  - Venue: Nature Methods\n  - URL: https://www.nature.com/articles/s41592-023-01969-x.pdf\nPhD thesis:\n  - Title: Neural Optimal Transport for Dynamical Systems\n  - Year: 2023\n  - Institution: ETH Zrich\n  - URL: https://www.research-collection.ethz.ch/bitstream/handle/20.500.11850/633762/thesis_bunnech.pdf\n\nResearcher: Gunnar Rtsch\nEmail: [gunnar.raetsch@inf.ethz.ch](mailto:gunnar.raetsch@inf.ethz.ch)\nData publicly available: yes\nLatest publication:\n  - Title: Efficient and accurate search in petabase-scale sequence repositories\n  - Year: 2025\n  - Venue: Nature\n  - URL: https://www.nature.com/articles/s41586-025-09603-w.pdf\nPhD thesis:\n  - Title: Robust Boosting via Convex Optimization: Theory and Applications\n  - Year: 2001\n  - Institution: Universitt Potsdam\n  - URL: https://publishup.uni-potsdam.de/opus4-ubp/files/40/raetsch.pdf\n\nResearcher: Mohammad Lotfollahi\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Toward learning a foundational representation of cells and genes\n  - Year: 2024\n  - Venue: Nature Methods\n  - URL: https://www.nature.com/articles/s41592-024-02367-7.pdf\nPhD thesis:\n  - Title: Modeling single-cell perturbations using deep learning\n  - Year: 2022\n  - Institution: Technical University of Munich (TUM), School of Life Sciences\n  - URL: https://mediatum.ub.tum.de/1631269\n\nResearcher: Fabian J. Theis\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Deep generative modeling of transcriptional dynamics for RNA velocity analysis in single cells\n  - Year: 2024\n  - Venue: Nature Methods\n  - URL: https://doi.org/10.1038/s41592-023-01994-w\nPhD thesis:\n  - Title: Geometric Source Separation: Algorithms and Applications\n  - Year: 2003\n  - Institution: Universidad de Granada\n  - URL: https://d-nb.info/1174513586",
        "structured": {
          "researchers": [
            {
              "name": "Syed Asad Rizvi",
              "email": "[syed.rizvi@yale.edu](mailto:syed.rizvi@yale.edu)",
              "latest_publication": {
                "title": "BrainLM: A foundation model for brain activity recordings",
                "year": 2024,
                "venue": "ICLR 2024",
                "url": "https://openreview.net/pdf?id=RwI7ZEfR27"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "David van Dijk",
              "email": "[david.vandijk@yale.edu](mailto:david.vandijk@yale.edu)",
              "latest_publication": {
                "title": "Intelligence at the Edge of Chaos",
                "year": 2025,
                "venue": "ICLR 2025",
                "url": "https://arxiv.org/abs/2410.02536"
              },
              "phd_thesis": {
                "title": "The Symphony of Gene Regulation",
                "year": 2013,
                "institution": "University of Amsterdam",
                "url": "https://pure.uva.nl/ws/files/1692458/126481_02.pdf"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Haotian Cui",
              "email": null,
              "latest_publication": {
                "title": "scGPT: toward building a foundation model for single-cell multi-omics using generative AI",
                "year": 2024,
                "venue": "Nature Methods",
                "url": "https://www.nature.com/articles/s41592-024-02201-0.pdf"
              },
              "phd_thesis": {
                "title": "Foundation Model for Single-Cell Omics",
                "year": 2024,
                "institution": "University of Toronto",
                "url": "https://utoronto.scholaris.ca/items/6a05cbf8-663b-4c27-b82e-4e799aa4d0dd/full"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Bo Wang",
              "email": "[bo.wang@uhn.ca](mailto:bo.wang@uhn.ca)",
              "latest_publication": {
                "title": "scGPT: toward building a foundation model for single-cell multi-omics using generative AI",
                "year": 2024,
                "venue": "Nature Methods",
                "url": "https://www.nature.com/articles/s41592-024-02201-0.pdf"
              },
              "phd_thesis": {
                "title": "Visualization and analysis of single-cell RNA-seq data by kernel-based similarity learning",
                "year": 2017,
                "institution": "Stanford University",
                "url": "https://purl.stanford.edu/cc855fh0112"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Jing Gong",
              "email": "[gongjing@biomap.com](mailto:gongjing@biomap.com)",
              "latest_publication": {
                "title": "Training Compute-Optimal Protein Language Models",
                "year": 2024,
                "venue": "NeurIPS 2024",
                "url": "https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf"
              },
              "phd_thesis": {
                "title": "RNA",
                "year": 2020,
                "institution": "Tsinghua University, School of Life Sciences",
                "url": "https://newetds.lib.tsinghua.edu.cn/qh/paper/summary?dbCode=ETDQH&sysId=264093"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Le Song",
              "email": "[songle@biomap.com](mailto:songle@biomap.com)",
              "latest_publication": {
                "title": "Training Compute-Optimal Protein Language Models",
                "year": 2024,
                "venue": "NeurIPS 2024",
                "url": "https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "Xingyi Cheng",
              "email": "[xingyi@biomap.com](mailto:xingyi@biomap.com)",
              "latest_publication": {
                "title": "Training Compute-Optimal Protein Language Models",
                "year": 2024,
                "venue": "NeurIPS 2024",
                "url": "https://keg.cs.tsinghua.edu.cn/jietang/publications/NeurIPS24-Cheng-et-al-ProteinLLM.pdf"
              },
              "phd_thesis": null,
              "data_publicly_available": "yes"
            },
            {
              "name": "William Thomas Connell",
              "email": null,
              "latest_publication": {
                "title": "Learning chemical sensitivity reveals mechanisms of cellular response",
                "year": 2024,
                "venue": "Communications Biology",
                "url": "https://www.nature.com/articles/s42003-024-06865-4.pdf"
              },
              "phd_thesis": {
                "title": "Learning Chemical Sensitivity to Understand Disease Mechanisms",
                "year": 2022,
                "institution": "University of California, San Francisco",
                "url": "https://escholarship.org/uc/item/0321d4q3"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Michael James Keiser",
              "email": null,
              "latest_publication": {
                "title": "Retrieval Augmented Docking Using Hierarchical Navigable Small Worlds",
                "year": 2024,
                "venue": "Journal of Chemical Information and Modeling",
                "url": "https://pubs.acs.org/doi/pdf/10.1021/acs.jcim.4c00683"
              },
              "phd_thesis": {
                "title": "Relating protein pharmacology by ligand chemistry",
                "year": 2009,
                "institution": "University of California, San Francisco",
                "url": "https://escholarship.org/uc/item/5vp5h8g4"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Charlotte Bunne",
              "email": null,
              "latest_publication": {
                "title": "Learning single-cell perturbation responses using neural optimal transport",
                "year": 2023,
                "venue": "Nature Methods",
                "url": "https://www.nature.com/articles/s41592-023-01969-x.pdf"
              },
              "phd_thesis": {
                "title": "Neural Optimal Transport for Dynamical Systems",
                "year": 2023,
                "institution": "ETH Zrich",
                "url": "https://www.research-collection.ethz.ch/bitstream/handle/20.500.11850/633762/thesis_bunnech.pdf"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Gunnar Rtsch",
              "email": "[gunnar.raetsch@inf.ethz.ch](mailto:gunnar.raetsch@inf.ethz.ch)",
              "latest_publication": {
                "title": "Efficient and accurate search in petabase-scale sequence repositories",
                "year": 2025,
                "venue": "Nature",
                "url": "https://www.nature.com/articles/s41586-025-09603-w.pdf"
              },
              "phd_thesis": {
                "title": "Robust Boosting via Convex Optimization: Theory and Applications",
                "year": 2001,
                "institution": "Universitt Potsdam",
                "url": "https://publishup.uni-potsdam.de/opus4-ubp/files/40/raetsch.pdf"
              },
              "data_publicly_available": "yes"
            },
            {
              "name": "Mohammad Lotfollahi",
              "email": null,
              "latest_publication": {
                "title": "Toward learning a foundational representation of cells and genes",
                "year": 2024,
                "venue": "Nature Methods",
                "url": "https://www.nature.com/articles/s41592-024-02367-7.pdf"
              },
              "phd_thesis": {
                "title": "Modeling single-cell perturbations using deep learning",
                "year": 2022,
                "institution": "Technical University of Munich (TUM), School of Life Sciences",
                "url": "https://mediatum.ub.tum.de/1631269"
              },
              "data_publicly_available": "unknown"
            },
            {
              "name": "Fabian J. Theis",
              "email": null,
              "latest_publication": {
                "title": "Deep generative modeling of transcriptional dynamics for RNA velocity analysis in single cells",
                "year": 2024,
                "venue": "Nature Methods",
                "url": "https://doi.org/10.1038/s41592-023-01994-w"
              },
              "phd_thesis": {
                "title": "Geometric Source Separation: Algorithms and Applications",
                "year": 2003,
                "institution": "Universidad de Granada",
                "url": "https://d-nb.info/1174513586"
              },
              "data_publicly_available": "unknown"
            }
          ],
          "promptNotes": "Compiled from all thesis discovery responses in this thread."
        }
      },
      "patents": {
        "text": "Patent: US20240386990A1\nTitle: Predicting cellular responses to perturbations\nAssignee: Insitro Inc\nFiling Date: 2024-05-17\nGrant Date: Not provided\nAbstract: Discloses generative machine-learning methods that model a cell's basal state and apply sparse latent treatment offsets to predict single- or multi-perturbation responses.\nOverlaps with paper claims: C2\nTechnical overlap: The claims teach disentangled latent representations for cells and perturbations, combining a basal embedding with a treatment mask and vector to predict post-perturbation states as sparse latent offsets. This closely matches the paper's perturbation-prediction framework and benchmarks (e.g., scFID, MMD, Wasserstein) that assess accuracy under chemical and genetic perturbations, validating the paper's approach of scaling model capacity for improved out-of-distribution prediction.\n\nPatent: US20240203531A1\nTitle: Cell type annotation\nAssignee: Illumina Inc (current); Fluent Biosciences Inc (original)\nFiling Date: 2023-12-19\nGrant Date: Not provided\nAbstract: Methods for annotating cell types from single-cell RNA sequencing using non-parametric differential expression scoring and correlation to annotated references, designed for high-throughput workflows.\nOverlaps with paper claims: C1\nTechnical overlap: The patent claims automated, scalable pipelines for cell-type labelling from single-cell data, overlapping the paper's multi-task evaluation where C2S performs or matches specialised models on cell-type annotation. Both address robust classification across diverse datasets; the patent's reference-based scoring complements the paper's LLM-style modelling while validating the same core task domain.\n\nPatent: WO2016050203A1\nTitle: Use of inhibiting activity of casein kinase 2 to enhance expression of type I interferon and interferon-induced genes\nAssignee: Not provided\nFiling Date: Not provided\nGrant Date: Not provided\nAbstract: Claims therapeutic use of CK2 inhibitors to enhance expression of type I interferon and interferon-stimulated genes.\nOverlaps with paper claims: C3\nTechnical overlap: By asserting that CK2 inhibition elevates interferon signalling and downstream gene expression, the patent aligns mechanistically with the paper's finding that the CK2 inhibitor silmitasertib acts as an interferon-conditional amplifier of MHC-I antigen presentation. This independent IP on the CK2-IFN axis provides validation for the biological mechanism exploited by the paper's virtual screen and experimental flow-cytometry results.\n\nPatent: WO2017070137A1\nTitle: Combination of CK2 inhibitors and immune checkpoint modulators for treatment of proliferative disorders\nAssignee: Not provided\nFiling Date: Not provided\nGrant Date: Not provided\nAbstract: Teaches combining CK2 inhibitors with PD-1/CTLA-4 checkpoint modulators based on immune-modulatory effects of CK2 blockade.\nOverlaps with paper claims: C3\nTechnical overlap: The claimed therapeutic synergy relies on CK2 inhibition increasing tumour immunogenicity, consistent with the paper's observation that CK2 blockade elevates MHC-I antigen presentation under low-level interferon. This supports the translational significance of the paper's interferon-conditional amplification effect within independently claimed immuno-oncology strategies.\n\nPatent: US10227344B2\nTitle: CK2 inhibitors, compositions and methods thereof\nAssignee: Polaris Pharmaceuticals, Inc.\nFiling Date: Not provided\nGrant Date: 2019-03-12\nAbstract: Claims CK2 inhibitor chemotypes, pharmaceutical compositions, and therapeutic methods for proliferative diseases.\nOverlaps with paper claims: C3\nTechnical overlap: The paper's hit compound silmitasertib is a CK2 inhibitor; this granted patent secures composition-of-matter and therapeutic claims for the CK2 inhibitor class used in the paper's validation experiments. The overlap in target class and intended oncology use provides independent IP evidence that CK2 blockade is a viable route to modulate tumour cell biology in ways consistent with enhanced antigen presentation.",
        "structured": {
          "patents": [
            {
              "patentNumber": "US20240386990A1",
              "title": "Predicting cellular responses to perturbations",
              "assignee": "Insitro Inc",
              "filingDate": "2024-05-17",
              "grantDate": null,
              "abstract": "Discloses generative machine-learning methods that model a cell's basal state and apply sparse latent treatment offsets to predict single- or multi-perturbation responses.",
              "overlapWithPaper": {
                "claimIds": [
                  "C2"
                ],
                "summary": "The claims teach disentangled latent representations for cells and perturbations, combining a basal embedding with a treatment mask and vector to predict post-perturbation states as sparse latent offsets. This closely matches the paper's perturbation-prediction framework and benchmarks (e.g., scFID, MMD, Wasserstein) that assess accuracy under chemical and genetic perturbations, validating the paper's approach of scaling model capacity for improved out-of-distribution prediction."
              },
              "url": null
            },
            {
              "patentNumber": "US20240203531A1",
              "title": "Cell type annotation",
              "assignee": "Illumina Inc (current); Fluent Biosciences Inc (original)",
              "filingDate": "2023-12-19",
              "grantDate": null,
              "abstract": "Methods for annotating cell types from single-cell RNA sequencing using non-parametric differential expression scoring and correlation to annotated references, designed for high-throughput workflows.",
              "overlapWithPaper": {
                "claimIds": [
                  "C1"
                ],
                "summary": "The patent claims automated, scalable pipelines for cell-type labelling from single-cell data, overlapping the paper's multi-task evaluation where C2S performs or matches specialised models on cell-type annotation. Both address robust classification across diverse datasets; the patent's reference-based scoring complements the paper's LLM-style modelling while validating the same core task domain."
              },
              "url": null
            },
            {
              "patentNumber": "WO2016050203A1",
              "title": "Use of inhibiting activity of casein kinase 2 to enhance expression of type I interferon and interferon-induced genes",
              "assignee": null,
              "filingDate": null,
              "grantDate": null,
              "abstract": "Claims therapeutic use of CK2 inhibitors to enhance expression of type I interferon and interferon-stimulated genes.",
              "overlapWithPaper": {
                "claimIds": [
                  "C3"
                ],
                "summary": "By asserting that CK2 inhibition elevates interferon signalling and downstream gene expression, the patent aligns mechanistically with the paper's finding that the CK2 inhibitor silmitasertib acts as an interferon-conditional amplifier of MHC-I antigen presentation. This independent IP on the CK2-IFN axis provides validation for the biological mechanism exploited by the paper's virtual screen and experimental flow-cytometry results."
              },
              "url": null
            },
            {
              "patentNumber": "WO2017070137A1",
              "title": "Combination of CK2 inhibitors and immune checkpoint modulators for treatment of proliferative disorders",
              "assignee": null,
              "filingDate": null,
              "grantDate": null,
              "abstract": "Teaches combining CK2 inhibitors with PD-1/CTLA-4 checkpoint modulators based on immune-modulatory effects of CK2 blockade.",
              "overlapWithPaper": {
                "claimIds": [
                  "C3"
                ],
                "summary": "The claimed therapeutic synergy relies on CK2 inhibition increasing tumour immunogenicity, consistent with the paper's observation that CK2 blockade elevates MHC-I antigen presentation under low-level interferon. This supports the translational significance of the paper's interferon-conditional amplification effect within independently claimed immuno-oncology strategies."
              },
              "url": null
            },
            {
              "patentNumber": "US10227344B2",
              "title": "CK2 inhibitors, compositions and methods thereof",
              "assignee": "Polaris Pharmaceuticals, Inc.",
              "filingDate": null,
              "grantDate": "2019-03-12",
              "abstract": "Claims CK2 inhibitor chemotypes, pharmaceutical compositions, and therapeutic methods for proliferative diseases.",
              "overlapWithPaper": {
                "claimIds": [
                  "C3"
                ],
                "summary": "The paper's hit compound silmitasertib is a CK2 inhibitor; this granted patent secures composition-of-matter and therapeutic claims for the CK2 inhibitor class used in the paper's validation experiments. The overlap in target class and intended oncology use provides independent IP evidence that CK2 blockade is a viable route to modulate tumour cell biology in ways consistent with enhanced antigen presentation."
              },
              "url": null
            }
          ],
          "promptNotes": "Converted from analyst notes; unknown fields set to null; URLs standardised to Google Patents."
        }
      },
      "verifiedClaims": {
        "text": "=== OVERALL ASSESSMENT ===\nAcross claims, the strongest support comes from the preprint's internal results and released code, with convergent literature on scalable single-cell Transformers and perturbation modelling. The silmitasertib finding benefits from non-peer-reviewed corroboration and mechanistic patents. Key gaps remain: no third-party replication of multi-task superiority or GRPO gains, limited community validation for the new scFID metric, and sparse public quantitative details for the interferon-conditional experiments; accordingly all three claims are Partially Verified with moderate confidence.\n\n=== VERIFIED CLAIMS ===\n\nClaim: C1\nOriginal: C2S-Scale outperforms or matches specialised single-cell models and general LLMs across predictive, generative, and natural-language single-cell tasks.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] scGPT: toward building a foundation model for single-cell multi-omics using generative AI\n    Establishes strong foundation-model baselines across annotation, integration, and perturbation tasks; provides comparators overlapping C2S-Scale benchmarks but is not an external replication of C2S-Scale.\n  - [Similar Paper] xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data\n    Demonstrates scalable Transformer pretraining for scRNA-seq with gains across tasks, supporting that single-cell Transformers can be competitive on annotation and perturbation.\n  - [Similar Paper] A single-cell gene expression language model (Exceiver)\n    Earlier language-model framing for single-cell data with set-like tokenisation; conceptually aligns with cell-as-text representation but does not benchmark against C2S-Scale.\n  - [Research Group] Scaling Large Language Models for Next-Generation Single-Cell Analysis\n    Internal multi-task benchmarking reports matching or surpassing scGPT and Geneformer on annotation and embeddings, and better natural-language interpretation and QA vs general LLMs, including an immune dataset annotation accuracy of 95.43 percent.\n  - [Research Group] Cell2Sentence GitHub repository\n    Implementation and resources released, enabling some level of reproducibility.\n\nContradicting Evidence:\n  - [Similar Paper] Independent community benchmarks\n    Large, independent benchmarks show method ranking varies by dataset and metric, cautioning against blanket superiority claims; not specific to C2S-Scale.\n\nSummary: The preprint reports that C2S-Scale matches or exceeds scGPT and Geneformer on standard predictive tasks and clearly beats general LLMs on natural-language single-cell tasks, with code released. Independent cross-group replication and exact metrics such as the stated 95.43 percent immune annotation accuracy have not been externally verified, and broad benchmarks caution that winners depend on task and dataset.\n\nClaim: C2\nOriginal: Scaling model and data size improves performance, and GRPO reinforcement learning further boosts perturbation predictions.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Research Group] Scaling Large Language Models for Next-Generation Single-Cell Analysis\n    Reported improvements from 410M to 27B parameters and with more data, including LoRA regimes, across predictive and generative tasks.\n  - [Research Group] Scaling Large Language Models for Next-Generation Single-Cell Analysis\n    GRPO reinforcement learning described for QA and perturbation prediction, with lower scFID, MMD, and Wasserstein than scGen, scGPT, and CellOT on stated benchmarks; reports a 16 percent scFID reduction on interferon genes and gains on L1000.\n  - [Similar Paper] xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data\n    Independently observes that larger model sizes improve performance on single-cell tasks, supporting the scaling component.\n  - [Similar Paper] scGen predicts single-cell perturbation responses\n    Provides a canonical perturbation-prediction baseline and evaluation framing used by later work.\n  - [Similar Paper] Learning single-cell perturbation responses using neural optimal transport (CellOT)\n    Provides a modern perturbation-prediction comparator using distributional metrics such as MMD and Wasserstein.\n  - [Patent] US20240386990A1: Predicting cellular responses to perturbations\n    Teaches latent-space disentanglement and additive offsets for predicting perturbation responses, aligning with the premise that richer models and learned latent manipulations can improve out-of-distribution prediction.\n\nContradicting Evidence:\n  - [Similar Paper] Independent community benchmarks\n    Studies emphasise inconsistent generalisation and lack of a single dominant method, tempering universal claims.\n\nSummary: Internal evidence shows clear scaling gains and GRPO improvements on perturbation metrics including scFID, MMD, and Wasserstein. External literature supports the scaling portion, but independent confirmation of GRPO's specific boost for perturbation prediction in this domain has not yet appeared.\n\nClaim: C3\nOriginal: A virtual screen identifies silmitasertib as an interferon-conditional amplifier of antigen presentation, validated experimentally in two unseen human cell models.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Research Group] Scaling Large Language Models for Next-Generation Single-Cell Analysis\n    Describes a dual-context virtual screen yielding silmitasertib as an interferon-conditional amplifier of antigen presentation with wet-lab validation.\n  - [Research Group] Google Research blog on C2S-Scale interferon-conditional amplifier\n    Reports that silmitasertib alone had no effect but combined with low-dose interferon markedly increased MHC-I in an unseen neuroendocrine model and replicated in a pulmonary model.\n  - [Patent] WO2016050203A1: Use of inhibiting casein kinase 2 to enhance type I interferon and interferon-induced genes\n    Asserts CK2 inhibition elevates interferon signalling and downstream gene expression, providing mechanistic support for an interferon-conditional MHC-I increase.\n  - [Patent] WO2017070137A1: Combination of CK2 inhibitors and immune checkpoint modulators for proliferative disorders\n    Claims therapeutic synergy relying on increased tumour immunogenicity from CK2 inhibition, consistent with interferon-conditioned amplification of antigen presentation.\n  - [Patent] US10227344B2: CK2 inhibitors, compositions and methods thereof\n    Covers composition and therapeutic use of CK2 inhibitors including silmitasertib, supporting the feasibility of modulating tumour cell biology relevant to antigen presentation.\n\nSummary: Independent communications and the preprint align that silmitasertib amplifies MHC-I only with low-level interferon, and patents provide a plausible CK2-interferon mechanism. Peer-reviewed third-party replication and fuller quantitative flow-cytometry details are still pending.\n",
        "structured": {
          "claims": [
            {
              "claimId": "C1",
              "originalClaim": "C2S-Scale outperforms or matches specialised single-cell models and general LLMs across predictive, generative, and natural-language single-cell tasks.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "scGPT: toward building a foundation model for single-cell multi-omics using generative AI",
                  "relevance": "Establishes strong foundation-model baselines across annotation, integration, and perturbation tasks; provides comparators overlapping C2S-Scale benchmarks but is not an external replication of C2S-Scale."
                },
                {
                  "source": "Similar Paper",
                  "title": "xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data",
                  "relevance": "Demonstrates scalable Transformer pretraining for scRNA-seq with gains across tasks, supporting that single-cell Transformers can be competitive on annotation and perturbation."
                },
                {
                  "source": "Similar Paper",
                  "title": "A single-cell gene expression language model (Exceiver)",
                  "relevance": "Earlier language-model framing for single-cell data with set-like tokenisation; conceptually aligns with cell-as-text representation but does not benchmark against C2S-Scale."
                },
                {
                  "source": "Research Group",
                  "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
                  "relevance": "Internal multi-task benchmarking reports matching or surpassing scGPT and Geneformer on annotation and embeddings, and better natural-language interpretation and QA vs general LLMs, including an immune dataset annotation accuracy of 95.43 percent."
                },
                {
                  "source": "Research Group",
                  "title": "Cell2Sentence GitHub repository",
                  "relevance": "Implementation and resources released, enabling some level of reproducibility."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Independent community benchmarks",
                  "relevance": "Large, independent benchmarks show method ranking varies by dataset and metric, cautioning against blanket superiority claims; not specific to C2S-Scale."
                }
              ],
              "verificationSummary": "The preprint reports that C2S-Scale matches or exceeds scGPT and Geneformer on standard predictive tasks and clearly beats general LLMs on natural-language single-cell tasks, with code released. Independent cross-group replication and exact metrics such as the stated 95.43 percent immune annotation accuracy have not been externally verified, and broad benchmarks caution that winners depend on task and dataset.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C2",
              "originalClaim": "Scaling model and data size improves performance, and GRPO reinforcement learning further boosts perturbation predictions.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Research Group",
                  "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
                  "relevance": "Reported improvements from 410M to 27B parameters and with more data, including LoRA regimes, across predictive and generative tasks."
                },
                {
                  "source": "Research Group",
                  "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
                  "relevance": "GRPO reinforcement learning described for QA and perturbation prediction, with lower scFID, MMD, and Wasserstein than scGen, scGPT, and CellOT on stated benchmarks; reports a 16 percent scFID reduction on interferon genes and gains on L1000."
                },
                {
                  "source": "Similar Paper",
                  "title": "xTrimoGene: An Efficient and Scalable Representation Learner for Single-Cell RNA-seq Data",
                  "relevance": "Independently observes that larger model sizes improve performance on single-cell tasks, supporting the scaling component."
                },
                {
                  "source": "Similar Paper",
                  "title": "scGen predicts single-cell perturbation responses",
                  "relevance": "Provides a canonical perturbation-prediction baseline and evaluation framing used by later work."
                },
                {
                  "source": "Similar Paper",
                  "title": "Learning single-cell perturbation responses using neural optimal transport (CellOT)",
                  "relevance": "Provides a modern perturbation-prediction comparator using distributional metrics such as MMD and Wasserstein."
                },
                {
                  "source": "Patent",
                  "title": "US20240386990A1: Predicting cellular responses to perturbations",
                  "relevance": "Teaches latent-space disentanglement and additive offsets for predicting perturbation responses, aligning with the premise that richer models and learned latent manipulations can improve out-of-distribution prediction."
                }
              ],
              "contradictingEvidence": [
                {
                  "source": "Similar Paper",
                  "title": "Independent community benchmarks",
                  "relevance": "Studies emphasise inconsistent generalisation and lack of a single dominant method, tempering universal claims."
                }
              ],
              "verificationSummary": "Internal evidence shows clear scaling gains and GRPO improvements on perturbation metrics including scFID, MMD, and Wasserstein. External literature supports the scaling portion, but independent confirmation of GRPO's specific boost for perturbation prediction in this domain has not yet appeared.",
              "confidenceLevel": "Moderate"
            },
            {
              "claimId": "C3",
              "originalClaim": "A virtual screen identifies silmitasertib as an interferon-conditional amplifier of antigen presentation, validated experimentally in two unseen human cell models.",
              "verificationStatus": "Partially Verified",
              "supportingEvidence": [
                {
                  "source": "Research Group",
                  "title": "Scaling Large Language Models for Next-Generation Single-Cell Analysis",
                  "relevance": "Describes a dual-context virtual screen yielding silmitasertib as an interferon-conditional amplifier of antigen presentation with wet-lab validation."
                },
                {
                  "source": "Research Group",
                  "title": "Google Research blog on C2S-Scale interferon-conditional amplifier",
                  "relevance": "Reports that silmitasertib alone had no effect but combined with low-dose interferon markedly increased MHC-I in an unseen neuroendocrine model and replicated in a pulmonary model."
                },
                {
                  "source": "Patent",
                  "title": "WO2016050203A1: Use of inhibiting casein kinase 2 to enhance type I interferon and interferon-induced genes",
                  "relevance": "Asserts CK2 inhibition elevates interferon signalling and downstream gene expression, providing mechanistic support for an interferon-conditional MHC-I increase."
                },
                {
                  "source": "Patent",
                  "title": "WO2017070137A1: Combination of CK2 inhibitors and immune checkpoint modulators for proliferative disorders",
                  "relevance": "Claims therapeutic synergy relying on increased tumour immunogenicity from CK2 inhibition, consistent with interferon-conditioned amplification of antigen presentation."
                },
                {
                  "source": "Patent",
                  "title": "US10227344B2: CK2 inhibitors, compositions and methods thereof",
                  "relevance": "Covers composition and therapeutic use of CK2 inhibitors including silmitasertib, supporting the feasibility of modulating tumour cell biology relevant to antigen presentation."
                }
              ],
              "contradictingEvidence": [],
              "verificationSummary": "Independent communications and the preprint align that silmitasertib amplifies MHC-I only with low-level interferon, and patents provide a plausible CK2-interferon mechanism. Peer-reviewed third-party replication and fuller quantitative flow-cytometry details are still pending.",
              "confidenceLevel": "Moderate"
            }
          ],
          "overallAssessment": "Across claims, the strongest support comes from the preprint's internal results and released code, with convergent literature on scalable single-cell Transformers and perturbation modelling. The silmitasertib finding benefits from non-peer-reviewed corroboration and mechanistic patents. Key gaps remain: no third-party replication of multi-task superiority or GRPO gains, limited community validation for the new scFID metric, and sparse public quantitative details for the interferon-conditional experiments; accordingly all three claims are Partially Verified with moderate confidence.",
          "promptNotes": "Most supporting results originate from the authors' own preprint and communications; independent replications are not yet available. The scFID metric is new and not widely benchmarked. Blog posts and press releases are not peer-reviewed sources and were treated as Research Group communications."
        }
      }
    }
  ]
} as const;
